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Abstract
Modulation of gene expression by small molecules is a challenge in the field of 
chemical biology.  Hairpin pyrrole-imidazole polyamides are a class of programmable 
small molecules that bind to the minor groove of DNA, and have been shown to inhibit 
gene expression by interfering with transcription factor-DNA interfaces.  When considering 
the biological implications of these molecules, improvement of sequence-specificities and 
binding affinities is of great interest.  The work described herein focuses on modifications 
to the turn sub-unit of hairpin polyamides, and subsequent effects on the biophysical and 
biological characteristics of these molecules.  The substitution of a γ-2,4-diaminobutyric 
acid with an α-2,4-diaminobutyric acid hairpin turn moiety resulted in greater selectivity, 
and diminished reactivity for polyamide-alkylator conjugates.  These molecules have been 
utilized in generating site-specific damage in histone H4 genes in cancer cells.  Employment 
of 3,4-diaminobutyric acid in the turn unit has resulted in increased DNA affinities for 
polyamides targeting particular sequences.  These molecules are also promising in their 
abilities to tolerate modifications that improve cellular uptake but would otherwise severely 
diminish binding. 
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Chapter I
Introduction

Deoxyribonucleic acid (DNA)
 The macromolecule DNA encodes the genetic information required for life.  The 
human genome contains approximately three billion base pairs, which encode 20,000 to 
25,000 protein-coding genes.1  Sequences of DNA can not only code for proteins, but are 
also associated with regulatory regions controlling transcription.  In the cell, gene expression 
is controlled by DNA-binding proteins and the interactions between proteins.2,3  
DNA consists of two anti-parallel polydeoxyribonucleotide strands wrapped 
together in a double helix.  Between the two strands, hydrogen bonding of the Watson-Crick 
heterocyclic base pairs occurs, with adenine (A) pairing with thymine (T), and guanine (G) 
pairing with cytosine (C).  B-form DNA is a right-handed helix containing ten base pairs 
per turn.4,5  The helix forms two grooves: the major groove, which is wide and shallow, and 
the minor groove, which is narrow and deep (Figure I.1).  The edges of the DNA base pairs 
present unique molecular surfaces at the major and minor groove floors, providing for the 
sequence-specific recognition of DNA by transcription factors and other molecules. 
DNA-binding small molecules
 The transcription of DNA into mRNA results in the synthesis of proteins, or 
translation.  Many proteins function as transcription factors, regulating gene expression. 
These proteins must recognize and bind particular sequences of DNA, whether in the minor, 
major, or a combination of the two grooves (Figure I.2).  NF-κB (p50/p65 heterodimer),6 
Zif268,7 and Ets-18 recognize the major groove, while TATA-Binding Protein (TBP)9 and 
LEF-110 recognize the minor groove of DNA.  
Figure I.1. The structure of DNA. (A) X-ray crystal structure of B-form DNA.  The phosphodiester-linked 
deoxyribose backbone is shown in blue, and the Watson-Crick base pairs are shown in gray (PDB YSA). 
(B) Chemical structures of hydrogen-bonded base pairs. Cytosine (C) is bonded to guanine (G) (top), and 
thymine (T) is bonded to adenine (A) (bottom). ‘R’ = the sugar phosphosphate backbone of DNA.  Dashed 
lines indicate hydrogen bonds.  The major and minor grooves are indicated in both representations.
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Figure I.2. Structures of five protein-DNA complexes: NF-κB (PBD 1VKX),6 Zif68 (PDB ZAA),7 LEF-1 
(PDB 2LEF),0 Ets- (PBD STW),8 and TBP (PDB TGH).9  All protein structures are determined by X-ray 
crystallography with the exception of Ets-, which was determined by NMR. 
NF-κB (p50/p65 heterodimer) Zif268
LEF-1 Ets-1 TBP

In addition to proteins, a number of small molecule natural products are capable of 
binding to specific sequences of DNA.  Calicheamicin,11 actinomycin D,12 chromomycin13 
and distamycin A14 have been shown to bind DNA with high affinity and modest sequence 
specificity within the minor groove (Figure I.3).  Chromomycin targets the sequence 5’-
GGCC-3’ and binds in the minor groove in a 2:1 stoichiometry.  Actinomycin D intercalates 
DNA at 5’-GC-3’ sequences in a 1:1 stoichiometry.  Calicheamicin oligosaccharide binds 
the minor groove as a monomer as well, and targets 5’-TCCT-3’.  Distamycin A is an A,T-
binding oligopeptide whose structure contains three N-methylpyrrole (Py) carboxamide 
units.  It was revealed via x-ray and NMR structural studies that two of these crescent-
shaped molecules can bind DNA as a 1:1 or 2:1 complex in an anti-parallel orientation 
(Figure I.4).  This results in expansion of the minor groove relative to the 1:1 ligand-DNA 
complex.15-17  
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Figure I.3. Chemical structures of DNA-binding natural products.  Structures of calicheamicin oligosaccha-
ride, actinomycin D, chromomycin A, and distamycin A are shown with targeted DNA sequences. 
6Figure I.4. Distamycin bound to DNA.  X-ray crystal structures of distamycin bound to DNA in (A) 1:1 
(PBD DND) and (B) 2:1 (right, PDB 378D)7 conformations are shown.
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7Minor groove recognition by pyrrole-imidazole polyamides 
 Pyrrole-imidazole polyamides bind in the minor groove of DNA and are able to 
discern the four Watson-Crick base pairs based upon the chemical features presented.18,19 
The exocyclic amine of guanine presents a steric clash to N-methylpyrrole (Py), however 
the nitrogen of N-methylimidazole (Im) is capable of hydrogen bonding to it.  Subsequently, 
a set of “pairing rules” have been developed, where a Py/Im pair targets C•G, the reverse 
(Im/Py) targets G•C, and Py/Py targets A•T or T•A.20  The degeneracy between A and 
T is successfully broken by usage of N-methylhydroxypyrrole (Hp), on account of its 
hydroxyl group’s ability to form hydrogen bonds with the O2 of thymine (Figure I.5).21,22 
Alternatively, a terminal 3-chlorothiophene (Ct) also shows a three-fold selectivity for 
T•A over A•T when paired opposite Py.23  The replacement of Py with β-alanine (β) can 
enhance polyamide binding affinity by allowing the polyamide to reset its curvature with 
that of the DNA minor groove.24,25  β/Py and β/β pairings both recognize T•A and A•T 
base pairs.  A β in the polyamide tail position and the 3-(dimethylamino)propylamine (Dp) 
tail itself also both code for T•A and A•T.  Structural verification of the pairing rules has 
been provided by X-ray crystal structures of polyamides bound to DNA (Figure I.6).20,22,26 
8Figure I.5. Recognition of the DNA minor groove by polyamides.  (A) Minor groove hydrogen bonding 
patterns of Watson-Crick base pairs. Circles with dots represent lone pairs of N() of purines and O() of 
pyrimidines, and circles containing an H represent the -amino group of guanine. ‘R’ represents the sugar-
phosphate backbone of DNA. Shaded orbitals represent electron pairs projecting into the minor groove. (B) 
Model of the polyamide ImHpPyPy-γ-ImHpPyPy-β-Dp binding its target sequence, 5’-AGTACT-3’ Putative 
hydrogen bonds are shown as dashed lines.  
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9Figure I.6. Crystal structures of polyamides bound to DNA. (A) Structure of the 2:1 complex between 
ImHpPyPy-β-Dp and the sequence 5’-CCAGTACTGG-3’ (PDB 407D). (B) Structure of the cyclic poly-
amide ImImPyPy-(R) α-amine-γ-ImImPyPy-(R) α-amine-γ bound to 5’-CCAGGCCTGG-3’ (PDB 3I5L).6 
Polyamides are shown below in ball-and-stick models, where a black circle represents Im, an open circle 
represents Py, a circle containing ‘H’ represents Hp, a diamond represents β-alanine, a half-circle with a plus 
represents Dp, and a half-circle represents γ-turn.
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Hairpin motifs in Py-Im polyamides
 By binding as side-by-side, anti-parallel dimers in the minor groove, the heterocyclic 
rings of two polyamide strands can recognize DNA via the pairing rules described above.27 
Covalent linkage of the carboxy terminus (C) of one strand to the amino terminus (N) of 
another via an alkyl turn moiety results in a ‘hairpin’ polyamide structure (Figure I.7).  Early 
studies explored a variety of linker lengths and revealed that the use of a γ-aminobutyric 
acid (γ-turn) is optimal, and resulted in increased affinities (~100-fold) and specificities 
compared to unlinked subunits.28  The γ-turn also enforces the register of the heterocyclic 
ring pairings, preventing slipped dimer binding modes.29  
The hairpin moiety also contributes to the polyamide’s recognition of particular 
DNA sequences.  The γ-turn prefers to bind at T•A and A•T base pairs over G•C and C•G.30 
Usage of a chiral (R)-2,4-diaminobutyric acid in the hairpin further improves binding affinity 
(~10-fold over the γ-turn), and retains specificity for T•A and A•T.31  Hairpin polyamides 
containing the γ-turn typically prefer to bind in the ‘forward’ direction N→C with respect 
to the 5’→3’ direction of the DNA strand,32 however in some instances the ‘reverse’ (C→N 
alignment with respect to the 5’→3’ direction of the DNA strand) orientation is preferred. 
The chiral turn adds stereochemical control, enforcing polyamide binding in the forward 
orientation.31
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Polyamide regulation of gene expression in cell culture 
 Eight-ring hairpin polyamides have been shown to bind a wide repertoire of DNA 
match sequences with subnanomolar affinities, similar to those of DNA-binding proteins 
(Table I.1).33-35  By using Py-Im polyamides to displace or prevent the binding of transcription 
factors to their respective promoter DNA sequences, the expression of particular genes can 
be modulated.  Cellular permeability is of vital importance to the successful design of gene 
regulation studies.  Confocal microscopy has been used to determine the nuclear uptake 
profiles of polyamide-fluorophore conjugates in a variety of cell lines.36-38  The presence 
of an isophthalic acid (IPA) moiety in the tail region has been shown to yield high affinity 
conjugates with improved nuclear permeability.39
Polyamides have been used to successfully affect gene expression in cell culture.  A 
polyamide designed to bind to the hypoxia response element (HRE) was shown to disrupt the 
binding of hypoxia-inducible factor (HIF) to the HRE, resulting in decreased transcription 
of vascular endothelial growth factor (VEGF) in cultured HeLa cells (Figure I.8A).40,41 
Another polyamide, designed to target the androgen response element (ARE), has been 
shown to down-regulate prostate-specific antigen (PSA) and other androgen responsive 
genes in prostate cancer cells (Figure 1.8B).42
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Table I.1. Library of imidazole-capped polyamides.  Shown are the targeted sequence, binding association 
constant (Ka), and sequence context for binding affinity determination for each polyamide (shown as ball-
and-stick models). 
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Figure I.8. Polyamides as regulators of gene expression in cell culture. (A) Schematic diagram of the VEGF 
promoter showing inhibition of HRE binding by HIF-1 (shown as HIF-1α/HIF-1β heterodimer), binding 
sequence of the HRE enhancer shown with match polyamide 1, and chemical structures and ball-and-stick 
models of match polyamide 1 and mismatch polyamide 2. (B) Schematic diagram of the androgen receptor 
transcription complex, binding sequence of the consensus ARE targeted by match polyamide 3, and chemical 
structures and ball-and-stick models of match polyamide 3 and mismatch polyamide 4. 
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Sequence-specific alkylation of DNA
 Polyamides have been used to regulate gene expression by binding to promoter 
and enhancer elements of DNA,40-42 but do not prevent RNA polymerase elongation when 
bound to the coding region of genes.43  DNA alkylators typically display limited sequence 
selectivity.  Conjugation of an alkylating moiety to a sequence-specific molecule results in 
a molecule capable of covalent DNA attachment that arrests transcription.44  An example 
of this is Tallimustine, which is a conjugate of distamycin A and the nitrogen mustard 
chlorambucil.45  
Several types of alkylating agents have been tethered to polyamide hairpin turn 
units, including: 1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benz[e]indole (seco-CBI),46 
cyclopropylpyrroloindole (CPI),47 and chlorambucil (Chl) (Figure I.9).48  Both seco-CBI 
and Chl conjugates showed alkylation at adenines proximal to the molecules’ binding 
sites,46,48-50 however polyamide-seco-CBI molecules were far more reactive at both match 
and mismatch sites than their chlorambucil counterparts.  Hairpin polyamide-chlorambucil 
conjugates have been shown to target specific sequences of the HIV-1 promoter48 and 
simian virus 40.51 
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Polyamide synthesis
 Synthesis methods for the polyamides described herein largely involve solid-phase 
techniques.  Protocols have been developed using standard Boc coupling chemistry,52,53 
with cleavage via aminolysis followed by further derivatization on the turn and/or tail 
residues.  Usage of either β-PAM or Kaiser oxime resin yields different C-terminal groups 
following cleavage with a primary amine, the former leaving a residual β-alanine, and the 
latter leaving none.  While solid phase methods have proved useful for the rapid synthesis 
of a variety of polyamides on micromolar scales, they are inefficient for making larger 
quantities of a particular core.  For this reason, solution-phase methodologies for gram-scale 
polyamide synthesis involving minimal chromatography have been recently developed.54
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Scope of this work
 The work described in this thesis relates to the effects of the hairpin turn subunit on 
Py-Im polyamides, including binding affinity and specificity, and cellular uptake properties. 
It is divided into two sections: part II describes studies relating to α-2,4-diaminobutyric 
acid as the hairpin subunit; part III describes effects of 3,4-diaminobutyric acid in the 
hairpin subunit.  The appendix describes methods for genome-wide analysis of polyamide 
binding using expertise gained in part III.  
 Chapters IIA and IIB describe the identification and characterization of polyamides 
and polyamide-Chl conjugates linked by α-2,4-diaminobutyric acid (also referred to as α-
diaminobutyric acid, or α-DABA), with comparisons to analogous γ-2,4-diaminobutyric 
acid (also referred to as γ-diaminobutyric acid, or γ-DABA) containing molecules.  Binding 
affinities and specificities for small libraries of α- and γ-DABA linked polyamides were 
determined, and alkylation properties of the Chl conjugates explored.  Effects of α- and 
γ-DABA-linked molecules on colon carcinoma cell growth and on mice were evaluated. 
In chapter IIC, α-DABA-linked polyamide-Chl conjugates targeting the coding region 
of histone H4c are studied in vitro and in vivo in an effort to affect chronic myelogenous 
leukemia.
Chapters IIIA and IIIB characterize polyamides containing various substituents in 
the γ-turn unit.  In Chapter IIIA, polyamides containing (R) and (S)-3,4-diaminobutyric acid 
(β-amino-γ-turn) in the hairpin turn are compared to analogues containing unsubstituted 
γ-DABA and γ-2,4-diaminobutyric acid (referred to as α-amino-γ-turn in part III) with 
respect to binding abilities and in cell culture.  In Chapter IIIB, six-ring polyamides are 
employed to determine the binding affinities and specificities of α-amino-γ-turn, (R) and 
(S)-β-amino-γ-turn, and fluoro- and hydroxyl-turn polyamides at the turn position. 
 In the appendix, a polyamide-biotin conjugate containing a β-amino-γ-turn 
subunit targeting the androgen response element is shown to affect androgen-responsive 
gene expression and used to capture chromatin following treatment in a prostate cancer cell 
8
line to determine genome-wide binding of polyamides.
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II. Py-Im Polyamides Linked by 2,4-Diaminobutyric 
Acid in the Hairpin Turn Unit
23
Chapter IIA
Unanticipated Differences Between α- and γ-Diaminobutyric 
Acid-Linked Hairpin Polyamide-Alkylator Conjugates
The text of this chapter was taken in part from a manuscript co-authored with Sherry M. 
Tsai,* Peter B. Dervan,* C. James Chou,‡ and Joel M. Gottesfeld ‡ ( * California Institute 
of Technology and ‡ The Scripps Research Institute)
(Tsai, S.M.; Farkas, M.E.; Chou, C.J.; Gottesfeld, J.M.; Dervan, P.B. Nucleic Acids Res. 
2007, 35, 307-316)
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Abstract
Hairpin polyamide-chlorambucil conjugates containing an α-diaminobutyric acid 
(α-DABA) turn moiety are compared to their constitutional isomers containing the well-
characterized γ-DABA turn. Although the DNA-binding properties of unconjugated 
polyamides are similar, the α-DABA conjugates display increased alkylation specificity 
and decreased rate of reaction.  Treatment of a human colon carcinoma cell line with α-
DABA versus γ-DABA hairpin conjugates reveals only slight differences in toxicities while 
producing similar effects on cell morphology and G2/M stage cell cycle arrest.  However, 
striking differences in animal toxicity between the two classes are observed.  While mice 
treated with an α-DABA hairpin polyamide do not differ significantly from control mice, 
the analogous γ-DABA hairpin is lethal.  This dramatic difference from a subtle structural 
change would not have been predicted.
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Introduction
 The ability to control gene expression through the use of   DNA sequence-specific, cell-
permeable molecules holds therapeutic promise.  Based on the natural product distamycin 
A, pyrrole-imidazole polyamides are a class of molecules that can be programmed to bind 
a broad repertoire of DNA sequences with specificities comparable to naturally occurring 
DNA-binding proteins.1  They have also been shown to permeate living cells, localize to 
the nuclei,2,3 and regulate gene expression.4,5
 Pairing rules have been established for minor groove recognition, whereby an 
N-methylpyrrole/N-methylimidazole (Py/Im) pair recognizes C•G, the reverse (Im/Py) 
recognizes G•C, and Py/Py specifies A•T or T•A.1,6  The replacement of Py with β-alanine 
(β) can enhance binding affinity by allowing the polyamide to reset its curvature with that 
of the DNA minor groove.7,8  Polyamides may be linked via a turn moiety to give a hairpin 
structure which binds in the “forward” direction N→C with respect to the 5’→3’ direction 
of the DNA strand.9  In earlier studies, linkage of antiparallel three-ring subunits via a γ-
aminobutyric acid moiety, resulting in a turn with three methylene units, was shown to 
enhance DNA binding affinity ~100-fold over unlinked subunits.10  The γ-aminobutyric 
acid turn demonstrates selectivity for A•T or T•A base pairs over G•C and C•G.11  Use 
of a glycine amino acid, with one methylene turn unit, resulted in a 3-fold reduction in 
affinity relative to the γ-aminobutyric acid.  Subsequent NMR studies revealed that the 
glycine amino acid substituted polyamide bound DNA in an extended, rather than a hairpin, 
conformation.12,13
 Substitution of the γ-aminobutyric acid with the chiral (R)-2,4-diaminobutyric 
acid ((R)-γ-DABA) was later found to further increase DNA binding affinity ~10-fold.14 
In contrast, hairpin polyamides with the opposite enantiomer (S)-γ-DABA result in an 
unfavorable steric clash with the DNA minor groove and decreased binding for the forward 
orientation.  Remarkably, binding affinity to the opposite orientation, in which the polyamide 
binds C→N with respect to the 5’→3’ direction of the DNA strand, is energetically favorable 
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due to relief of the steric clash.
 Polyamides have been used to regulate gene expression by binding to promoter and 
enhancer elements, but they do not prevent RNA polymerase elongation when bound to the 
coding region of genes.1  Conjugation of an alkylating moiety to a sequence-specific DNA-
binding molecule would be expected to result in a molecule capable of covalent DNA 
attachment that could arrest transcription.15,16  An early example of this is Tallimustine (FCE 
24517), which is a conjugate of distamycin A and the nitrogen mustard chlorambucil.17 
When attached to a DNA minor groove binder, chlorambucil is capable of alkylation at the 
N3 position of an adenine proximal to the binding site.18,19  Hairpin polyamide-chlorambucil 
conjugates have been demonstrated to target specific sequences of the HIV-1 promoter and 
simian virus 40.19,20
Recently, a hairpin polyamide-chlorambucil conjugate, synthesized at The 
Scripps Research Institute, was found to alkylate within the coding region of the histone 
H4c gene of the human colon carcinoma cell line SW620 and to block proliferation of 
these cells in culture.21  In addition, this conjugate was found to block tumor growth in a 
SW620 xenograft mouse model without apparent toxicity.  When we attempted to scale-
up additional conjugate at Caltech, the newly-synthesized molecule was found to be 
highly toxic in athymic nude mice, contrary to prior experiments.22  Subsequent studies 
showed that the two laboratories had utilized two different turn units in the synthesis of 
the conjugate:  the conjugate synthesis at Scripps used Boc-D-Dab(Fmoc)-OH, while the 
conjugate synthesis at Caltech used Fmoc-D-Dab(Boc)-OH.  The molecules are therefore 
constitutional isomers differing in the hairpin turn moiety.  The original molecule made at 
Scripps continues to be called 1R-Chl,22 and the new molecule is designated 2R-Chl.  1R-
Chl utilizes an α-diaminobutyric acid (α-DABA) turn unit, whereas 2R-Chl employs the 
standard γ-DABA turn unit (Figure IIA.1).  Linkage via the new α-DABA turn unit results 
in one methylene group in the hairpin, whereas 2R-Chl has three methylene groups.  In 
addition, the linker between the polyamide core and the chlorambucil alkylator in 1R-Chl 
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is lengthened by two methylene groups relative to 2R-Chl.
Polyamides utilizing the α-DABA turn moiety have not been studied previously, 
and the reasons for the unique biological properties displayed by 1R-Chl are unknown. 
In the current study, we report the chemical and biological characterization of α-DABA 
polyamides and compare them to the analogous γ-DABA polyamides.  A series of four 
parent molecules and their corresponding chlorambucil conjugates was synthesized (Figure 
IIA.1A).  Each molecule contains the heterocyclic sequence:  ImImβIm-HT-PyPyPyPy-
βDp (where HT = hairpin turn and Dp = 3-(dimethylamino)-propylamine).  Molecules 
in series 1 contain the new α-DABA turn, and molecules in series 2 utilize the γ-DABA 
turn.  The R and S enantiomers of the parent polyamides and chlorambucil conjugates 
in each series have been generated for comparison.  The DNA binding affinities of the 
parent molecules were measured by DNase I footprinting, and the alkylation profiles 
(sequence specificity and reactivity) of the polyamide-chlorambucil conjugates were 
established using thermal cleavage assays.  The effects of polyamide treatment on SW620 
cell morphology, proliferation, viability, and cell cycle profiles were compared using phase 
contrast microscopy, cell counting, trypan blue exclusion assay, and fluorescence-assisted 
cell sorting (FACS) analysis, respectively.  Importantly, toxicity effects of the polyamide 
constitutional isomers on mice were determined.
Results and Discussion
Polyamide synthesis 
Four hairpin polyamides were prepared by solid phase synthesis.23  The hairpin 
polyamides differed in the turn substituents utilized: Boc-D-Dab(Fmoc)-OH (1R, 1R-Chl), 
Boc-Dab(Fmoc)-OH (1S, 1S-Chl), Fmoc-D-Dab(Boc)-OH (2R, 2R-Chl), and Fmoc-
Dab(Boc)-OH (2S, 2S-Chl) (Figure IIA.1B).  Conjugates were generated by coupling 
the HBTU-activated carboxylic acid of chlorambucil to the parent polyamide following 
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Figure IIA.1.  Polyamide structures and syntheses. (A)  Chemical and ball-and-stick structures for poly-
amides 1R, 1S, 2R, 2S, and their Chl conjugates. (B)  Chemical structures of the four turn units used in the 
syntheses of the parent polyamides and polyamide-chlorambucil conjugates:  Boc-D-Dab(Fmoc)-OH (top 
left, used in the syntheses of 1R and 1R-Chl); Boc-Dab(Fmoc)-OH (top right, used in the syntheses of 1S and 
1S-Chl); Fmoc-D-Dab(Boc)-OH (bottom left, used in the syntheses of 2R and 2R-Chl); Fmoc-Dab(Boc)-
OH (bottom right, used in the syntheses of 2S and 2S-Chl).
reverse-phase HPLC of the free amine and purified similarly.
Plasmid design 
The core polyamide structure was constructed to bind the sequence 5’-WWGGWGW-
3’, where W = A or T.  In order to probe the affinity and sequence specificity of the parent 
polyamides, plasmid pMFST2 was designed with an insert containing a single match site 
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(‘M’ = 5’-TAGGTGT-3’) and two single base-pair mismatch sites (Figure IIA.2A).  The 
mismatch sites consist of single G•C to C•G replacements at different locations within 
each binding site (‘A’ = 5’-TAGGTCT-3’, ‘B’ = 5’-TAGCTGT-3’).  For the purpose of 
thermal cleavage assays, each binding site was designed with proximal adenines which 
the chlorambucil moiety would be expected to alkylate.19  In addition to the designed sites, 
inherent in the plasmid structure is a single base-pair mismatch site (‘C’ = 5’-AGTGGTG-
3’) for a polyamide binding in reverse (Figure IIA.3). 
DNA affinity and sequence specificity
Quantitative DNase I footprint titrations to determine binding site affinities and 
specificities were conducted for parent polyamides 1R, 1S, 2R, and 2S on the 5’-labeled 
280-base-pair PCR product of plasmid pMFST2 (Figure IIA.2 and Table IIA.1).  Previous 
studies have indicated that attachment of the chlorambucil moiety does not significantly 
alter the DNA binding affinity of the parent polyamide.19
The α-DABA polyamide 1R bound the match site, M, with Ka = 6.7 x 109 M -1, and 
it had a 94-fold specificity over single mismatch site A and 26-fold specificity over single 
mismatch site B (Figure IIA.2B).  The enantiomer 1S bound the match site M with Ka = 
4.8 x 108 M -1, a 14-fold decrease relative to 1R.  Binding affinities at the other sites were 
too low to be measured, and the polyamide was found to coat DNA at high concentrations 
(Figure IIA.2C).
The γ-DABA polyamides 2R and 2S bound DNA in accordance with the expected 
orientation of the free amine.14  2R was shown to bind the match and both single base-pair 
mismatch binding sites (Figure IIA.2D).  The affinity of 2R for site M was Ka = 1.6 x 1010 
M -1, with 15-fold and 6-fold preferences over mismatch sites A and B, respectively.  The 
enantiomer, 2S, bound the single base-pair mismatch reverse site C with Ka = 1.2 x 109 M-1, 
a 21-fold enhancement over the forward match site M (Figure IIA.2E). 
The binding isotherms for all four molecules were best-fit to a 1:1 binding model. 
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Figure IIA.2.  Plasmid design and DNA binding properties of the parent polyamides.  (A)  Illustration of 
the designed portion of the EcoRI/PvuII restriction fragment derived from plasmid pMFST2.  The four poly-
amide binding sites are indicated by boxes.  Single base-pair mismatches are indicated by shaded regions. 
Site C is a mismatch site for a polyamide binding in reverse.  (B-E)  Quantitative DNase I footprint titration 
experiments for polyamides 1R (B), 1S (C), 2R (D), 2S (E) on the 280 bp, 5’-end-labeled PCR product of 
plasmid pMFST2:  lanes 1-11, 100 nM, 30 nM, 10 nM, 3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, 
and 1 pM polyamide, respectively; lane 12, DNase I standard; lane 13, intact DNA; lane 14, A reaction; lane 
15, G reaction.  Each footprinting gel is accompanied by its respective binding isotherms for the indicated 
sites (below).
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Figure IIA.3.  Illustration of the parent polyamides (A) 2R and (B) 2S binding DNA.
Polyamide        5’-TAGGTGT-3’        5’-TAGGTCT-3’        5’-TAGCTGT-3’        5’-AGTGGTG-3’
-1Equilibrium Association Constants: K   (M   )a
1.1  (± 0.1) x 109 2.9 (± 1.0) x 1091.6  (± 0.3) x 10102R --
6.7  (± 0.1) x 10 9 7.1  (± 1.8) x 10 7 2.6  (± 0.2) x 1081R
1.2  (± 0.2) x 1092S 5.8  (± 2.1) x 10 7 ----
1S 4.8  (± 0.9) x 10 8 ------
--
Table 1. 
Table IIA.1.  Binding affinities (M-1) for parent polyamides.  Equilibrium association constants reported are 
mean values from three DNase I footprint titration experiments; standard deviations are shown in
parentheses.
Previous studies have found a glycine amino acid-linked polyamide is able to bind DNA in 
an extended dimeric conformation that can be observed via a larger binding site in a DNase 
I footprinting gel.  We do not observe evidence of an extended conformation for either 1R 
or 1S, as the binding sites of both molecules are the same size as those of 2R and 2S.  The 
substituted glycine favors a turn conformation.
The DNase I footprinting experiments reveal that the α-DABA polyamide 1R has 
a 2-fold reduced binding affinity relative to the γ-DABA polyamide 2R.  A contributing 
factor to the decreased binding observed for 1R and 1S could be a reduced ability of the 
molecules to fit into the minor groove.  The shorter turn linkage between the two subunits in 
an α-DABA polyamide may reduce its flexibility in conforming to the shape of the groove 
(Figure IIA.4).  The energetics of α-DABA hairpin polyamides appear less sensitive than 
the γ-DABA series to the R and S stereochemistry at the turn. 
site C reverse binding of 2S
5’ - A  G  T  G  G  T  G - 3’
3’ - T  C  A  C  C  A  C - 5’
H3
+ N
5’ - T  A  G  G  T  G  T - 3’
3’ - A  T  C  C  A  C  A - 5’
NH3
+
match site binding of 2R
A B
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1S
NH+3
NH+3
1R
A
B
Figure IIA.4.  Models of the binding of (A) 1R and (B) 1S to the match site of pMFST2.  DNA atoms are 
indicated with gold; polyamide atoms are indicated as follows: carbon with gray, oxygen with red, nitrogen 
with blue, and hydrogen with white.  Illustrations were rendered using Chimera.
DNA alkylation specificity and time-dependence
To determine the alkylation properties of the polyamide-chlorambucil conjugates, 
thermal cleavage assays were performed on the 5’ 32P-labeled 280-base-pair PCR product 
of pMFST2 (Figure IIA.5).  The alkylation profiles of 1R-Chl and 2R-Chl are dramatically 
different:  1R-Chl alkylates DNA more specifically than 2R-Chl and appears less reactive. 
For the designed sequence, 1R-Chl appears to specifically alkylate the adenine proximal 
to the turn at the match site M at concentrations up to 30 nM (Figure IIA.5A).  It only 
33
M
A
B
C
5'-AGCTG CGCCCTT TAGGTGT TACGT AGTGGTG CCG TAGGTCT TAGCCG TAGCTGT TGCCGT AAGGG-3'
    3'-C GCGGGAA ATCCACA ATGCA TCACCAC GGC ATCCAGA ATCGGC ATCGACA ACGGCA TTCCC-5'*
C
on
tro
l
G
10
0 
nM
A 1
 p
M
1    2    3    4    5    6    7    8    9  10   11  12  13 14
B
A
M
C
1R-Chl Co
nt
ro
l
G
10
0 
nM
A 1
 p
M
1    2    3     4    5    6    7    8    9   10  11  12   13 14
2R-Chl
B
A
M
C
Chl Chl
A B
M
A
B
C
5'-AGCTG CGCCCTT TAGGTGT TACGT AGTGGTG CCG TAGGTCT TAGCCG TAGCTGT TGCCGT AAGGG-3'
    3'-C GCGGGAA ATCCACA ATGCA TCACCAC GGC ATCCAGA ATCGGC ATCGACA ACGGCA TTCCC-5'*
C
on
tro
l
GA 1
 p
M
1    2    3    4    5    6     7   8    9   10  11  12  13 14
1S-Chl Co
nt
ro
l
GA 1
 p
M
1    2    3    4    5     6    7    8    9  10  11   12  13 14
2S-Chl
B
A
M
C
B
A
M
C
Chl Chl
C D
10
0 
nM
M
A
B
C
5'-AGCTG CGCCCTT TAGGTGT TACGT AGTGGTG CCG TAGGTCT TAGCCG TAGCTGT TGCCGT AAGGG-3'
    3'-C GCGGGAA ATCCACA ATGCA TCACCAC GGC ATCCAGA ATCGGC ATCGACA ACGGCA TTCCC-5'*
M
A
B
C
5'-AGCTG CGCCCTT TAGGTGT TACGT AGTGGTG CCG TAGGTCT TAGCCG TAGCTGT TGCCGT AAGGG-3'
    3'-C GCGGGAA ATCCACA ATGCA TCACCAC GGC ATCCAGA ATCGGC ATCGACA ACGGCA TTCCC-5'*
10
0 
nM
Figure IIA.5.  Alkylation specificities of the polyamide conjugates.  Thermal cleavage assay experiments 
with (A) 1R-Chl, (B) 2R-Chl, (C) 1S-Chl, and (D) 2S-Chl on the 280 bp, 5’-end-labeled PCR product of 
pMFST2:  lane 1, A reaction; lane 2, G reaction; lanes 3-13, 100 nM, 30 nM, 10 nM, 3 nM, 1 nM, 300 pM, 
100 pM, 30 pM, 10 pM, 3 pM, and 1 pM polyamide, respectively; lane 14, intact DNA.  Putative major sites 
of alkylation on the DNA fragment are indicated by arrows on the sequences adjacent to each gel.
34
begins to alkylate at the designed mismatch binding sites at 100 nM concentration, and 
alkylation can be observed at concentrations as low as 1 nM.  In contrast, 2R-Chl is more 
promiscuous, alkylating at site M and both mismatch sites, A and B, at concentrations 
as low as 3 nM (Figure IIA.5B).  Only at 1 nM concentration was 2R-Chl observed to 
specifically alkylate at site M versus sites A and B.  
 The S enantiomers of the conjugates are similar to their R analogs in their alkylation 
specificities, but they are muted in activity.  In contrast to 1R-Chl, 1S-Chl appears to 
specifically alkylate the guanine between sites M and C up to a concentration of 30 nM 
(Figure IIA.5C).  Alkylation at N3 of guanine has been previously observed.18,21,24  Based 
on the DNase I footprinting data for 1S, the observed alkylation is probably due to binding 
of 1S-Chl at the match site M.  The 2S-Chl alkylation profile at 100 nM is similar to that 
of 2R-Chl at 10 nM, with the polyamide alkylating at the match site and both single base-
pair mismatch sites (Figure IIA.5D).  However, at 30 nM, 2S-Chl is specific for the match 
site.
 Outside of the designed pMFST2 insert, 1R-Chl and 1S-Chl alkylate fewer sites 
than 2R-Chl and 2S-Chl, respectively, further demonstrating their enhanced alkylation 
specificity.  There are a number of forward-binding and reverse-binding single base-pair 
mismatch sites, as well as one reverse-binding match site, inherent in the labeled fragment of 
pMFST2 used in these studies.  The major sites of alkylation observed for 1R-Chl and 2R-
Chl outside of the designed plasmid insert can generally be attributed to forward-binding 
single base-pair mismatch sites, although the gel resolution is often too poor to definitively 
identify specific alkylation sites.  The additional major alkylation sites observed for 2S-Chl 
can be attributed to a combination of forward-binding and reverse-binding single base-
pair mismatch sites, while the additional major alkylation site observed for 1S-Chl may 
correspond to a reverse-binding single base-pair mismatch site.
 We next studied the time-dependence of alkylation for 1R-Chl and 2R-Chl to 
quantitate their kinetic parameters (Figure IIA.6).  At 500 nM polyamide and 37 oC, the 
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half-life of the labeled DNA (i.e. disappearance of full-length DNA) is 20 h for 1R-Chl and 
10 min for 2R-Chl.  Thus, 2R-Chl alkylates DNA 120 times faster than 1R-Chl under these 
conditions.  Given the minimal structural differences between 1R-Chl and 2R-Chl and the 
similar binding affinities of their parent molecules, the dramatic difference in alkylation 
specificity and kinetics between hairpins with a common alkylator moiety would not have 
been predicted.
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Figure IIA.6.  Time-dependence of alkylation for polyamide conjugates.  Thermal cleavage assay experi-
ments with (A) 500 nM 1R-Chl and (B) 500 nM 2R-Chl on the 280 bp, 5’-end-labeled PCR product of 
pMFST2:  lane 1, A reaction; lane 2, G reaction; lanes 3-8, equilibrations for 24 h, 14.5 h, 4 h, 1 h, 30 min, 
10 min, respectively; lane 9, intact DNA.
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Effects of polyamides on SW620 cells
1R-Chl treatment of cultured SW620 cells has been shown to induce a morphology 
change and arrest cell growth in the G2/M phase.  In addition, the polyamide was found 
to be a cytostatic agent, decreasing cell proliferation without significantly affecting cell 
viability, as determined by trypan blue staining.21  A two-hit mechanism for growth arrest 
by 1R-Chl was suggested by experiments where a different polyamide-chlorambucil 
conjugate, which by itself had no effect on SW620 cell proliferation, was found to cause 
growth arrest after treatment of these cells with an siRNA directed against H4c mRNA.25 
Our model for the action of 1R-Chl involves direct alkylation of the H4c gene, leading to 
a block in transcription and eventual depletion of H4 protein, opening up the genome for 
massive alkylation by 1R-Chl and G2/M arrest.
 We studied the effects of our polyamide library on SW620 cultured cells to determine 
whether the differences between the polyamides observed in vitro would translate to 
disparities in cell morphology, proliferation, viability, and cell-cycle profile.  As expected, 
no effects were observed for the treatment of cells with the four parent polyamides (Figure 
IIA.7).  Cells treated for 3 days with 1R-Chl or 2R-Chl show the same morphological change 
as previously established (Figure IIA.8A).  Each conjugate also decreases cell proliferation 
to ~30% relative to control with only a small decrease in cell viability, as measured with 
trypan blue exclusion staining (Figure IIA.8B).  FACS analysis using propidium iodide 
staining indicates both molecules arrest cells in the G2/M phase of growth (38% for 1R-
Chl and 34% for 2R-Chl, compared to 20% for control; Figure IIA.8C).   
 Interestingly, a less pronounced cellular effect is observed for cells treated with 
1S-Chl and 2S-Chl.  Although most cells appear identical to control, some of the cells 
treated with each of the S enantiomers display a morphology change (Figure IIA.8A).  Cell 
viability is not significantly reduced, but proliferation decreases slightly (77% for 1S-Chl 
and 65% for 2S-Chl relative to control; Figure IIA.8B), indicating a slight cytostatic effect 
for these conjugates.  This is also apparent in the FACS data for 1S-Chl, where 31% of the 
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Figure IIA.7.  Effects of parent polyamides on cultured SW620 cells.  Cells were treated with 200 nM of 
the indicated polyamide for 3 days prior to analysis.  (A)  Representative phase microscopy images.  (B) 
Normalized cell viabililty and proliferation values.  Data shown are the averages of three samples; error bars 
indicate standard deviations.  (C)  Fluorescence-activated cell-sorting analysis of cells.  Plots indicate cell 
numbers versus propidium iodide staining.  Percentages of cells in G0/G1, S, G2/M, and apoptotic/necrotic 
cells (A/N) are indicated.
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Figure IIA.8.  Effects of polyamide conjugates on cultured cells.  Cultured SW620 cells were treated with 
200 nM of the indicated polyamide for 3 days prior to analysis.  (A)  Representative phase microscopy im-
ages.  (B)  Normalized cell viabililty and proliferation values.  Data shown are the averages of three samples; 
error bars indicate standard deviations.  (C)  Fluorescence-activated cell-sorting analysis of cells.  Plots 
indicate cell numbers versus propidium iodide staining.  Percentages of cells in G0/G1, S, G2/M, and apop-
totic/necrotic cells (A/N) are indicated.
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cells are found to be in the G2/M phase of growth.  The greater population of apoptotic/
necrotic cells following 2S-Chl treatment may explain why significant growth arrest is not 
observed with these cells.  We find that the trend of similar but muted effects of S relative to 
R enantiomers observed in the alkylation data appears to correlate to biological effects on 
SW620 cells.  Previous studies have correlated the DNA interstrand crosslinking ability of 
alkylating agents with biological activity.26,27  Since the S isomers are poor DNA alkylators 
and have minimal biological activity in SW620 cells, we chose not to investigate them 
further.
 Additional experiments were performed with longer incubation times to determine 
if cells treated with 1R-Chl or 2R-Chl die by apoptosis (Figure IIA.9).  SW620 cells were 
treated with 200 nM polyamide for either 3 or 6 days, with the 6-day experiment involving 
replacement of media with fresh media containing 200 nM polyamide on the third day. 
Comparison of the FACS analyses of these cells using annexin V-FITC and propidium 
iodide staining shows that after 6 days, 2R-Chl treatment leads to greater cell death than 
1R-Chl treatment (33.7% versus 20.2%, respectively).  However, a significant difference 
in apoptosis (i.e. cells that are annexin V positive and propidium iodide negative) between 
treatments with 1R-Chl and 2R-Chl is not observed (5.28% versus 6.73%, respectively).
In vivo effects of polyamides on BALB/c mice
 1R-Chl has been shown to arrest cancer growth in a SW620 xenograft nude mouse 
tumor model, whereas 2R-Chl treatment was toxic to the mice.21  The effects of 1R-Chl 
and 2R-Chl on a normal mouse strain were tested.  Groups of five BALB/c mice were 
injected with PBS (control), 100 nmol 1R-Chl, or 100 nmol 2R-Chl every other day for 
up to 5 days.  The mice were observed and weighed each day for up to 17 days (Figure 
IIA.10A).  Mice treated with 1R-Chl do not differ significantly from the control group. 
However, 2R-Chl treatment of mice results in an average weight loss of 17% after 3 days 
and is found to be lethal to 100% of the mice after 4 days (Figure IIA.10B).
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Figure IIA.9.  Fluorescence-activated cell-sorting analysis of the effects of polyamide conjugates on SW620 
cells.  Cells were treated with 200 nM of the indicated polyamide or no polyamide (control) for (A) 3 days 
or (B) 6 days prior to analysis.  For 6 day treatments, media was exchanged for fresh media containing 200 
nM polyamide after 3 days.  Cells were incubated with annexin V-FITC (AV) and propidium iodide (PI) prior 
to analysis.  Percentages of cells that are AV-/PI- (bottom left quadrants; viable cells), AV+/PI- (bottom right 
quadrants; early apoptotic cells), AV-/PI+ (top left quadrants), and AV+/PI+ (top right quadrants; end-stage 
apoptotic/dead cells) are indicated.
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Figure IIA.10.  Effects of polyamide conjugates on BALB/c mice. Female BALB/c mice were treated with 
PBS (control), 100 nmols 1R-Chl, or 100 nmols 2R-Chl at 0, 2, and 4 (PBS and 1R-Chl only) days.  Five 
mice were treated for each experimental condition.  (A)  Average mouse weights, normalized to weight at day 
0, over time. Error bars indicate standard deviations.  (B)  Survival rates for treated mice.
Conclusion
 We have shown that changing the turn unit of a hairpin pyrrole-imidazole polyamide-
chlorambucil conjugate from the standard γ-diaminobutyric acid to an α-diaminobutyric 
acid can result in dramatically different chemical and biological properties.  Although 
unconjugated parent hairpin polyamides 1R and 2R bind DNA with comparable binding 
affinities, their corresponding chlorambucil conjugates have different alkylation profiles. 
The polyamide conjugate 1R-Chl, which contains the (R)-α-diaminobutyric acid turn 
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unit, alkylates DNA much more specifically and at a decreased rate relative to 2R-Chl, 
which contains the (R)-γ-diaminobutyric acid turn.  Strikingly, treatment of a common 
mouse strain with 1R-Chl did not appear to have adverse effects on the mice, whereas 
treatment with 2R-Chl was lethal.  Although it is possible that the difference in toxicities 
between the two molecules is due to variance in absorption, distribution, metabolism, or 
excretion, given their structural similarities, it is not unreasonable to speculate the origin 
is the dramatic difference in alkylation specificity and reactivity.  These results would 
not have been predicted a priori and indicate that hairpin polyamides containing the α-
diaminobutyric acid turn unit may be an important class of DNA-binding small molecules 
with interesting biological properties.
Materials and Methods
Polyamide Synthesis and Characterization
Polyamides were synthesized on solid phase on Boc-β-Pam resin using Boc-
protected monomers and dimers according to previously described protocols.23  The 
following monomers/dimers were used in generating each of the molecules:  Boc-Py-OBt 
(OBt = benzotriazol-1-yloxy), Boc-β-Im-OH, and Im-Im-OH.  Boc deprotection was 
conducted at room temperature for 30 min using 80% TFA/DCM prior to the first coupling 
reaction and after addition of each heterocycle. Carboxylic acids were activated with N,N-
diisopropylethylamine (DIEA) and 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate (HBTU) for 30 min at 37 °C.  Monomer and dimer couplings were 
allowed to continue for 1 h (OBt esters) or 2 h (activated carboxylic acids).  Polyamides 
were cleaved from resin with 3-(dimethylamino)-propylamine neat at 55 °C for ~18 h, 
and subsequently purified by reverse-phase high-performance liquid chromatography 
(HPLC). 
 Conjugation of polyamides to chlorambucil (4 eq) proceeded by activating the 
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carboxylic acid with HBTU (4 eq) and DIEA (excess) for 30 min at room temperature, 
after which the activation mixture was added to the polyamide.  After allowing the reaction 
to continue for 1.5-2 h, products were purified by reverse-phase HPLC and immediately 
lyophilized.
 The purity of all compounds were established by analytical HPLC and matrix-
assisted laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry.
1R: ImImβIm-(R)H2Nα-PyPyPyPy-Dp Synthesized using Boc-D-Dab(Fmoc)-OH.  
MALDI-TOF C54H71N22O10
+ calculated [M+H]+: 1188.28, found: 1188.02
1S: ImImβIm-(S)H2Nα-PyPyPyPy-Dp Synthesized using Boc-Dab(Fmoc)-OH.  
MALDI-TOF C54H71N22O10
+ calculated [M+H]+: 1188.28, found: 1187.99
2R: ImImβIm-(R)H2Nγ-PyPyPyPy-Dp Synthesized using Fmoc-D-Dab(Boc)-OH.  
MALDI-TOF C54H71N22O10
+ calculated [M+H]+: 1188.28, found: 1187.95
2S: ImImβIm-(S)H2Nγ-PyPyPyPy-Dp Synthesized using Fmoc-Dab(Boc)-OH.  
MALDI-TOF C54H71N22O10
+ calculated [M+H]+: 1188.28, found: 1187.77 
1R-Chl: ImImβIm-(R)Chlα-PyPyPyPy-Dp Synthesized from 1R.  MALDI-TOF C68H88
Cl2N23O10
+calculated [M+H]+: 1474.48, found: 1474.98
1S-Chl: ImImβIm-(S)Chlα-PyPyPyPy-Dp Synthesized from 1S.  MALDI-TOF 
C68H88Cl2N23O10
+ calculated [M+H]+: 1474.48, found: 1475.03
2R-Chl: ImImβIm-(R)Chlγ-PyPyPyPy-Dp Synthesized from 2R.  MALDI-TOF 
C68H88Cl2N23O10
+ calculated [M+H]+: 1474.48, found: 1474.92
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2S-Chl: ImImβIm-(S)Chlγ-PyPyPyPy-Dp Synthesized from 2S.  MALDI-TOF 
C68H88Cl2N23O10
+ calculated [M+H]+: 1474.48, found: 1474.73
Construction of Plasmid pMFST2
 Oligonucleotides were purchased from Integrated DNA Technologies.  The 
plasmid pMFST2 was constructed by annealing the two oligonucleotides 5’-AGCTGC- 
GCCCTTTAGGTGTTACGTAGTGGTGCCGTAGGTCTTAGCCGTAGCTGTTGCC-
GTAAGG-GCGAATTCTGC-3’ and 5’-GATCGCAGAATTCGCCCTTACGGCAAC- 
AGCTACGGCTAAGACCTACGGCACCACTACGTAACACCTAAAGGGCGC-3’, 
followed by ligation into the BamHI/HindIII restriction fragment of pUC19 using T4 DNA 
ligase.  The plasmid was then transformed into E. Coli JM109 competent cells.  Ampicillin-
resistant white colonies were selected from 25 mL Luria-Bertani agar plates containing 50 
mg/mL ampicillin treated with XGAL and IPTG solutions, and grown overnight at 37 °C. 
Cells were harvested the following day, and purification of the plasmid was performed 
with a Wizard Plus Midiprep DNA purification kit (Promega).  DNA sequencing of the 
plasmid insert was performed by the Sequence Analysis Facility at the California Institute 
of Technology.
Preparation of 5’ 32P-End-Labeled DNA  
 The primer 5’-GAATTCGAGCTCGGTACCCGGG-3’ was labeled at the 5’-end 
and subsequently used with the primer 3’-CAGCCCTTTGGACAGCACGGTC-5’ to 
amplify plasmid pMFST2 as previously described.28
DNase I Footprint Titrations
 Polyamide equilibrations and DNase I footprint titrations were conducted on the 
5’-end-labeled PCR product of pMFST2 according to standard protocols.28  DNA was 
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incubated with polyamide conjugates or water (control) for 12 h at room temperature prior 
to reaction with DNase. 
Thermal Cleavage Assays
 Thermal cleavage assay experiments were conducted on the 5’-end-labeled PCR 
product of pMFST2 as previously described.19  DNA was incubated with polyamide 
conjugates or water (control) for 24 h at 37 oC prior to work-up, unless otherwise noted.
Cell Culture
 The cells used in this work were derived from the human colon adenocarcinoma 
cell line SW620 (purchased from ATCC) and were maintained in Leibovitz’s L-15 medium 
(Gibco) supplemented with 10% heat-inactivated fetal bovine serum (Cambrex), 10 mM 
HEPES buffer (Gibco), 1 mM sodium pyruvate (Gibco), and 1% antibiotic-antimycotic 
(Invitrogen).  Cells were grown in a humidified 5% CO2 atmosphere at 37 °C.  For polyamide 
treatment experiments, cells were plated in 25 cm2 cell culture flasks (Corning) at 600,000 
cells/flask in 10 mL media.  Flasks were incubated at 37 oC for 2.5 h prior to addition of 
polyamide stock solution or water (control).  Three flasks were treated per condition.  Cells 
were incubated for 3 days prior to analysis.  Cell morphology was recorded by phase contrast 
microscopy with 40x magnification (Nikon Diaphot with attached Nikon D100 camera). 
Cells were then trypsinized for 7 min at 37 oC and recombined with their media.  An aliquot 
was removed to determine cell viability and proliferation via trypan blue exclusion and 
cell count using a Vi-Cell XR cell viability analyzer (Beckman-Coulter).  100 images were 
obtained per flask (3 flasks/condition).  The remaining cells from each treatment condition 
were then combined, pelleted, and washed with Dulbecco’s PBS (Gibco), and fixed at -20 
oC with 70% EtOH for 35 min.  The fixed cells were then pelleted, washed with Dulbecco’s 
PBS, re-pelleted, and suspended in a solution containing 0.1% Triton X-100, 0.2 mg/mL 
RNAse A (Sigma), and 0.02 mg/mL propidium iodide (Sigma) in Dulbecco’s PBS.  Cells 
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were incubated overnight at 4 oC in the dark prior to FACS analysis (FACSCalibur; Becton 
Dickinson).  Parameters for FL2 were adjusted to give histograms with G0/G1 peaks 
centered at 200 for each sample to compensate for differences in cell size. 
Animal Experiments
Female BALB/c mice were purchased from The Scripps Research Institute Division 
of Animal Resources.  Mice 8-12 weeks of age were given injections of PBS (control) or 
100 nmol polyamide/injection via the tail vein on days 0, 2, and 4, with the exception of 
2R-Chl.  Doses of 2R-Chl were given only on days 0 and 2 due to lethality by day 4. 
The mice were weighed and their behavior monitored and recorded daily.  Experimental 
protocols were approved by The Scripps Institutional Animal Welfare Committee and 
were conducted in conformity with institutional guidelines, which are in compliance with 
national and international laws and policies.
Acknowledgements
 We thank David Alvarez for helpful discussions; David M. Chenoweth for molecular 
modeling; Kathy Klingensmith, Pastorcito Nieto, and Antonio Reyes from TSRI ICND 
Vivarium; and Dr. Kent Osborn DMV and Leslie Nielsen from TSRI Pathology lab for 
helpful discussions and assistance on animal care and protocols. We are grateful to the 
National Institutes of Health for research support (CA107311) and for a pre-doctoral NRSA 
training grant to M.E.F. 
47
References
1. Dervan, P. B.; Poulin-Kerstien, A. T.; Fechter, E. J.; Edelson, B. S. Top. Curr. Chem. 
    2005.  253, 1-31.
2. Best, T. P.; Edelson, B. S.; Nickols, N. G.; Dervan, P. B. Proc. Natl. Acad. Sci. U. S. A. 
    2003.  100, 12063-12068.
3. Edelson, B. S.; Best, T. P.; Olenyuk, B.; Nickols, N. G.; Doss, R. M.; Foister, S.; 
    Heckel, A.; Dervan, P. B. Nucleic Acids Res. 2004.  32, 2802-2818.
4. Olenyuk, B. Z.; Zhang, G. J.; Klco, J. M.; Nickols, N. G.; Kaelin, W. G.; Dervan, P. B. 
    Proc. Natl. Acad. Sci. U. S. A.      2004.  101, 16768-16773.
5. Burnett, R.; Melander, C.; Puckett, J. W.; Son, L. S.; Wells, R. B.; Dervan, P. B.; 
    Gottesfeld, J. M. Proc. Natl. Acad. Sci. U. S. A. 2006.  103, 11497-11502.
6. Wemmer, D. E.; Dervan, P. B. Curr. Opin. Struct. Biol. 1997.  7, 355-361.
7. Turner, J. M.; Swalley, S. E.; Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc.  1998.  120, 
    6219-6226.
8. Wang, C. C. C.; Ellervik, U.; Dervan, P. B. Bioorg. Med. Chem.  2001.  9, 653-657.
9. White, S.; Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc. 1997.  119, 8756-8765.
10. Mrksich, M.; Parks, M. E.; Dervan, P. B. J. Am. Chem. Soc. 1994.  116, 7983-7988.
11. Swalley, S. E.; Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc.  1999.  121, 1113-1120.
12. Geierstanger, B. H.; Mrksich, M.; Dervan, P. B.; Wemmer, D. E. Nat. Struct. Biol. 
      1996.  3, 321-324.
13. de Clairac, R. P. L.; Seel, C. J.; Geierstanger, B. H.; Mrksich, M.; Baird, E. E.; 
      Dervan, P. B.; Wemmer, D. E. J. Am. Chem. Soc.  1999.  121, 2956-2964.
14. Herman, D. M.; Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc. 1998.  120, 1382-1391.
15. Shinohara, K.; Sasaki, S.; Minoshima, M.; Bando, T.; Sugiyama, H. Nucleic Acids 
      Res. 2006.  34, 1189-1195.
16. Bando, T.; Sugiyama, H. Accounts Chem. Res. 2006.  39, 935-944.
48
17. Pezzoni, G.; Grandi, M.; Biasoli, G.; Capolongo, L.; Ballinari, D.; Giuliani, F. C.; 
      Barbieri, B.; Pastori, A.; Pesenti, E.; Mongelli, N.; Spreafico, F. Br. J. Cancer. 1991.  
      64, 1047-1050.
18. Wyatt, M. D.; Lee, M.; Hartley, J. A. Anti-Cancer Drug Des. 1997.  12, 49-60.
19. Wurtz, N. R.; Dervan, P. B. Chem. Biol. 2000.  7, 153-161.
20. Wang, Y. D.; Dziegielewski, J.; Wurtz, N. R.; Dziegielewska, B.; Dervan, P. B.; 
      Beerman, T. A. Nucleic Acids Res. 2003.  31, 1208-1215.
21. Dickinson, L. A.; Burnett, R.; Melander, C.; Edelson, B. S.; Arora, P. S.; Dervan, P. 
      B.; Gottesfeld, J. M. Chem. Biol. 2004.  11, 1583-1594.
22. Dickinson, L. A.; Burnett, R.; Melander, C.; Edelson, B. S.; Arora, P. S.; Dervan, P. 
      B.; Gottesfeld, J. M. Chem. Biol. 2006.  13, 339-339.
23. Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc. 1996.  118, 6141-6146.
24. Wyatt, M. D.; Lee, M.; Garbiras, B. J.; Souhami, R. L.; Hartley, J. A. Biochemistry. 
      1995.  34, 13034-13041.
25. Alvarez, D.; Chou, C. J.; Latella, L.; Zeitlin, S. G.; Ku, S.; Puri, P. L.; Dervan, P. B.; 
      Gottesfeld, J. M. Cell Cycle. 2006.  5, 1537-1548.
26. Pawlak, K.; Pawlak, J. W.; Konopa, J. Cancer Res. 1984.  44, 4289-4296.
27. Sunters, A.; Springer, C. J.; Bagshawe, K. D.; Souhami, R. L.; Hartley, J. A. Biochem. 
      Pharmacol. 1992.  44, 59-64.
28. Trauger, J. W.; Dervan, P. B. Methods Enzymol. 2001.  340, 450-466.
49
Chapter IIB
α-Diaminobutyric Acid-Linked Hairpin Polyamides
The text of this chapter was taken in part from a manuscript co-authored with Sherry M. 
Tsai and Peter B. Dervan (California Institute of Technology)
(Farkas, M.E.; Tsai, S.M; Dervan, P.B. Bioorg. Med. Chem. 2007, 15, 6927-6936)
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Abstract
A hairpin polyamide-chlorambucil conjugate linked by α-diaminobutyric acid 
(α-DABA) has been shown to have interesting biological properties in cellular and 
small animal models.  Remarkably, this new class of hairpin polyamides has not been 
previously characterized with regard to energetics and sequence specificity.  Herein we 
present a series of pyrrole-imidazole hairpin polyamides linked by α-DABA and compare 
them to polyamides containing the standard γ-DABA turn unit.  The α-DABA hairpins 
have decreased binding affinities overall.  However, α-DABA polyamide-chlorambucil 
conjugates are sequence-specific DNA alkylators with increased specificities.  Affinity 
cleavage studies of α-DABA polyamide-EDTA conjugates confirmed their preference for 
binding DNA in a forward hairpin conformation.  In contrast, an unsubstituted glycine-
linked polyamide prefers to bind in an extended binding mode.  Thus, substitution on the 
turn unit locks the α-DABA polyamide into the forward hairpin binding motif.
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Introduction
 Pyrrole-imidazole polyamides are a class of synthetic ligands that can be programmed 
to bind a broad repertoire of DNA sequences with affinities and specificities similar to 
DNA-binding proteins.1,2  Eight-ring hairpin polyamides have been shown to localize to the 
nuclei of living cells,3,4 and regulate transcription by interfering with transcription factor-
DNA interfaces in the promoters of endogenous genes.5-9  Conjugation of polyamides to 
the DNA alkylating agent chlorambucil produces molecules capable of sequence-specific 
covalent reaction with DNA,10 previously demonstrated for targeted sequences in the HIV-
1 promoter, simian virus 40, and the histone H4c gene.11-13 
 DNA recognition by polyamides depends on side-by-side, aromatic amino acid 
pairings in the minor groove.  Pairing rules have been established for DNA base pair 
recognition:  an N-methylpyrrole/N-methylimidazole (Py/Im) pair recognizes C•G, the 
reverse (Im/Py) specifies G•C, and a Py/Py pair targets both A•T and T•A.2  For some 
sequences, replacement of Py with a flexible β-alanine (β) residue can enhance polyamide 
binding affinity by relaxing ligand curvature, affording a more optimal fit in the minor 
groove of DNA.14
 Although Py-Im polyamides will bind in the minor groove as anti-parallel dimers,15 
polyamides bind DNA optimally as a single oligomer in a hairpin structure.16  Early studies 
demonstrated the optimal length for the turn element is three methylene units, via the use 
of γ-aminobutyric acid as the turn residue.16  The polyamide hairpin binds in the ‘forward’ 
direction N→C with respect to the 5’→3’ direction of the DNA strand.17  Utilization of the 
substituted turn (R)-2,4-diaminobutyric acid (γ-DABA) further enhances DNA binding 
affinity.18  Notably, employment of a linkage containing one methylene unit – provided 
by the use of glycine as the turn amino acid – resulted in polyamides that bound DNA in 
an extended 2:1 binding mode, rather than as a 1:1 hairpin complex.16,19-21  In contrast, the 
γ-aminobutyric acid linkage appears to prefer the U-shaped conformation rather than an 
extended dimeric conformation.20  
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We recently reported a new turn unit with remarkable properties in small animal 
models:  (R)-α-diaminobutyric acid (α-DABA), which is formally a substituted glycine 
linkage since it also includes a single methylene unit within the hairpin turn.22  This initial 
study characterized an α-DABA polyamide-chlorambucil conjugate and compared its 
biological activity to its γ-DABA analog.  A dramatic difference in toxicity was observed 
for the two conjugates:  normal mice treated with the α-DABA polyamide-chlorambucil 
conjugate did not differ significantly from control, while the analogous γ-DABA conjugate 
was lethal.22  Notably, only the α-DABA conjugate has been demonstrated to arrest cancer 
growth in a SW620 xenograft nude mouse tumor model without apparent toxicity.13
 Given the striking in vivo effects demonstrated by the α-DABA polyamide conjugate, 
this new turn unit merits further study.  In particular, α-DABA polyamides appear to bind 
in a hairpin conformation and not as an extended dimer, as would be expected based on 
studies of glycine-linked polyamides.  
 We report herein the characterization of α-DABA polyamides.  A series of α-DABA 
polyamides and their chlorambucil conjugates were synthesized, along with their γ-DABA 
analogs.  DNA binding properties of the parent molecules were established by DNase I 
footprinting titration experiments, and DNA alkylation properties of the chlorambucil 
conjugates were determined by thermal cleavage assay experiments.  Importantly, we study 
the binding orientation of α-DABA polyamides and address their ability to bind as hairpins 
by comparing them to their glycine-linked analogs.
Results and Discussion
Synthesis of the polyamide series
Four core ring sequences were selected for characterization (Figure IIB.1).  Two 
standard eight-ring hairpin sequences, as well as a hairpin containing a β/Py pair and a 2- 
β-2 configuration, were chosen.  Eight parent hairpin polyamides were thus prepared:  four 
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molecule pairs which code for different sequences according to the pairing rules.  For each 
pair, one molecule was linked via the α-DABA turn unit (polyamides 1, 3, 5, and 7), and 
the other was connected with the γ-DABA turn (polyamides 2, 4, 6, and 8).  Polyamides 
were synthesized on Pam resin using standard solid phase methods.22,23  The chlorambucil 
conjugates of the eight parent hairpin polyamides were also prepared based on previously 
published methods.22
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Figure IIB.1.  Chemical and ball-and-stick structures of polyamides 1-8 and their Chl conjugates.  Shown are 
α-diaminobutyric acid-linked hairpin polyamides (left) and γ-diaminobutyric acid-linked hairpin polyamides 
(right).  The ball and stick symbols are defined as follows: an open circle denotes a pyrrole ring, a filled circle 
denotes an imidazole, and a diamond shape denotes β-alanine.
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Plasmid design
 Polyamides 1 and 2 were designed to bind the sequence 5’-WWGGWGW-3’ (where 
W = A or T).  The plasmid pMFST2 was designed with an insert containing a single match 
site (‘M’ = 5’-TAGGTGT-3’) and two single base pair mismatch sites (‘A’ = 5’-TAGGTCT-
3’ and ‘B’ = 5’-TAGCTGT-3’) for polyamides 1 and 2 (Figure IIB.2A).22  
 A single plasmid, pMFST, was prepared to characterize polyamides 3-6 (Figure 
IIB.2B).  Polyamides 3 and 4 were targeted to the sequence 5’-WWGGWCW-3’, and 
polyamides 5 and 6 were designed to bind 5’-WWGWGGW-3’.  The designed insert for 
pMFST contains match sites for each set of polyamides (‘M1’ = 5’-TAGTGGT-3’, targeted 
to 5 and 6, and ‘M2’ = 5’-ATGGTCA-3’, targeted to 3 and 4), as well as two single base 
pair mismatch sites for each (‘A’ = 5’-ATATGGT-3’ and ‘B’ = 5’-TAGTCGT-3’ for 5 and 
6, and ‘C’ = 5’-AACGACT-3’ and ‘D’ = 5’-TAGCACA-3’ for 3 and 4).  
The plasmid pMFST3 was used to characterize polyamides 7 and 8 (Figure IIB.2C) 
which target the sequence 5’-WWGCWGCW-3’.  The insert for this plasmid contains 
a single match site (‘M’ = 5’-TAGCTGCT-3’), as well as a site for polyamide reverse 
binding (‘R’ = 5’-TCGTCGAT-3’), and two single base pair mismatch sites (‘A’ = 5’-
TAGGTGCT-3’ and ‘B’ = 5’-TAGCTGTT-3’).  The chlorambucil moiety is expected to 
alkylate at adenines proximal to the polyamide binding sites.11,22  Thus, for the purposes of 
the thermal cleavage assays, adenines were placed next to the 3’ end of the match sites and 
at least one of the mismatch sites for all plasmid inserts (Figure IIB.2).  
DNA binding affinity and sequence specificity
 Quantitative DNase I footprinting titrations were performed with the parent 
polyamides to measure their binding site affinities and specificities (Figure IIB.3 and Table 
IIB.1).  The α-DABA polyamide 1 and its γ-DABA analog 2 were footprinted on the 5’ 
32P-labeled 280 base pair PCR product of plasmid pMFST2 (Figure IIB.3A and 3B).  α-
DABA polyamide 1 bound the match site M with Ka = 3.0 x 108 M-1 and the mismatch site A 
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C
32P
pMFST3
 288 bp
Eco RIPvu II
M
5'-TCCCGTC TAGCTGCT TAGGCGAT TCGTCGAT CTGGCGTC TAGGTGCT TAGGCGTC TAGCTGTT TAGGCGT AGGGCAG-3'
3'-AGGGCAG ATCGACGA ATCCGCTA AGCAGCTA GACCGCAG ATCCACGA ATCCGCAG ATCGACAA ATCCGCA TCCCGTC-5'*
R BA
B
32P
M1 B
5'-TACAATCAT TAGTGGT TACAATC ATATGGT CATACAATCAT TAGTCGT TACAATCAT TAGCACA CACAATCAT-3'
3'-ATGTTAGTA ATCACCA ATGTTAG TATACCA GTATGTTAGTA ATCAGCA ATGTTAGTA ATCGTGT GTGTTAGTA-5'*
A
M2 C D
5'-TACAATCAT TAGTGGT TACAATCAT ATGGTCA TACAATCATT AGTCGTT ACAATCAT TAGCACA CACAATCAT-3'
3'-ATGTTAGTA ATCACCA ATGTTAGTA TACCAGT ATGTTAGTAA TCAGCAA TGTTAGTA ATCGTGT GTGTTAGTA-5'*
pMFST
284 bp
Eco RIPvu II
A
Eco RIPvu II
32P
5'-CGCCCTT TAGGTGT TACGT AGTGGTG CCG TAGGTCT TAGCCG TAGCTGT TGCCGT AAGGGCGAATTCTG-3'
3'-GCGGGAA ATCCACA ATGCA TCACCAC GGC ATCCAGA ATCGGC ATCGACA ACGGCA TTCCCGCTTAAGAC-5’*
M BA
pMFST2
280 bp
Figure IIB.2.  Illustration of the EcoRI/PvuII restriction fragments derived from plasmids (A) pMFST2, (B) 
pMFST, and (C) pMFST3.  Polyamides 1 and 2 were characterized on pMFST2. Polyamides 3-6 were char-
acterized on pMFST.  Polyamides 7 and 8 were characterized on pMFST3.  The designed polyamide binding 
sites are indicated by boxes.  Single base pair mismatches are indicated by shaded regions.  For pMFST, the 
designed insert is shown twice with binding sites for polyamides 3 and 4 (B, bottom) and polyamides 5 and 
6 (B, top).
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with Ka = 8.5 x 10
7 M-1 (Table IIB.1).  Binding of 1 at the mismatch site B was not detected. 
In contrast, the γ-DABA polyamide 2 bound the match site M with Ka = 4.4 x 1010 M-1 and 
the mismatch sites A and B with Ka = 1.1 x 10
10 M-1 and Ka = 1.1 x 10
9 M-1, respectively.  The 
γ-DABA polyamide 2 displays a 147-fold increased binding affinity over the α-DABA 
polyamide 1 for their match site M.  
 The α-DABA polyamides 3 and 5 and their γ-DABA analogs 4 and 6, respectively, 
were footprinted on the 5’ 32P-labeled 284 base pair PCR product of plasmid pMFST (Figure 
IIB.3C-3F).  α-DABA polyamide 3 bound its match site M2 with Ka = 4.4 x 109 M-1 and 
the mismatch site C with Ka = 1.5 x 10
8 M-1.  There was no detectable binding at mismatch 
site D.  However, the analogous γ-DABA polyamide 4 bound the match site M2 with Ka 
= 4.9 x 1010 M-1 and the mismatch sites C and D with Ka = 1.8 x 10
10 M-1 and Ka = 3.9 x 10
8 
M-1, respectively.  The α-DABA polyamide 3 binds its match site with 11-fold decreased 
affinity relative to the analogous γ-DABA polyamide 4.
 α-DABA polyamide 5 bound its match site M1 with Ka = 8.0 x 108 M-1 and its 
mismatch site B with Ka = 6.2 x 10
7 M-1.  Binding was not observed at mismatch site A.  In 
comparison, the γ-DABA polyamide 6 binds the match site M1 with Ka = 4.3 x 1010  M-1 
and the mismatch sites A and B with Ka = 9.9 x 10
8 M-1 and Ka = 6.2 x 10
9 M-1, respectively. 
The α-DABA polyamide 5 shows a 54-fold decreased affinity for its match site compared 
to the analogous γ-DABA polyamide 6.  
 α-DABA polyamide 7 bound the match site M with Ka = 1.3 x 1010 M-1 and its 
mismatch site B with Ka = 1.0 x 10
8 M-1.  There was no detectable binding at mismatch site 
A.  The analogous γ-DABA polyamide 8 binds the match site M with Ka = 2.9 x 1010  M-1 
and mismatch sites A and B with Ka = 2.2 x 10
9 M-1 and Ka = 5.2 x 10
9 M-1, respectively.  The 
α-DABA polyamide 7 shows a 2.2-fold decreased affinity for its match site compared to 
the γ-DABA polyamide 8.
These results indicate that α-DABA polyamides are proficient DNA binders, with 
decreased affinity and comparable or improved specificity relative to γ-DABA molecules. 
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Figure IIB.3.  Quantitative DNase I footprinting titration experiments for polyamides (A) 1 and (B) 2 on the 
280 base pair, 5’ end-labeled PCR product of plasmid pMFST2; for polyamides (C) 3, (D) 4, (E) 5, and (F) 
6 on the 284 base pair, 5’ end-labeled PCR product of plasmid pMFST; and for polyamides (G) 7 and (H) 8 
on the 288 base pair, 5’ end-labeled PCR product of plasmid pMFST3:  lanes 1-11, 100 nM, 30 nM, 10 nM, 
3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 pM polyamide, respectively; lane 12, DNase I 
standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction.  Each footprinting gel is accompanied 
by its respective binding isotherms (below).
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The decrease in affinity is dependent on the polyamide core ring sequence. Varying the 
heterocyclic order of polyamides has also been shown to affect binding affinities in γ-
DABA molecules.24
Polyamide
Match
 Site K   (M   ) a
-1
1 5’-TAGGTGT-3’ 3.0 (± 1.3) x 108
2 5’-TAGGTGT-3’ 4.4 (± 0.4) x 1010
5 5’-TAGTGGT-3’ 8.0 (± 0.6) x 108
6 5’-TAGTGGT-3’ 4.3 (± 0.3) x 1010
3 5’-ATGGTCA-3’ 4.4 (± 0.6) x 109
4 5’-ATGGTCA-3’ 4.9 (± 0.7) x 1010
[147]
[54]
[11]
5’-TAGGTCT-3’ 8.5 (± 3.1) x 107
5’-TAGGTCT-3’ 1.1 (± 0.8) x 1010
5’-ATATGGT-3’ --
5’-ATATGGT-3’ 9.9 (± 0.3) x 108
5’-AACGACT-3’ 1.5 (± 0.3) x 108
5’-AACGACT-3’ 1.8 (± 0.3) x 1010
5’-TAGCTGT-3’ --
5’-TAGCTGT-3’ 1.1 (± 0.3) x 109
5’-TAGTCGT-3’ 6.2 (± 3.0) x 107
5’-TAGTCGT-3’ 6.2 (± 0.2) x 109
5’-TAGCACA-3’ --
5’-TAGCACA-3’ 3.9 (± 1.0) x 108
Mismatch
    Site K   (M   ) a
-1
Mismatch
    Site K   (M   ) a
-1
[129]
[120]
[100]
7 5’-TAGCTGCT-3’ 1.3 (± 0.2) x 1010
8 5’-TAGCTGCT-3’ 2.9 (± 0.3) x 1010
[2.2]
5’-TAGGTGCT-3’ --
5’-TAGGTGCT-3’ 2.2 (± 0.3) x 109
5’-TAGCTGTT-3’ 1.0 (± 0.7) x 108
5’-TAGCTGTT-3’ 5.2 (± 0.5) x 109
[52]
Table IIB.1.  Binding affinities (M-1) for parent polyamides on plasmid pMFST2 (1-2), plasmid pMFST (3-
6), and pMFST3 (7-8).  Equilibrium association constants reported are mean values from three DNase I foot-
printing titration experiments.  Standard deviations are shown in parentheses.  Bolded numbers in brackets 
indicate fold decrease in match site binding affinity for α-DABA-linked versus γ-DABA-linked polyamides. 
Mismatch base pairs are indicated in bold.
 We previously reported the α-DABA polyamide of sequence ImImβIm-(R)H2Nα-
PyPyPyPy-βDp (where Dp = 3-(dimethylamino)-propylamine) binds the match site M of 
pMFST2 with Ka = 6.7 x 10
9 M-1.22  Polyamide 1 has an identical structure except for the 
replacement of a β residue in the core sequence with a Py, and it binds the same match site 
M of pMFST2 with 22-fold decreased affinity.  Polyamide 5 also has the same structure 
except for the movement of the β residue from the third position in the sequence to the 
second, and it binds its designed match site with 8-fold decreased affinity.  These results 
suggest the presence and position of the β residue is important in determining the DNA 
binding affinities of α-DABA polyamides.  We hypothesize that the shortened α-DABA 
turn unit requires the flexibility provided by the β to optimize binding.
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DNA alkylation properties
 Thermal cleavage assays were performed with the polyamide-chlorambucil 
conjugates to determine their DNA alkylation properties (Figure IIB.4).  Previous studies 
have shown conjugates to alkylate at N3 of adenines proximal to DNA binding sites.11,13 
Attachment of the chlorambucil moiety to the parent polyamide does not appear to affect 
DNA binding properties.11
 The α-DABA conjugate 1-Chl and its γ-DABA analogue 2-Chl were assayed 
on the 5’ 32P-labeled 280 base pair PCR product of plasmid pMFST2 (Figure IIB.4A). 
Alkylation was only observed in the designed insert of pMFST2 at the match site M for the 
α-DABA conjugate 1-Chl, whereas the γ-DABA conjugate 2-Chl is more promiscuous, 
alkylating at the match site M and both mismatch sites A and B, as well as at additional 
unexpected sites.  γ-DABA conjugate 2-Chl also alkylates at lower concentrations than 
conjugate 1-Chl (Figure IIB.4A, lanes 9).
 Conjugates 3-Chl and 4-Chl were assayed on the 5’ 32P-labeled 284 base pair PCR 
product of plasmid pMFST (Figure IIB.4B).  While parent polyamide 3 binds at site M2 and 
site C, α-DABA conjugate 3-Chl only alkylates at match site M2 in the designed insert. 
Alkylation is observed at both the match site M2 and the mismatch site C for the γ-DABA 
conjugate 4-Chl.  Although the parent polyamide 4 binds at mismatch site D, alkylation 
would not be expected to occur there because an A•T base pair is not located adjacent to the 
turn unit upon conjugate binding.  Again, alkylation is observed at lower concentrations for 
the γ-DABA conjugate 4-Chl than the α-DABA conjugate 3-Chl (Figure IIB.4B, lanes 
7).
 Conjugates 5-Chl and 6-Chl were also assayed on the PCR product of plasmid 
pMFST (Figure IIB.4C).  For the α-DABA conjugate 5-Chl, strong alkylation is only 
observed at match site M1 in the designed insert, with minor alkylation occurring at 
mismatch site B.  In contrast, the γ-DABA conjugate 6-Chl strongly alkylates at both 
match site M1 and mismatch site B, as well as at other unexpected sites.  As previously, 
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Figure IIB.4.  (A) Thermal cleavage assay experiments with polyamide-chlorambucil conjugates (left)  1-
Chl and (right) 2-Chl on the on the 280 base pair, 5’ end-labeled PCR product of plasmid pMFST2:  lane 
1, A reaction; lane 2, G reaction; lanes 3-13, 1 μM, 300 nM, 100 nM, 30 nM, 10 nM, 3 nM, 1 nM, 300 pM, 
100 pM, 30 pM, and 10 pM polyamide, respectively; lane 14, intact DNA.  (B-D)  Thermal cleavage assay 
experiments with polyamide-chlorambucil conjugates 3-Chl (B, left) and 4-Chl (B, right), and 5-Chl (C, 
left) and 6-Chl (C, right) on the 284 base pair, 5’ end-labeled PCR product of plasmid pMFST, and 7-Chl (D, 
left) and 8-Chl (D, right) on the 288 base pair, 5’ end-labeled plasmid pMFST3:  lane 1, A reaction; lane 2, 
G reaction; lanes 3-13, 100 nM, 30 nM, 10 nM, 3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 
pM polyamide, respectively; lane 14, intact DNA.  Putative major sites of alkylation on the DNA fragments 
are indicated by arrows on the sequences adjacent to each gel.
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alkylation is not expected at mismatch site A since an A•T base pair is not located next to 
the turn unit upon conjugate binding.  In addition, γ-DABA conjugate 6-Chl is able to 
alkylate at a lower concentration than α-DABA conjugate 5-Chl (Figure IIB.4C, lanes 
9).
 Alkylation of the MFST3 plasmid insert was studied with polyamides 7-Chl and 8-
Chl (Figure IIB.4D).  The α-DABA conjugate 7-Chl was observed to specifically alkylate 
at the match site M, whereas the γ-DABA conjugate 8-Chl alkylated at both the match 
and mismatch sites A and B.  These results indicate that α-DABA conjugates are alkylators 
with increased specificity and decreased reactivity relative to γ-DABA conjugates.  
Polyamide binding orientation
   Previous footprinting studies indicated that glycine-linked polyamides bind DNA in 
extended, dimeric 2:1 complexes,16,20 and the structures were confirmed by NMR studies.19,21 
Two possible binding modes were established (Figure IIB.5).  In the “overlapped” binding 
mode, the two polyamides bind directly opposite one another with each heterocycle paired 
to another on the other strand.  In the “slipped” binding mode, the polyamides integrate the 
R
5'- WWWWWNWGGCCWNWWWWW -3'
3'- WWWWWNWCCGGWNWWWWW -5'
R
R
R
5'- WWGGWCWGWCCWW -3'
3'- WWCCWGWCWGGWW -5'
R
5'- WWGGWCW -3'
3'- WWCCWGW -5'
Folded Hairpin
Slipped Overlapped
Extended Dimer Extended Dimer
Forward Match
NH3
+R =   H   or
Figure IIB.5.  Illustration of the binding modes for polyamides 3 and 7.  ‘W’ signifies A or T; ‘N’ represents 
any nucleotide.  Sequence specificity for the slipped binding mode has been presumed based on the polyam-
ide literature.
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2:1 and 1:1 polyamide-DNA binding motifs at a single site.  
 Formally, the α-DABA moiety is a substituted glycine turn, as glycine-linked 
polyamides also contain a single methylene group linking the heterocyclic subunits.    Yet, 
based on their footprinting data (i.e. binding site sequence and size, and cooperativity 
as measured in the binding isotherms), α-DABA polyamides bind in a 1:1 hairpin 
conformation.22  Although it is well-established that γ-DABA polyamides bind in the 
forward direction,17 there is still ambiguity as to the preferred binding orientation of α-
DABA polyamides.
 We hypothesized that a polyamide with the unsubstituted glycine linkage would 
favor the extended conformation, whereas substitution of the turn using the α-DABA 
moiety would force the polyamide to bind in a forward hairpin conformation.  A similar 
phenomenon has been observed by Boger and coworkers, who studied a series of α-
substituted β-linked polyamides and found that a polyamide linked by (R)-α-methoxy-
β preferentially adopts a hairpin conformation versus the unsubstituted molecule, which 
binds in an extended conformation.25  Interestingly, other substitutions disrupted binding 
affinity.
 α-DABA polyamide 3 was chosen as the parent molecule for study.  To verify its 
binding orientation, the EDTA conjugate EDTA-3 was synthesized for affinity cleavage 
studies (Figure IIB.6).  Polyamide 9 – the glycine-linked analog of  3 – was prepared, 
as well as its EDTA conjugate, EDTA-9.  Four binding orientations are possible for 
polyamides 3 and 9.  The expected match site for the molecules binding as forward hairpins 
is 5’-WWGGWCW-3’, whereas for reverse-binding hairpins the expected match site is 
5’-WCWGGWW-3’.  In the overlapped binding mode, the expected target sequence is 
5’-WWGGWCWGWCCWW-3’.  It should be noted that the overlapped match site is 
inherently ambiguous because it contains two side-by-side copies of the forward hairpin 
match site.  Binding affinity in the slipped mode is sensitive to the particular sequence of 
the 1:1 binding portion, and there are multiple slipped binding modes for a given polyamide 
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Figure IIB.6.  Chemical and ball-and-stick structures of EDTA-3, and of the glycine-linked polyamide 9 and 
its EDTA conjugate EDTA-9.  
core ring sequence.20  Since an Im/Im pair is disfavored,26  we studied the slipped orientation 
for 3 and 9 believed to be preferred for binding.  We expect this binding model to give an 
18 base pair match site with sequence 5’-WWWWWNWGGCCWNWWWWW-3’ where 
N = A, T, G, or C.20,27    
 Plasmid pMFST5 was prepared to study the binding preferences of the selected 
molecules (Figure IIB.7A).  The designed insert contains four match sites for each 
of the possible binding modes for polyamides 3 and 9:  slipped extended binding 
(‘S’ = 5’-ATTAACAGGCCACAATTA-3’), overlapped extended binding (‘O’ = 5’-
ATGGTCAGACCAT-3’), reverse hairpin binding (‘R’ = 5’-ACTGGTA-3’), and forward 
hairpin binding (‘M’ = 5’-ATGGTCA-3’).  Quantitative DNase I footprinting titrations were 
performed with α-DABA polyamide 3 and glycine polyamide 9 (Figure IIB.7B and Table 
IIB.2), and affinity cleavage studies were performed with α-DABA conjugate EDTA-3 
and glycine conjugate EDTA-9 (Figure IIB.7C and 7D) on the 5’ 32P-labeled, 301 base pair 
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Figure IIB.7. (A)  Illustration of the EcoRI/PvuII restriction fragment derived from plasmid pMFST5.  The 
designed polyamide binding sites are indicated by boxes.  Binding models are illustrated below the DNA 
sequence by ball-and-stick structures of EDTA-9.  (B)  Quantitative DNase I footprinting titration experi-
ments for polyamides 3 (left) and 9 (right) on the 301 base pair, 5’ end-labeled PCR product of plasmid 
pMFST5:  lanes 1-11, 100 nM, 30 nM, 10 nM, 3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 
pM polyamide, respectively; lane 12, DNase I standard; lane 13, intact DNA; lane 14, A reaction; lane 15, 
G reaction.  Site X indicates an undesigned match site inherent in the plasmid sequence.  Each footprinting 
gel is accompanied by its respective binding isotherms (below).  (C)  Affinity cleavage experiments with 
polyamide-EDTA conjugates (left) EDTA-3 and (right) EDTA-9 on the 301 base pair, 5’ end-labeled PCR 
product of plasmid pMFST5:  lane 1, A reaction; lane 2, G reaction; lanes 3-13, 1 μM, 300 nM, 100 nM, 30 
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nM, 10 nM, 3 nM, 1 nM, 300 pM, 100 pM, 30 pM, and 10 pM polyamide, respectively; lane 14, intact DNA. 
(D)  Summary of affinity cleavage patterns for EDTA-3 (top) and EDTA-9 (bottom).  Bar heights are propor-
tional to the relative cleavage intensities at each base pair, normalized to each gel.  Ball-and-stick structures 
illustrating their respective proposed modes of binding are shown using EDTA-9 for clarity.  Designed bind-
ing sites are indicated in bold in the DNA sequence.
Polyamide M
3 9.8 (± 1.3) x 109
9 7.0 (± 1.0) x 108
4.7 (± 1.3) x 109
5.9 (± 2.1) x 108
--
1.3 (± 0.2) x 109
O S
Table IIB.2.  Binding affinities (M-1) for parent polyamides 3 and 9 on plasmid pMFST5.  Equilibrium as-
sociation constants reported are mean values from three DNase I footprinting titration experiments.  Standard 
deviations are shown in parentheses.
PCR product of plasmid pMFST5.  A dramatic difference between the two molecules was 
observed.  The α-DABA polyamide 3 binds the forward hairpin binding site M with Ka = 
9.8 x 109 M-1, while no binding was detected at the slipped binding site S or reverse hairpin 
site R.  Cleavage by EDTA-3 was observed at match site M at the locus in agreement with 
forward binding and is 3’-shifted, consistent with minor groove occupancy.28  
 Additional binding of polyamide 3 was observed at the overlapped site O with Ka 
= 4.7 x 109 M-1.  Unequal cleavage intensities by EDTA-3 were observed at the 3’ and 5’ 
ends of the match site.  A fully anti-parallel overlapped motif would be expected to afford 
equal intensities.  Therefore it is likely that polyamide 3 is binding as a hairpin in either 
of the adjacent hairpin match sites embedded in the 13 base-pair sequence O (Figure 
IIB.7D, top).
 In contrast, the glycine polyamide 9 binds the slipped extended site S with Ka = 
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1.3 x 109 M-1, and it binds the forward hairpin site M and overlapped site O with ~ 2-fold 
decreased affinities (Ka = 7.0 x 10
8 M-1 and Ka = 5.9 x 10
8 M-1, respectively).  No binding 
was observed at the reverse hairpin site R.  Strong cleavage by EDTA-9 was only observed 
at site S, probably due to the weaker binding affinities at the other sites.  The cleavage 
pattern was 3’ shifted, verifying minor groove occupancy of the ligand, and the observed 
pattern was consistent with dimeric, antiparallel binding in the slipped mode.  There is again 
ambiguity regarding the binding mode at the overlapped site O.  It is interesting to note that 
though polyamide 9 is a relatively small ligand (MW = 1196), it displays specificity for an 
18 base pair sequence.  It is likely that the binding affinity of 9 in the slipped binding mode 
could be enhanced by modifying the sequence of the W tracts in the 1:1 binding portions 
of the molecules to a DNA sequence that favors a narrower minor groove.20 
 These data show a clear distinction in preferred binding modes between α-DABA 
polyamide 3 and glycine polyamide 9.  The α-DABA polyamide appears to bind exclusively 
in a forward hairpin conformation, while the glycine polyamide seems to exhibit mixed 
binding motifs, preferring the extended binding mode but also appearing to be capable of 
binding as a forward hairpin.  Thus, substitution of the glycine turn ‘locks’ the polyamide 
into a hairpin conformation.  
Additional affinity cleavage studies were performed on the EDTA conjugates of 
polyamides 7 and 8, 7-EDTA and 8-EDTA, respectively (Figure IIB.8A), and EDTA-
10, the EDTA conjugate of polyamide 10, which has been previously described (Figure 
IIB.9A).22  Affinity cleavage experiments for EDTA-7 and EDTA-8 were performed on 
pMFST3 (Figure IIB.2C and 8B).  Cleavage was observed at both 5’ and 3’ sites flanking the 
polyamides (Figure IIB.8C); this is likely due to the nature of the targeted DNA sequence, 
which allows for the molecules to bind in a forward orientation, 5’→3’ with respect to 
either the top or bottom strands.  
Plasmid pMFST4 (Figure IIB.9B) was designed to study the binding mode of 
polyamide 10, and was designed with both a forward and reverse match site (‘M’ = 5’-
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Figure IIB.8.  (A)  Chemical structures for polyamide-EDTA conjugates EDTA-7 and EDTA-8.  (B)  Af-
finity cleavage experiments with polyamide-EDTA conjugates EDTA-7 (left) and EDTA-8 (right) on the 
288 base pair, 5’ end-labeled PCR product of plasmid pMFST3:  lane 1, A reaction; lane 2, G reaction; lanes 
3-13, 1 μM, 300 nM, 100 nM, 30 nM, 10 nM, 3 nM, 1 nM, 300 pM, 100 pM, 30 pM, and 10 pM polyamide, 
respectively; lane 14, intact DNA.  (C)  Summary of affinity cleavage patterns for (top) EDTA-7 (top) and 
EDTA-8 (bottom).  Bar heights are proportional to the relative cleavage intensities at each base pair.  The 
designed polyamide binding sites are indicated in bold.
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Figure IIB.9.  (A)  Chemical structures for polyamide 10 and its EDTA conjugate EDTA-10.  (B)  Illustration 
of the EcoRI/PvuII restriction fragment derived from plasmid pMFST4.  The designed polyamide binding 
sites are indicated by boxes.  (C)  Quantitative DNase I footprinting titration experiments for polyamide 10 
on the 283 base pair, 5’ end-labeled PCR product of plasmid pMFST4:  lanes 1-11, 100 nM, 30 nM, 10 nM, 
3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 pM polyamide, respectively; lane 12, DNase I 
standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction.  Binding isotherms (below).  Bind-
ing affinities for sites M and O are 9.8 (±0.5) x 108 M-1 and 1.1 (±0.6) x 109 M-1, respectively.  (D)  Affinity 
cleavage experiment with EDTA-10 on the 283 base pair, 5’ end-labeled PCR product of plasmid pMFST4: 
lane 1, A reaction; lane 2, G reaction; lanes 3-13, 1 μM, 300 nM, 100 nM, 30 nM, 10 nM, 3 nM, 1 nM, 300 
pM, 100 pM, 30 pM, and 10 pM polyamide, respectively; lane 14, intact DNA.  (E)  Summary of affinity 
cleavage patterns for EDTA-10.  Bar heights are proportional to the relative cleavage intensities at each base 
pair.  Ball-and-stick structures illustrating the proposed modes of binding are shown.  Designed binding sites 
are indicated in bold in the DNA sequence.
69
TAGGTGT-3’ and ‘R’ = 5’-TGTGGAT-3’, respectively), and an overlapped binding site 
(‘O’ = 5’-TAGGTGTCACCAT-3’).  DNase I footprint titrations were performed using 
the parent polyamide 10 (Figure IIB.9C).  Cleavage patterns observed are consistent with 
polyamide binding as a hairpin in the forward orientation (Figure IIB.9D and 9E). 
Conclusion
 Herein we present a characterization of α-DABA polyamides.  We have confirmed 
their ability to bind DNA and established their binding affinities to be decreased 2-fold to 
147-fold relative to γ-DABA polyamides.  The magnitude of this reduced affinity appears 
to be sensitive to the presence and positioning of an internal β residue in the polyamide 
structure.  Remarkably, despite the reduced affinity, α-DABA polyamide-chlorambucil 
conjugates alkylate DNA with greater specificity and lower reactivity than γ-DABA 
conjugates.  Importantly, we have demonstrated that polyamides linked by the (R)-α-
diaminobutyric acid moiety bind DNA in a forward hairpin binding mode.  Polyamides 
linked by a glycine amino acid prefer to bind DNA in an extended binding mode, indicating 
that it is the substitution of the glycine turn unit that locks the α-DABA polyamide into 
the hairpin conformation.  While it has been previously shown that α-DABA polyamide-
chlorambucil conjugates are efficacious in cellular and small animal models,13,22,29 cellular 
uptake experiments of polyamide-fluorescein conjugates displayed limited nuclear uptake 
properties (Figure IIB.10, Table IIB.3), possibly limiting the general use of α-DABA 
polyamides in vivo.
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Figure IIB.10.  Chemical and ball-and-stick structures for polyamide-fluorescein conjugates prepared for 
studying the cellular uptake properties of α-DABA polyamides.
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Table IIB.3.  Cellular uptake properties of α-DABA polyamide-fluorescein conjugates in 3 cell lines as 
determined by confocal microscopy.  ++, Nuclear staining exceeds that of the medium; +, nuclear staining 
is less than or equal to that of the medium, but still prominent; -, very little nuclear staining, with the most 
fluorescence seen in the cytoplasm and/or medium; --, no nuclear staining.  Polyamides were assayed at 5 
μM concentration.
Materials and Methods
General 
 Boc-β-Ala-Pam resin was from Peptides International.  Trifluoroacetic acid (TFA) 
was purchased from Halocarbon.  Dichloromethane (DCM) was from Fisher Scientific. 
(Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyBOP) was 
from Novabiochem.  Chlorambucil, N,N-diisopropylethylamine, 3-(dimethylamino)-
propylamine, 3,3’-diamino-N-methyl-dipropylamine, N,N-dimethylformamide, and 
1-methyl-2-pyrrolidone (NMP) were purchased from Aldrich.  Oligonucleotides were 
synthesized by Integrated DNA Technologies.  Enzymes were purchased from Roche. 
RNase free water was from USB and used for all footprinting and cleavage reactions.
   α-Turn
Polyamide MCF-7 HeLaPC3
NH3
+FITC
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-- +--
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Polyamide synthesis
 Polyamides were synthesized on Boc-β-Ala-Pam resin following manual solid-
phase methods using Boc-protected amino acids as previously reported.23  Boc-Py-OBt 
(OBt = benzotriazol-1-yloxy), Boc-β-Im-OH, Im-CCl3, Boc-Py-Py-OBt, Boc-Py-Im-OH, 
Boc-Im-OH, and Im-Im-OH were used as building blocks.  The α-DABA polyamides 1, 3, 
5, 7, 10, 1-Chl, 3-Chl, 5-Chl, 7-Chl, EDTA-3, EDTA-7, and EDTA-10 were synthesized 
using Boc-D-Dab(Fmoc)-OH as the turn unit.  The γ-DABA polyamides 2, 4, 6, 8, 2-Chl, 
4-Chl, 6-Chl, 8-Chl, and 8-EDTA were synthesized using Fmoc-D-Dab(Boc)-OH as the 
turn unit.  The glycine-linked polyamides 9 and EDTA-9 were synthesized using Boc-Gly-
OH as the turn unit.
 Boc deprotections were conducted at room temperature for 25 min using 80% 
TFA/DCM.  Carboxylic acids (3 eq) were activated with DIEA (5 eq) and PyBOP (2.5 
eq) for 30-45 min at 37 oC prior to coupling.  Couplings were allowed to proceed in 
NMP for 2 h at room temperature.  Polyamides were cleaved from resin with either 3-
(dimethylamino)-propylamine (Dp) or 3,3’-diamino-N-methyl-dipropylamine (Da) neat at 
55 oC overnight.  Products were purified by preparatory reverse-phase high performance 
liquid chromatography (prep HPLC) and characterized by analytical HPLC, UV-visible 
spectroscopy, and matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) 
mass spectrometry.
 Polyamide-chlorambucil conjugates were generated by activating the chlorambucil 
carboxylic acid (4 eq) with PyBOP (4 eq) and DIEA (12 eq) for 30 min at room temperature 
followed by addition of the polyamide.  The reaction was allowed to proceed at room 
temperature for 1-2 h.  Products were purified by reverse-phase prep HPLC, immediately 
lyophilized, and characterized as above.
 Polyamide-EDTA conjugates were synthesized by slow addition of a 50% DMF/
DIEA polyamide solution to a solution of EDTA dianhydride (20 eq) dissolved in a 1:1:2 
DMSO:DMF:DIEA mixture, vigorously shaking at 55 oC.  The reaction was allowed to 
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proceed an additional 30 min, followed by hydrolysis of the remaining EDTA dianhydride 
with 0.1 N NaOH for 10 min.  The reaction was diluted and purified by reverse-phase prep 
HPLC.  Subsequent Boc deprotection was accomplished by dissolving the dried EDTA 
conjugate in a minimum volume of neat TFA doped with triethylsilane.  The reaction was 
allowed to proceed for 10-30 min at room temperature, then immediately diluted with 
water and purified by reverse-phase prep HPLC.
 Polyamide-fluorescein conjugates were synthesized by dissolving the cleaved 
polyamide in DMF, followed by addition of DIEA (50 eq). A solution of 5-fluorescein 
isothiocyanate (Molecular Probes) in DMF (4 eq) was added to the polyamide. The 
reaction was allowed to proceed for 40 min at room temperature. The polyamide was then 
precipitated by addition of chilled ether (~90 mL). The dried polyamide precipitate was 
then dissolved in a minimal volume of trifluoroacetic acid with triethylsilane solution. The 
reaction was allowed to shake at room temperature for 20 min, followed by dilution with 
water and acetonitrile and immediate purification by prep HPLC.
1:  ImImPyIm-(R)H2Nα-PyPyPyPy-βDp MALDI-TOF MS C57H72N23O10+ calculated 
[M+H]+: 1238.58; found: 1238.82
2:  ImImPyIm-(R)H2Nγ-PyPyPyPy-βDp MALDI-TOF MS C57H72N23O10+ calculated 
[M+H]+: 1238.58; found: 1238.59
3:  ImImPyPy-(R)H2Nα-ImPyPyPy-βDp MALDI-TOF MS C57H72N23O10+ calculated 
[M+H]+: 1238.58; found: 1238.90
4:  ImImPyPy-(R)H2Nγ-ImPyPyPy-βDp MALDI-TOF MS C57H72N23O10+ calculated 
[M+H]+: 1238.58; found: 1238.65
5:  ImβImIm-(R)H2Nα-PyPyPyPy-βDp MALDI-TOF MS C54H71N22O10+ calculated 
[M+H]+: 1188.28; found: 1188.5
6:  ImβImIm-(R)H2Nγ-PyPyPyPy-βDp MALDI-TOF MS C54H71N22O10+ calculated 
[M+H]+: 1188.28; found: 1188.86
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7:  ImPyβImPy-(R)H2Nα-ImPyβImPy-βDp MALDI-TOF MS C62H81N26O12+ calculated 
[M+H]+: 1382.47; found: 1382.15
8:  ImPyβImPy-(R)H2Nγ-ImPyβImPy-βDp MALDI-TOF MS C62H81N26O12+ calculated 
[M+H]+: 1382.47; found: 1382.58
9:  ImImPyPy-Gly-ImPyPyPy-βDp MALDI-TOF MS C55H67N22O10
+ calculated [M+H]+: 
1195.54; found: 1195.43
10: ImImβIm-(R)H2Nα-PyPyPyPy-βDp MALDI-TOF C54H71N22O10+ calculated [M+H]+: 
1188.28, found: 1188.02
1-Chl:  ImImPyIm-(R)Chlα-PyPyPyPy-βDp MALDI-TOF MS C71H89Cl2N24O11+  
calculated [M+H]+: 1523.65; found: 1523.66
2-Chl:  ImImPyIm-(R)Chlγ-PyPyPyPy-βDp MALDI-TOF MS C71H89Cl2N24O11+ 
calculated [M+H]+: 1523.65; found: 1523.70
3-Chl:  ImImPyPy-(R)Chlα-ImPyPyPy-βDp MALDI-TOF MS C71H89Cl2N24O11+ 
calculated [M+H]+: 1523.65; found: 1523.88
4-Chl:  ImImPyPy-(R)Chlγ-ImPyPyPy-βDp MALDI-TOF MS C71H89Cl2N24O11+ 
calculated [M+H]+: 1523.65; found: 1523.57
5-Chl:  ImβImIm-(R)Chlα-PyPyPyPy-βDp MALDI-TOF MS C68H88Cl2N23O10+ 
calculated [M+H]+: 1474.48, found: 1474.95
6-Chl:  ImβImIm-(R)Chlγ-PyPyPyPy-βDp MALDI-TOF MS C68H88Cl2N23O10+ 
calculated [M+H]+: 1474.48, found: 1474.26
7-Chl:  ImPyβImPy-(R)Chlα-ImPyβImPy-βDp MALDI-TOF MS C76H98Cl2N27O13+ 
calculated [M+H]+: 1668.67, found: 1668.37
8-Chl:  ImPyβImPy-(R)Chlγ-ImPyβImPy-βDp MALDI-TOF MS C76H98Cl2N27O13+ 
calculated [M+H]+: 1668.67, found: 1668.48
EDTA-3:  ImImPyPy-(R)H2Nα-ImPyPyPy-βDa-EDTA  MALDI-TOF MS C69H91N26O17+ 
calculated [M+H]+: 1555.71; found: 1555.73
EDTA-7:  ImPyβImPy-(R)H2Nα-ImPyβImPy-βDa-EDTA MALDI-TOF MS 
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C74H100N29O19
+ calculated [M+H]+: 1698.77, found: 1698.81
EDTA-8: ImPyβImPy-(R)H2Nγ-ImPyβImPy-βDa-EDTA MALDI-TOF MS 
C76H98Cl2N27O13
+ calculated [M+H]+: 1698.77, found: 1698.58 
EDTA-9:  ImImPyPy-Gly-ImPyPyPy-βDa-EDTA MALDI-TOF MS C67H86N25O17
+ 
calculated [M+H]+: 1512.66; found: 1512.54
EDTA-10: ImImβIm-(R)H2Nα-PyPyPyPy-βDa-EDTA MALDI-TOF MS C66H90N25O17+ 
calculated [M+H]+: 1504.70; found: 1504.84
Construction of plasmids
 Plasmids were constructed by annealing oligonucleotide pairs as follows: for 
pMFST – 5’-AGCTGTACAATCATTAGTGGTTACAATCATATGGTCATACAATC-
ATTAGTCGTTACAATCATTAGCACACACAATCATC-3’ and 5’-GATCGATGATT-
GTGTGTGCTAATGATTGTAACGACTAATGATTGTATGACCATATGATTGTAA-
CCACTAATGATTGTAC-3’; for pMFST5 – 5’-AGCTGCGGCTATAATTAACAGGC-
CACAATTATACGATATATGCTAATGGTCAGACCATTACGATACATACTGGTA-
ATCTACTAATGGTCATACGGC-3’ and 5’-GATCGCCGTATGACCATTAGTAGAT-
TACCAGTATGTATCGTAATGGTCTGACCATTAGCATATATCGTATAATTGTG-
GCCTGTTAATTATAGCCGC-3’.  
 Annealed nucleotides were ligated into the BamHI/HindIII restriction fragment of 
pUC19 using T4 DNA ligase, and the plasmid was transformed into Escherichia coli JM109 
competent cells. Ampicillin-resistant white colonies were selected from 25 mL Luria-
Bertani agar plates containing 50 mg/mL ampicillin treated with XGAL and isopropyl-
β-D-thiogalactopyranoside (IPTG) solutions and grown overnight at 37 °C. Cells were 
harvested the following day, and purification of the plasmids were performed with a Wizard 
Plus Midiprep DNA purification kit (Promega).  DNA sequencing of the plasmid insert 
was performed by the sequence analysis facility at the California Institute of Technology. 
Plasmids pMFST3 and pMFST4 were prepared similarly with oligonucleotides of the 
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indicated sequences.
Preparation of 5’ 32P-end-labeled DNA
The primer 5’-GAATTCGAGCTCGGTACCCGGG-3’ was 32P-labeled at the 5’ 
end and used with the primer 3’-CAGCCCTTTGGACAGCACGGTC-5’ to PCR amplify 
plasmids as described previously.28
DNase footprinting titrations
Polyamide equilibrations and DNase I footprinting titrations were conducted on the 
5’ end-labeled PCR product of the appropriate plasmid according to standard protocols.28 
DNA was incubated with polyamide or water (controls) for 12-16 h at room temperature 
prior to reaction.  Determination of equilibrium association constants were performed as 
previously described.28  Data points were fitted to a Langmuir binding isotherm by using 
the modified Hill equation with n = 1, except for the quantitation of glycine polyamide 9, 
where n was optimized to the generated curve for the slipped site S and the overlapped site 
O.
Thermal cleavage assays
Thermal cleavage assay experiments were conducted on the 5’ end-labeled PCR 
products of the designated plasmids as described previously.11  DNA was incubated with 
polyamide conjugates or water (control) for 24 h at 37 °C prior to work-up. 
Affinity cleavage assays 
Affinity cleavage experiments were conducted on the 5’ end-labeled PCR product of 
plasmids pMFST3, pMFST4, and pMFST5 as previously described.28  DNA was incubated 
with polyamide conjugates or water (control) for 13 h at room temperature prior to addition 
of ferrous ammonium sulfate.
77
Acknowledgements
The authors thank the National Institutes of Health for research support and for a 
pre-doctoral NRSA training grant to M.E.F.  Mass spectrometry analyses were performed in 
the Mass Spectrometry Laboratory of the Division of Chemistry and Chemical Engineering 
at the California Institute of Technology.
References
1. Wemmer, D. E.; Dervan, P. B. Curr. Opin. Struct. Biol. 1997.  7, 355-361.
2. Dervan, P. B.; Poulin-Kerstien, A. T.; Fechter, E. J.; Edelson, B. S. Top. Curr. Chem. 
    2005.  253, 1-31.
3. Best, T. P.; Edelson, B. S.; Nickols, N. G.; Dervan, P. B. Proc. Natl. Acad. Sci. U. S. A. 
    2003.  100, 12063-12068.
4. Edelson, B. S.; Best, T. P.; Olenyuk, B.; Nickols, N. G.; Doss, R. M.; Foister, S.; 
    Heckel, A.; Dervan, P. B. Nucleic Acids Res. 2004.  32, 2802-2818.
5. Olenyuk, B. Z.; Zhang, G. J.; Klco, J. M.; Nickols, N. G.; Kaelin, W. G.; Dervan, P. B. 
    Proc. Natl. Acad. Sci. U. S. A.      2004.  101, 16768-16773.
6. Burnett, R.; Melander, C.; Puckett, J. W.; Son, L. S.; Wells, R. D.; Dervan, P. B.; 
    Gottesfeld, J. M. Proc. Natl. Acad. Sci. U. S. A. 2006.  103, 11497-11502.
7. Kageyama, Y.; Sugiyama, H.; Ayame, H.; Iwai, A.; Fujii, Y.; Huang, L. E.; Kizaka-
    Kondoh, S.; Hiraoka, M.; Kihara, K. Acta Oncol. 2006.  45, 317-324.
8. Nickols, N. G.; Jacobs, C. S.; Farkas, M. E.; Dervan, P. B. Nucleic Acids Res. 2007.  
    35, 363-370.
9. Nickols, N. G.; Dervan, P. B. Proc. Natl. Acad. Sci. U. S. A. 2007.  104, 10418-10423.
10. Bando, T.; Sugiyama, H. Accounts Chem. Res. 2006.  39, 935-944.
11. Wurtz, N. R.; Dervan, P. B. Chem. Biol. 2000.  7, 153-161.
12. Wang, Y. D.; Dziegielewski, J.; Wurtz, N. R.; Dziegielewska, B.; Dervan, P. B.; 
      Beerman, T. A. Nucleic Acids Res. 2003.  31, 1208-1215.
78
13. Dickinson, L. A.; Burnett, R.; Melander, C.; Edelson, B. S.; Arora, P. S.; Dervan, P. 
      B.; Gottesfeld, J. M. Chem. Biol. 2004.  11, 1583-1594.
14. Turner, J. M.; Swalley, S. E.; Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc. 1998.  
      120, 6219-6226.
15. Mrksich, M.; Wade, W. S.; Dwyer, T. J.; Geierstanger, B. H.; Wemmer, D. E.; Dervan, 
      P. B. Proc. Natl. Acad. Sci. U. S. A.      1992.  89, 7586-7590.
16. Mrksich, M.; Parks, M. E.; Dervan, P. B. J. Am. Chem. Soc. 1994.  116, 7983-7988.
17. White, S.; Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc. 1997.  119, 8756-8765.
18. Herman, D. M.; Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc.  1998.  120, 1382-1391.
19. Geierstanger, B. H.; Mrksich, M.; Dervan, P. B.; Wemmer, D. E. Nat. Struct. Biol. 
      1996.  3, 321-324.
20. Trauger, J. W.; Baird, E. E.; Mrksich, M.; Dervan, P. B. J. Am. Chem. Soc. 1996.  118, 
      6160-6166.
21. de Clairac, R. P. L.; Seel, C. J.; Geierstanger, B. H.; Mrksich, M.; Baird, E. E.; 
      Dervan, P. B.; Wemmer, D. E. J. Am. Chem. Soc.  1999.  121, 2956-2964.
22. Tsai, S. M.; Farkas, M. E.; Chou, C. J.; Gottesfeld, J. M.; Dervan, P. B. Nucleic Acids 
      Res. 2007.  35, 307-316.
23. Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc. 1996.  118, 6141-6146.
24. Hsu, C. F.; Phillips, J. W.; Trauger, J. W.; Farkas, M. E.; Belitsky, J. M.; Heckel, A.; 
      Olenyuk, B.; Puckett, J. W.; Wang, C. C.; Dervan, P. B. Tetrahedron. 2007.  63, 6146-
      6151.
25. Woods, C. R.; Ishii, T.; Wu, B.; Bair, K. W.; Boger, D. L. J. Am. Chem. Soc. 2002.  
      124, 2148-2152.
26. White, S.; Baird, E. E.; Dervan, P. B. Chem. Biol. 1997.  4, 569-578.
27. Urbach, A. R.; Dervan, P. B. Proc. Natl. Acad. Sci. U. S. A. 2001.  98, 4343-4348.
28. Trauger, J. W.; Dervan, P. B. Meth. Enzymol. 2001.  340, 450-466.
29. Alvarez, D.; Chou, C. J.; Latella, L.; Zeitlin, S. G.; Ku, S.; Puri, P. L.; Dervan, P. B.; 
      Gottesfeld, J. M. Cell Cycle. 2006.  5, 1537-1548.
79
Chapter IIC
Small Molecules Targeting Histone H4 as Potential 
Therapeutics for Chronic Myelogenous Leukemia
The text of this chapter was taken in part from a manuscript co-authored with Sherry 
M. Tsai,* Peter B. Dervan,* C. James Chou,‡ David Alvarez,‡ and Joel M. Gottesfeld ‡ ( * 
California Institute of Technology and ‡ The Scripps Research Institute)
(Chou, C.J..; Farkas, M.E.; Tsai, S.M.; Alvarez, D.; Gottesfeld, J.M.; Dervan, P.B. Mol. 
Cancer Ther. 2008, 7, 769-778)
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Abstract
 We recently identified a polyamide-chlorambucil conjugate, 1R-Chl, that alkylates 
and down-regulates transcription of the human histone H4c gene, and inhibits the growth of 
several cancer cell lines in vitro and in a murine SW620 xenograft model without apparent 
animal toxicity.  In this study, we analyzed the effects of 1R-Chl in the chronic myelogenous 
leukemia cell line K562 and identified another polyamide conjugate, 6R-Chl, which targets 
H4 genes and elicits a similar cellular response.  Other polyamide conjugates that do not 
target the H4 gene do not elicit this response.  Gene chip expression analysis has shown 
that only 156 genes (p = 0.00125) are affected by 1R-Chl in K562 cells, and has identified 
three genes of interest encoding histone H4: H4c and H4k/j.  In a murine model, both 1R-
Chl and 6R-Chl were found to be highly effective in blocking K562 xenograft growth 
with high dose tolerance.  Unlike with conventional and distamycin-based alkylators, little 
or no cyto- and animal toxicities were observed in mg/kg dosage ranges.  These results 
suggest that these polyamide alkylators may be a viable treatment alternative for chronic 
myelogenous leukemia.
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Introduction
Therapies targeting specific genes or gene products are a major aim of modern cancer 
biology and intervention.1-4  Notable recent successes in the field include both mononclonal 
antibodies5,6 and small molecules that target enzymes and receptors that are over-expressed 
or mutated in various cancers.3,7,8  Notwithstanding these important developments, DNA 
alkylating agents remain the most common drugs for the treatment of several solid and 
hematological malignancies.9-11  Myelotoxicity and concomitant cytotoxicity due to limited 
DNA sequence selectivity is often the dose-limiting factor for use of these compounds in 
humans.  Alkylating agents based on the minor groove binder distamycin A, including 
Tallimustine and Brostallicin, have shown improvements over non-conjugated DNA 
alkylating agents in terms of affinity and specificity at the nucleotide level.12-15  However, 
these compounds possess only limited specificity,16 and myelotoxicity is still the dose-
limiting factor in establishing an effective chemotherapy.12,13  
Pyrrole-imidazole (Py-Im) polyamides are a class of sequence-specific DNA- 
binding small molecules that have been shown to have high binding specificity and affinity, 
with some molecules even exceeding the binding affinities of transcription factors.17 
Many polyamides are cell permeable and readily localize to the nuclei of cultured cells.18-
21  Polyamides are effective inhibitors of RNA transcription when they disrupt essential 
protein-DNA interactions at promoter and enhancer elements,17,22-25 and they may also 
modulate gene expression by modifying chromatin structure.26-28  Linked with DNA-
alkylating agents, such as chlorambucil (Chl)29 or CC-1065/CBI derivatives,30,31 polyamide 
conjugates react covalently with DNA at specific sites and inhibit transcription by stalling 
RNA polymerase during elongation. 
Recently, α-diaminobutyric acid-linked hairpin polyamide-Chl conjugates have 
been shown to bind and alkylate DNA sequences both in vitro and in cell culture models, 
with good sequence specificity.32-34  Initial screens of various hairpin polyamide-Chl 
conjugates have shown the polyamide 1R-Chl (Figure IIC.1, top) to be an inhibitor of 
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cell proliferation in various cancer cell lines with no apparent cytotoxicity and little or no 
murine animal toxicity.32,33,35  This molecule binds within the coding region of the histone 
H4c gene both in vitro and in SW620 human colon carcinoma cells, and down-regulates 
H4c transcription.  Polyamides with similar pyrrole and imidazole compositions targeted to 
different DNA sequences failed to alkylate the coding region of the histone H4c gene and 
were found to be inactive in both cell culture and a SW620 xenograft cancer model.32
Studies suggest a two-hit mechanism for the observed cellular effects of 1R-Chl: 
down-regulation of histone gene transcription causes nucleosome depletion, followed by 
widespread alkylation of open chromatin, which elicits cell cycle arrest through the DNA 
repair pathway.35  While our initial results point to the histone H4c gene as the major target 
of 1R-Chl, microarray studies in the SW620 cancer cell line indicate that the mRNA levels 
of several other genes are also affected.32  Thus, down-regulation of other genes may be 
involved in the cellular response to 1R-Chl. 
In the present study we extend our analysis to the well-established chronic 
myelogenous leukemia (CML) cell line K562.  If histone H4 genes are the primary targets 
of 1R-Chl that lead to a block in cancer cell proliferation,35 other polyamide-Chl conjugates 
targeting H4 genes would be predicted to elicit the same cellular response.  We describe 
the synthesis and characterization of a small library of constitutional isomers of 1R-Chl. 
These molecules have the same chemical composition as 1R-Chl but would be expected 
to bind different DNA sequences.  One conjugate, 6R-Chl (Figure IIC.1A, bottom), which 
targets sites adjacent to and overlapping the binding site for 1R-Chl (Figure IIC.1B) in 
the H4c gene was found to have biological properties similar to 1R-Chl in both K562 cell 
culture and in a mouse xenograft model established with K562 cells.  Other polyamide-Chl 
alkylators that did not bind within the H4c gene or down-regulate histone H4 expression 
had no effect on cell proliferation.  Microarray analysis in K562 cells reveals that the 
histone H4 genes H4c and H4j/k are down-regulated by 1R-Chl treatment.  Transcripts for 
the H4k and H4j genes cannot be distinguished due to similarity in sequence.  In addition, 
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we explored the pharmacokinetic properties of 1R-Chl, the results of which point to this 
class of molecules as potential human cancer therapeutics.
Figure IIC.1.  DNA sequence of the coding region of the human histone H4c gene and chemical structures of 
1R-Chl and 6R-Chl.  (A) Chemical structures of 1R-Chl (top) and 6R-Chl (bottom), which target the DNA 
sequences 5’-WGGWGW-3’ and 5’-WGGWCW-3’, respectively (where W = A or T).  Imidazole rings are 
shown in bold.  (B) DNA sequence of the coding region of the human histone H4c gene. Potential binding 
sites for 1R-Chl and 6R-Chl are in bold.  The alkylation sites of 1R-Chl and 6R-Chl as verified by LM-PCR 
are italic-bold and underlined, respectively.   
atgtctggtc gcggcaaagg cggaaaaggc ttggggaagg gtggtgctaa 
gcgccatcgt aaggtgctcc gggataacat ccagggcatt acaaaaccgg
ctattcgccg tttggctcgg cgcggtggcg tcaagcgcat ttccggtctt
atctatgagg agactcgagg tgtgcttaag gttttcttag agaacgttat
tcgagacgcc gtcacctata cggagcacgc caagcgcaaa actgtcacag
ccatggatgt agtatatgcc ctaaaacgtc aggggcgcac tctgtatggc
ttcggcggct gaatctaaga atacgcggtc tcctgagaac ttcaaaaaac
aaaaacaaaa aaacccaaag gcccttttca gggccgctca
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Results and Discussion
Inhibition of K562 cell proliferation by polyamides targeting histone H4 genes 
To investigate the effects of Py-Im polyamide-Chl conjugates on K562 cells, 
we synthesized a small library of constitutional isomers of 1R-Chl, along with its 
stereoisomer, 1S-Chl (Table IIC.1).  All molecules targeted the general DNA sequence 
5’-WGNNNW-3’ (where W = A or T; N = A, C, G, or T); the binding site for 1R-Chl is 5’-
WGGWGW-3’.  Binding affinities for non-alkylating parent molecules were determined 
via quantitative DNase I footprinting on plasmid inserts containing matched sites.  It has 
been previously shown that attachment of the Chl moiety does not appear to affect DNA 
binding properties.29  Affinities for 1R, 3R, 5R, and 1S have been previously reported 
(Table IIC.1);33-35 polyamides 4R and 6R were analyzed on plasmid insert pMFST6 (Figure 
IIC.2A and 2B).  All polyamides were found to bind their expected match sites. 
 
Table IIC.1.  Analysis of a polyamide library.  Shown in the table are the following: ball-and-stick model 
for the structure of each polyamide (closed circles are imidazoles, open circles are pyrroles, diamonds are 
β-alanines, semicircle with positive sign is dimethylaminopropylamine, and X indicates a free amino group 
in the parent polyamide or Chl in the conjugates);  targeted match binding sites for the polyamides, where 
‘W’ = A or T, (names of plasmid constructs on which footprinting and alkylation assays were performed are 
shown in parentheses); equilibrium association constants of the parent polyamides as determined by quantita-
tive DNase I footprinting (standard deviations are in parentheses);  effects of polyamide-Chl conjugates on 
cell morphology (enlargement) and growth.  
Polyamide Sequence
       Cell 
Enlargement
Growth
 Arrest
1R
3R
4R
5R
6R
+ X
+ X
+ X
+ X
+ X
1S + X
5'-WGGWGW-3'
5'-WGGWCW-3'
5'-WGCWGW-3'
5'-WGWGGW-3'
5'-WGWGCW-3'
5'-WGWGGW-3'
yes
no
no
no
yes
no
yes (>50%)
slight (~25%)
  no
no
yes (>70%)
no
Match Site (Plasmid)
K   Match Site (M-1)
         X = NH+
5’-TAGGTGT-3’ (pMFST2) 6.7(± 0.1) x 10 9
7.4(± 0.6) x 10 8
8.0 (± 0.6) x 10 8
1.1 (± 0.3) x 10 8
4.9 (± 0.5) x 10 9
4.8 (± 0.9) x 10 8
5’-TAGGTCT-3’ (pJG)
5’-AAGCTGT-3’ (pMFST6)
5’-TAGTGGT-3’ (pMFST)
5’-TAGTGCT-3’ (pMFST6)
5’-TAGGTGT-3’ (pMFST2)
a
3
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Figure IIC.2.  Polyamide analysis on pMFST6.  (A)  Illustration of the EcoRI/PvuII restriction fragments de-
rived from plasmid pMFST6.  The designed polyamide binding sites are indicated by boxes.  Single base pair 
mismatches are indicated by shaded regions.  (B) Quantitative DNaseI footprinting titration experiments for 
polyamides 4R (left) and 6R (right) on the 5’ end-labeled PCR product of plasmid pMFST6: lanes 1-11, 100 
nM, 30 nM, 10 nM, 3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 pM polyamide, respectively; 
lane 12, DNase I standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction. Each footprinting gel 
is accompanied by its respective binding isotherms (below).  Binding affinities (M-1) for polyamides 4R and 
6R, with equilibrium association constants reported as mean values from three DNase I footprinting
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titration experiments; standard deviations are shown in parentheses (bottom). (C) Thermal cleavage assay 
experiments on pMFST6 with 4R-Chl and 6R-Chl.  Experiments were performed at 1 µM, 100 nM, and 10 
nM for each polyamide.  Putative major sites of alkylation on the resolved portion of pMFST6 are indicated 
by arrows under the sequences for 4R-Chl (left) and 6R-Chl (right).  Lanes irrelevant to the figure have been 
cropped between lanes 5 and 6.
The ability of each polyamide-Chl conjugate to alkylate nucleotides adjacent to its 
match binding sites on synthetic DNA constructs was also evaluated.  Alkylation profiles 
of polyamides 1R-Chl, 3R-Chl, 5R-Chl, and 1S-Chl have been previously reported;33-35 
polyamides 4R-Chl and 6R-Chl were analyzed on plasmid insert pMFST6 (Figure IIC.2C). 
All polyamides alkylated DNA in the nanomolar concentration range.  H4c gene-specific 
DNA alkylation activities were monitored with the polyamide-Chl conjugates on a PCR 
product derived from the H4c gene.  Significantly, only 1R-Chl and 6R-Chl have binding 
sites within the H4c gene and only these compounds effectively alkylate the H4c PCR 
product in vitro (Figure IIC.3).  6R-Chl targets the DNA sequence 5’-WGWGCW-3’; the 
sequence 5’-TGTGCT-3’ is found both adjacent to and overlapping the binding site for 1R-
Chl on the top strand of the H4c and H4k/j genes (5’-AGGTGT-3’, Figure IIC.1B).  
Polyamide-Chl DNA alkylators were then tested for effects on growth and 
morphology of K562 cells. Only cells treated with either 1R-Chl or 6R-Chl exhibited 
growth inhibition; all others were inactive against K562 proliferation (Table IIC.1, Figure 
IIC.4A).  These molecules also caused an enlargement of cell volume with an IC
50
 of ~250 
nM and induced G2/M cell cycle arrest, effects not observed with other molecules (Figure 
IIC.4B, 4C, 5A, and 5B).  Following treatment with 1R-Chl or 6R-Chl for 3 to 6 days, 
an increase in the number of apoptotic cells was observed via annexin V-FITC/propidium 
iodine FACS analysis (Figure IIC.4C).  Other polyamide-Chl conjugates had no effect on 
apoptosis (Figure IIC.5C). 
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Figure IIC.3.  Alkylation of the H4c gene in vitro.  Approximately 10 ng of a 240 bp PCR product derived 
from the H4c gene was incubated for 16 h at 37 oC in 100 µL of 20 mM NaCl, 10 mM Tris-Cl, pH 7.4, with 
the indicated polyamide-Chl conjugates at 100 nM concentration, followed by thermal cleavage and primer 
extension.  The radiolabeled primer interrogates alkylation events on the bottom, coding strand of DNA. 
Input DNA was not treated with polyamide or heat.  ‘0’ indicates a no polyamide control, and ‘G’ denotes a 
guanine-only sequencing reaction.  Binding sites for 1R-Chl (bold) and 6R-Chl (underlined) are shown at 
the left.  1R-Chl alkylates the adenine at the 5’ end of its binding site and an adjacent guanine two bases 5’ of 
the polyamide site, on the bottom strand (3’-TCCACACG-5’, where the alkylated bases are shown in bold). 
6R-Chl alkylates two adenines at the 5’ end of the binding site on the bottom strand (3’-ACACGAA-5’, 
where the alkylated A’s are shown in bold).  Non-specific background bands are present in all lanes, including 
the input DNA, which are unrelated to the polyamides.
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Figure IIC.4.  Effects of polyamides in cell culture. (A) Effect of polyamides on growth and viability of 
K562 cells.  Cells were incubated with the indicated polyamides at 250 nM for 3 days.  Only 1R-Chl and 
6R-Chl affected cell proliferation.  (B) Phase microscopy images illustrate that 1R-Chl and 6R-Chl induce 
an increase in cell volume at 250nM after 3 days. (C) G2/M cell cycle arrest is observed for 1R-Chl and 6R-
Chl after 24 h of treatment with 250 nM polyamide (top).  6R-Chl caused a greater G2/M cycle arrest than 
1R-Chl. (D) AnnexinV/PI staining of 1R-Chl and 6R-Chl treated cells after 3 and 6 days. Treatment of cells 
with 250 nM 1R-Chl or 6R-Chl resulted in increased AnnexinV-positive and PI-negative populations and 
AnnexinV-positive and PI-positive populations. 
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Figure IIC.5. Analysis of inactive polyamides in K562 cells.  (A) Phase microscopy images illustrate that 
3R-Chl, 1S-Chl, and chlorambucil did not induce increases in cell volume at 250nM after 3 days.  (B) No 
significant cell cycle perturbation (i.e. G2/M cycle arrest) is observed for 3R-Chl and 1S-Chl after 24 h of 
treatment with 250 nM polyamide.  (C) AnnexinV/PI staining of of 3R-Chl and 1S-Chl treated cells after 3 
and 6 days (at 250 nM); neither molecule resulted in any effect.
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Alkylation of the histone H4 genes by 1R-Chl and 6R-Chl in K562 cells 
Ligation-mediated PCR (LM-PCR)36 was used to determine sites of alkylation by 
1R-Chl and 6R-Chl in the H4c gene in K562 cells.  Cells were incubated with each of the 
hairpin polyamide-Chl conjugates for 24 h at a concentration shown to cause growth arrest 
with 1R-Chl and 6R-Chl (250 nM).  After purification of genomic DNA and digestion 
with the restriction enzyme DraI, the DNA was heated to induce strand breakage at sites 
of alkylation.29  LM-PCR with H4c gene-specific primers demonstrated that both 1R-
Chl and 6R-Chl alkylate the H4c gene in cultured K562 cells. Consistent with in vitro 
alkylation results, other molecules in the library failed to alkylate the H4c gene in vivo 
(Figure IIC.6).
Global gene expression, RT-PCR and Western blot analyses of 1R-Chl in K562 cells 
Microarray studies have been previously conducted on SW620 cells treated with 
1R-Chl.32  To determine whether 1R-Chl treatment would cause similar changes to global 
gene expression in K562 cells, Affymetrix gene chip analysis was performed on K562 cells 
treated with 1R-Chl.  Through class comparison analysis, 1R-Chl affected the levels of 
transcription of 156 genes: 60 genes were down-regulated and 96 genes were up-regulated 
(p = 0.00125).  Quantitative real-time PCR was used to verify the results of the expression 
arrays for several selected genes.  The expression of histone H4 mRNAs H4c and H4k/
j were decreased more than 60% compared to untreated control cells (Figure IIC.7A). 
Identical DNA binding and alkylation sites for 1R-Chl are present in the H4c, H4k, and 
H4j genes.  Western blot analysis for total histone H4 protein in whole cell lysate shows 
significant down-regulation of total H4 protein levels after 24 h of incubation with 1R-Chl 
(Figure IIC.7B).  
Through Affymetrix expression pathway analysis of 1R-Chl treated K562 cells vs. 
untreated control (p = 0.001, MIT Board protocol), 2 significant pathways were identified: 
87 genes in chemicalPathway_h and 55 genes in mitochondriapathway_h.  Both pathways 
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Figure IIC.6.  Alkylation of the H4c gene in K562 cells.  Cells were incubated with the indicated polyamide-
Chl conjugates for 24 h, followed by DNA purification and LM-PCR.  The radiolabeled primer interrogates 
alkylation events on the bottom, coding strand of DNA.  “0” indicates a no polyamide control, and “G” de-
notes a guanine-only sequencing reaction performed on a PCR product from the H4c gene, followed by LM-
PCR.  Binding sites for 1R-Chl (bold) and 6R-Chl (underlined) are shown at left. Both molecules alkylate 
the adenine at the 5’ end of their respective binding site.  Non-specific background bands appear in all lanes 
and are unrelated to the polyamides.
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Figure IIC.7.  Effect of polyamides on histone H4c and H4k/j transcript expression and Western blot analy-
sis.  (A) Chart showing polyamide effect on H4c and H4k/j expression; only 1R-Chl and 6R-Chl caused gene 
down-regulation.  (B)  K562 cells were treated with 1R-Chl and 6R-Chl, at the indicated concentrations for 
24 h, and histone H4 and GAPDH protein levels were assayed by Western blot analysis (top left and bottom 
right, respectively).  Analysis of treatment with 1S-Chl and 3R-Chl (top right and bottom left, respectively) 
did not show significant decreases in histone H4 levels.
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suggest initiation of apoptotic signaling in response to DNA damage with several known 
genes identified (i.e., BAX, BID, STAT1, ATM, BCL2, CASP3, CASP6, CASP7, CASP8, 
CASP9).  These results correlate with up-regulated genes found in the expression array 
class comparison with increases in CHEK2 and BID expression levels.  Surprisingly, 
several of the most down-regulated and highly significant genes, based on p-values and 
extent of down-regulation in microarray analysis (i.e. SMG1, RPL13, HNRPD, RAB35, 
and H2AFY) appeared not to be significantly affected by 1R-Chl when analyzed by real-
time qRT-PCR (Figure IIC.8).
1R-Chl and 6R-Chl arrest the growth of K562 xenografts  
K562 cells were injected into athymic nude mice, and tumors were staged to >100 
mm3 (approximately 7 to 14 days post injection of cells).  In the first experiment, mice were 
then intravenously injected with three doses of 1R-Chl, 1S-Chl, or PBS vehicle control 
(Figure IIC.9A, left); in a second experiment mice were injected with 1R-Chl, 6R-Chl, or 
PBS vehicle (Figure IIC.9A, right).  The molecule 1S-Chl was used as a control polyamide; 
although it targets the same sequence as 1R-Chl, the opposite stereochemistry of its turn 
unit results in a greatly reduced ability to bind and alkylate DNA.32,33  The dosage routine 
was 7.5 mg/kg per injection and the polyamides were administered on treatment days 0, 2, 
and 5.  The treatment dose of 1R-Chl was determined based on the LD
20
 of Tallimustine 
and Brostallicin, both of which have shown severe dose limiting toxicities in the murine 
model and during phase II clinical trails.9,37 
Mice treated with 1R-Chl and 6R-Chl showed immediate growth regression of the 
tumor xenografts, while 1S-Chl and PBS vehicle had no effect on tumor growth (Figure 
IIC.9A and 9B).  Importantly, all mice treated with either 1R-Chl or 6R-Chl appeared 
healthy with minimal weight loss, while all 1S-Chl and PBS vehicle treated mice showed 
signs of wasting with significant weight loss due to exponential tumor growth.  No obvious 
toxicity was associated with polyamide treatment.  Based on the T/C% (tumor volume 
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Figure IIC.8.  Real-time qRT-PCR of several genes identified in Affymetrix microarray experiments: H4c, 
H4k/j, SMG1, H2A.Y, HNRPD, and RAB35.  All transcripts were interrogated with appropriate primers 
against GAPDH as a normalization control.  Only H4c (Red) and H4k/j (Blue) are down-regulated signifi-
cantly from 250 nM to 1000 nM within 24 h while the rest of the gene transcripts are without significance.
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Figure IIC.9.  Murine K562 xenograft studies.  (A)  Athymic nude mice were injected with K562 cells and 
tumors were allowed to develop for either 7 days (left) or 14 days (right), after which mice were treated with 
the indicated polyamides; tumor volumes were determined 14 days later.  (B)  Representative photographs of 
1R-Chl, 6R-Chl, 1S-Chl, and PBS-treated animals.  (C)  mRNA was isolated from tumor xenografts after 
treatment with 1R-Chl and 1S-Chl, 24 h after the last injection.  Real-time qRT-PCR showed down-regula-
tion of H4c and H4k/j transcripts in vivo by 1R-Chl; 1S-Chl did not significantly down-regulate either H4c 
or H4k/j.  (D)  Kaplan-Meier survival plot showing extended lifespan of 1R-Chl and 6R-Chl treated mice. 
The life extensions by both 1R-Chl and 6R-Chl are approximately 2 weeks with p = 4.44 x 10-7 and 4.64 x 
10-5, respectively.
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analysis) and LCK values (tumor growth delay; Log Cell Kill), 1R-Chl and 6R-Chl 
treatments are highly effective: according to the National Cancer Institute standards, T/C < 
42% and LCK > 0.7 are minimal levels for activity.37  For the two experiments conducted, 
the T/C% for 1R-Chl treated mice versus untreated control were 24.4% and 12.52%, and 
LCK was 1.41 and 1.57, respectively.  For 6R-Chl the T/C% was 11.30% and LCK was 
1.63.  In contrast, treatment with 1S-Chl gives results outside of the therapeutic range (T/
C% = 78.13 and LCK = 0.20).
24 h following the final 1R-Chl treatment, K562 xenograft tumors were dissected 
and their mRNA was isolated for qRT-PCR analysis.  Both H4c and H4k/j transcripts were 
observed to be down-regulated in tumors from 1R-Chl treated mice.  Analysis of tumor 
samples from 1S-Chl and PBS treated mice revealed no effect on histone H4c/k/j mRNA 
levels (Figure IIC.9C), consistent with in vitro results.  
A Kaplan-Meier survival plot for mice treated with 1R-Chl or 6R-Chl versus 
PBS shows a significant extension in lifespan, even after only one dosing regimen (Figure 
IIC.9D).  We expect that prolonged administration of these polyamide-Chl conjugates 
would extend lifespan even further, and will be determined in future studies.
Pharmacokinetic parameters and pharmacotoxicity of 1R-Chl.  
To predict the behavior and likely dosage regime of the polyamides in humans, 
pharmacokinetic parameters for 1R-Chl and 1S-Chl were determined in Balb/c mice. 
Mass spectrometry was used to determine polyamide concentration in serum following 
injection of 1R-Chl or 1S-Chl.  Both compounds appeared to exhibit first-order decay 
kinetics after a brief lag time (Figure IIC.10A), indicating that the rate of elimination from 
serum is proportional to the concentration of the compound in serum at a particular time-
point.  From these results, we determined that both 1R-Chl and 1S-Chl have t
1/2
 values of 
~2 h.  The constant of elimination (kel) was determined by plotting the natural logarithm 
of 1R-Chl serum concentration vs. time (during the clearance phase), and calculating the 
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Figure IIC.10.  Pharmacokinetic parameters and biodistribution of 1R-Chl.  (A) Concentration (in mg/mL, 
y-axis) of 1R-Chl (rhombus) and 1S-Chl (squares) in serum over time.  Mice were injected with either 1R-
Chl or 1S-Chl (100 nmol, equivalent to 7.5 mg/kg) and blood extracted at indicated time-points.  Amounts 
of polyamide were determined by mass spectrometry, and half-lives (t
1/2
) for 1R-Chl and 1S-Chl calculated. 
(B) Graph depicting the natural logarithm (ln) of 1R-Chl (rhombus) and 1S-Chl (squares) concentration ver-
sus time.  The y-intercept represents the theoretical concentration at t = 0, where the constant of elimination 
and the apparent volume of distribution were calculated.  (C) Graph depicting the biodistribution of 1R-Chl. 
Mice were treated with 1R-Chl (500 nmol = 37.5 mg/kg), and euthanized either 2 h (black bars) or 24 h 
(white bars) post-injection.  Major organs were harvested, and a weighed portion of each homogenized and 
sonicated.  1R-Chl concentration was determined by mass spectrometry.
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slope of the best fit straight line; kel was found to be ~0.45 h-1.  The concentration of the 
compound achieved in blood at t = 0 was determined by extrapolating the line to the y-
intercept.  Volume of distribution (Vd) was calculated by dividing the dose injected by this 
theoretical initial concentration (t
0
).  1R-Chl was predicted to have a Vd of ~0.48 L/kg, 
corresponding to ~33.8 L for a 70 kg human (Figure IIC.10B).  PK parameters for 1S-Chl 
were also determined and are similar to those of 1R-Chl: Kel ~ 0.55 h-1; Vd ~0.68 L/kg; 
Vd ~ 47.62 for a 70 kg human.
The distribution of 1R-Chl in various mouse organs was determined by mass 
spectrometry (Figure IIC.10C).  Following a 500 nmol dose, equal amounts of 1R-Chl 
were detected in the brain, muscle, stomach, liver, heart and kidney; it is likely that 1R-
Chl crosses the blood-brain barrier. Extensive amounts of 1R-Chl were found in the lung, 
spleen, small intestine, and pancreas after 2 h post-injection and at t
1/2
, as well as 24 h post-
injection, at which point 1R-Chl is undetectable in serum (Figure IIC.10A). These results 
indicate that 1R-Chl can be readily eliminated from serum, and persist in peripheral organs 
after tissue entry.
Histone genes as primary targets of polyamide-chl conjugates leading to growth 
inhibition of cancer cells.  
In the library of polyamide-Chl conjugates described herein, 1R-Chl and 6R-Chl 
are the only molecules expected to bind and alkylate within histone H4c/k/j genes.  Sites 
of alkylation within the H4c gene are on the template strand, at the 5’ ends of the 1R-Chl 
and 6R-Chl targeted sequences (Figure IIC.1, 3, and 6).  Alkylation of this strand would be 
predicted to block transcription elongation by RNA polymerase II.  Reporter gene assays 
have shown that alkylation of the template strand produces a more pronounced effect on 
transcription inhibition than on the non-coding strand.38  Real-time qRT-PCR and Western 
blot analyses confirm that K562 cells treated with 1R-Chl or 6R-Chl (250 nM for 24 h) 
exhibit down-regulation of H4c and H4k/j transcripts and total histone H4 protein levels. 
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Other polyamide-Chl conjugates do not alkylate H4 genes in vitro or in living cells and 
neither affect H4c and H4k/j mRNA and histone H4 levels, nor inhibit K562 cell growth. 
Previous studies involving 1R-Chl have shown that down-regulation of the H4c gene 
in SW620 cells is required for growth inhibition, but changes in H4k/j transcription were 
not observed.32  Further inspection of Affymetrix microarray data for SW620 cells revealed 
that H4k/j genes are not highly expressed in SW620 cells relative to H4c.  However, K562 
cells have similar H4c and H4k/j expression levels as confirmed by real-time qRT-PCR. 
The primary targets of down-regulation by 1R-Chl in K562 cells were the histone H4 
genes, H4c and H4j/k.  The only gene down-regulated by 1R-Chl in both K562 and SW620 
cells is H4c, indicating it to be the key target that elicits growth effects.  Furthermore, only 
cultured cell lines that express the histone H4c gene at high levels have been shown to be 
affected by 1R-Chl.32,35  
Polyamide-Chl conjugates block tumor progression with little animal toxicity
  Polyamides 1R-Chl and 6R-Chl are the first sequence-specific DNA alkylators 
reported to show little animal toxicity at mid to high mg/kg range with three consecutive 
injections every other day over 5 days.  This dosing regimen is highly effective in blocking 
the growth of established tumors (Figure IIC.9).  No behavior or significant weight changes 
were observed during experiments with normal Balb/c or xenograft mice.  In comparison, 
Tallimustine and Brostallicin, both of which are micromolar DNA alkylators targeting 
AT-rich sequences, have shown significant animal toxicity at 4 mg/kg and 0.8 mg/kg 
respectively.9,37  
We have shown here that 1R-Chl possesses desirable PK parameters: it has a t
1/2
 of 
~ 2 hours – enough time to allow the drug to effectively reach its target while minimizing 
prolonged presence in the blood stream, which can result in toxic effects.  The constant of 
elimination of 1R-Chl is relatively low (~0.45/h) compared to those of most anti-cancer 
drugs, indicating that should a steady concentration of the drug be necessary to achieve 
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efficacy, a regime of constant infusion may be considered.  The kel of 1R-Chl is similar 
to that of Capecitabine (0.5/h), a non-alkylating anti-cancer drug used to treat breast 
cancer.  Also, Vd > 30 for 1R-Chl, indicating that it is very well distributed in the body, 
an observation which is consistant with the presence of the molecule in the brain, muscle, 
stomach, liver, heart, and kidney in our biodistribution analysis (Figure IIC.10C).  The PK 
parameters for 1R-Chl are close to those of some commonly used chemotherapeutic drugs, 
including both alkylating agents and other types of compounds.
Conclusion
The development of the selective p210 Bcr-Abl tyrosine kinase inhibitor Gleevec 
(STI 571, Imatinib mesylate, Novartis) as a directed therapeutic for CML has been a 
major advance in cancer therapy.39,40  However, many Gleevec patients acquire resistance 
mutations to the drug or acquisition of Bcr-Abl-independent genetic abnormalities during 
the course of treatment.41-44  Thus, development of additional therapeutic approaches for 
CML and other maligancies is worthwhile.  Here we describe two sequence-specific DNA 
alkylators, 1R-Chl and 6R-Chl, that are capable of inhibiting K562 CML cell growth both 
in vitro and in vivo.  1R-Chl and 6R-Chl treatments are also highly effective in blocking 
K562 xenograft growth, with high dose tolerance in the murine model.  Based on these 
observations and the finding that 1R-Chl blocks SW620 xenograft growth in nude mice,32 
and the growth of two other xenograft models (Calu-1 lung cancer cells and 22Rv1 prostate 
cancer cells, data not shown), polyamide-Chl conjugates appear to be promising cancer 
therapeutics.  The inhibitory mechanism of 1R-Chl and 6R-Chl in K562 cells is likely to be 
independent of Bcr-Abl because no significant down-regulation of Bcr-Abl transcripts was 
observed in either Affymatrix genechip analysis or real time qRT-PCR (data not shown). 
These results suggest that 1R-Chl maybe an effective treatment alternative for CML or 
may be useful in combination with Gleevec.
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Materials and Methods
Synthesis and characterization of pyrrole-imidazole polyamides.  
Pyrrole-imidazole (Py-Im) polyamides were synthesized by standard solid phase 
methods,45 using α-(R)- or α-(S)-2,4-diaminobutyric acid as the hairpin turn unit.33 
Polyamide-Chl conjugates were generated as previously described,29 whereby the carboxylic 
acid of Chl (Sigma-Aldrich) is activated and coupled to the free amine of the hairpin turn. 
The identity and purity of the compounds were established by mass spectrometry analysis 
(MALDI-TOF-MS and ES-MS) and analytical HPLC, respectively.    
Binding affinities of the parent polyamides (which lack chlorambucil) for target 
match and mismatch sites were determined by quantitative DNase I footprinting,46 
using a radiolabeled DNA fragment of the plasmid pMFST6.  The plasmid was 
constructed by annealing the oligonucleotide pair:  5 ’ - A G C T G TA G TAT C TATA -
GTGCTTACTATCTATAGTCCTTACTATCTATAGCTCTTACTATCTATAGCTGTTA-
CTATCTATACT-ATCTAC-3’ and 5’-CATCATAGATATCACGAATGATAGATATCA-
GGAATGATAGATATCGAGAATATAGATATCGACAATGATAGATAGATAGATG-
CTAG-3’.  Annealed nucleotides were ligated into the BamHI/HindIII restriction fragment 
of pUC19 using T4 DNA ligase, and the plasmid was transformed into Escherichia coli 
JM109 competent cells.  Ampicillin-resistant white colonies were selected from 25 mL 
Luria-Bertani agar plates containing 50 mg/mL ampicillin treated with XGAL and isopropyl-
β-D-thiogalactopyranoside (IPTG) solutions and grown overnight at 37 °C.  Cells were 
harvested the following day, and purification of the plasmid was performed with a Wizard 
Plus Midiprep DNA purification kit (Promega).  Alkylation experiments performed on the 
pMFST6 insert were performed as previously described.29  Alkylation experiments were 
also performed on a 240 bp region of the H4c mRNA-coding sequence, which was amplified 
from genomic DNA with the following PCR primers: 5’-GTGCTAAGCGCCATCGTAAG-
3’ and 5’-CCCTGACGTTTTAGGGCATA-3’.  These experiments were conducted using 10 
ng of the PCR product incubated for 16 h at 37 oC in 100 µL of 20 mM NaCl, 10 mM Tris-Cl, 
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pH 7.4, with each of the polyamide-Chl conjugates at 10, 100 and 1000 nM concentration, 
followed by thermal cleavage and primer extension labeling, as described.32 
Cell lines and cell viability assays  
The human CML lymphoblast cell line K562 (purchased from ATCC), which 
contains the b3a2 Bcr-Abl translocation, was used in this study.  Cells were grown and 
maintained in RPMI 1640 medium containing 10% FBS, under standard mammalian cell 
culture conditions as recommended by the ATCC.  Direct phase contrast microscopic 
visualization was used to monitor the effects of polyamide-Chl conjugates on cell growth 
rates and cell morphology.  Promega CellTiter 96 Aqueous One Solution Cell Proliferation 
assay (Promega, WI; utilizing [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H tetrazolium (MTS) conversion to formazan to examine mitochondrial 
activity), Trypan blue exclusion, and Annexin V-FITC/propidium iodide (PI) apoptosis 
staining (BD Pharmingen, CA) were used to determine cell proliferation, viability, and 
initiation of apoptosis, respectively.
Cell cycle analysis  
The effects of polyamide-Chl conjugates on cell cycle progression were monitored 
by flow cytometry analysis in the Scripps FACS core facility.  Polyamide-treated cells (250 
nM of polyamide in culture media for 24 h) were collected by centrifugation (200X g for 5 
min).  Cell pellets were re-suspended in 500 µL of PBS and fixed with addition of 4.5 mL 
of pre-chilled 70% ethanol, stained with propidium iodide (50 µg/mL), and analyzed for 
DNA content, reflecting the fraction of cells at each point in the cell cycle (Go/G1, S, and 
G2/M).  Cells with less than a 2C DNA content are indicative of DNA fragmentation and 
apoptosis.
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Ligation-mediated PCR
K562 CML cells were incubated in culture medium for 24 h with each of the 
polyamide-Chl conjugates at a 250 nM concentration, followed by digestion of purified 
DNA with DraI, thermal cleavage and ligation-mediated PCR, using the primers for the 
H4c gene listed above, as previously described.32
Affymetrix expression array experiments and data analysis 
K562 cells were incubated with 1R-Chl (at 250 nM) or in the absence of polyamide, in 
triplicate for 24 h before RNA  purification and microarray analysis at The Scripps Research 
Institute microarray facility.  Affymetrix U133A Plus 2.0 GeneChips were hybridized in 
groups of three for each of the two groups.  The Affymetrix probe set data were imported 
into BRB Arraytools (3.5.0 Beta 2), selecting the U133 chips used in the experiment and 
leaving all filters off.  For class comparison analysis, 1R-Chl treated vs. untreated controls, 
all three replicates of each group were used, and the random variance model was selected, 
with the univariate significant threshold set to 0.00125.  For the pathway analysis, MIT 
Board pathway library was used.  Random variance model was used with LS permutation 
test or KS permutation test significance set at the nominal 0.001 level.  Microarray data has 
been deposited at Gene Expression Omnibus (accession number GSE8832).
Real-time quantitative RT-PCR 
RNA from polyamide-treated cells was extracted using the Absolutely RNA 
Miniprep kit (Stratagen, CA).  RT-PCR was performed using iScript One-Step TR-PCR 
kit with SYBR green (Bio-Rad Laboratories, CA) in accordance with the manufacturer’s 
instructions.  Levels of H4c, H4k/j, SMG1, RPL13, HNRPD, RAB35, and H2AFY 
transcripts were quantified by amplifying a segment of their respective mRNAs with 
appropriate primer sets (Table IIC.2).  The reverse-transcription reaction was carried out 
at 50 oC for 10 min, followed by iTaq hot-start DNA polymerase activation by heating 
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at 95 oC for 15 min.  Three-step cycling was performed: denaturation – 15 s at 95 oC, 
annealing – 30 s at 55 oC, and extension – 30 s at 72 oC, for 45 cycles.  All gene expression 
levels were normalized by parallel amplification and quantification of mRNA levels for the 
housekeeping gene glyceraldehyde-3-phospahte dehydrogenase (GAPDH) mRNA, as an 
endogenous reference with the following primers: 5’-GAGTCAACGGATTTGGTCGT-3’ 
and 5’-GAGGTCAATGAGGGGTCAT-3’.
Table IIC.2.  Primers used for real-time qRT-PCR.  The primers are designed with primer3 and amplification 
efficiency is verified by titration of K562 mRNA in comparison to GAPDH primers.
H4c Primers
Forward 5’- GGG ATA ACA TCC AGG GCA TT- 3’
Reverse 5’ - CCC TGA CGT TTT AGG GCA TA- 3’
H4k/j Primers
Forward 5’- CGC CGT GAC CTA TAC AGA GC-3’
Reverse 5’- AAC CAC CGA AAC CGT AGA GG-3’
SMG1 Primers
Forward 5’- CAA GCG ATG TCA GCA GAT GT- 3’
Reverse 5’- TGC TGA CAA AAG CCA TTC AG- 3’
RPL13
Forward 5’- GCA TTT CTG TGG ATC CGA GGA G- 3’
Reverse 5’- CGA CTG ATT CCA AGT CCC C- 3’
H2A.Y
Forward 5’ - CTG ACA GCG GAG ATT CTG G- 3’
Reverse 5’- CTT CAT CAT TGG CCA CAG C - 3’
HNRPD
Forward 5’- TTT TGT TGG TGG CCT TTC TC - 3’
Reverse 5’- GTT GTC CAT GGGGAG CTC TA- - 3’
RAB35
Forward 5’ - GCA TCC AGT TGT TCG AGA CC- 3’
Reverse 5’- GCC AGG TTG TCT TTC TTT GC - 3’
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SDS-PAGE and Western blot analysis  
Equal numbers of cells were lysed with RIPA buffer (50 mM Tris-HCl, pH 7.4, 
1% NP-40, 0.25% deoxycholate, 1 mM EDTA) with 1 X complete mini protease inhibitor 
cocktail (Roche Diagnostics, IN) for 30 min at 4 oC followed by 15 s sonication pulses 
(Branson Sonifier-150 at 3 watts).  Cell lysates were then centrifuged at 14,000 rpm (12,000 
g) for 15 min and the supernatants removed and combined with LDS sample loading buffer 
(Invitrogen, CA).  SDS-PAGE was performed with the Invitrogen NuPAGE system using 
4-12% Bis-Tris gels and MES running buffer (Invitrogen, CA).  Electrophoresis was carried 
out at 200 V for 45 min, and gel contents were transferred at 30 V for 1 h to a 0.2 µm 
nitrocellulose membrane.  Membranes were then blocked with 5% bovine serum albumin 
for 1 h at 4 oC and probed with histone H4 or GAPDH (Abcam, CA) primary antibodies. 
Protein-antibody complexes were then visualized by enhanced chemiluminescence using 
Amersham ECL system (GE Healthcare, UK), with either anti-rabbit or anti-goat horseradish 
peroxidase (HRP) conjugated secondary antibodies (Santa Cruz Biotechnology, CA).
Xenograft studies of 1R-Chl, 6R-Chl, and 1S-Chl 
Female athymic nude mice were purchased from The Scripps Research Institute 
Division of Animal Resources.  Experimental protocols were approved by the Scripps 
Institutional Animal Welfare Committee.  K562 cells were suspended to 50 million cells/
mL in Matrigel (BD Biosciences, CA), 0.2 mL of which was subcutaneously injected into 
the rear left flank of each mouse (6-8 wks of age).  Mice were monitored and tumor sizes 
measured daily; tumor volumes were calculated as ½ length x (width)2.  Tumors were 
staged for 7 to 14 days to enter growth phase. At this point compounds were administered 
at a dose of 7.5 mg/kg per injection, via the tail vein three times over a five-day period.
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Pharmacokinetic properties of 1R-Chl and 1S-Chl  
Pharmacokinetic (PK) studies were performed in normal Balb/c mice in order to 
determine plasma levels of the compounds 1R-Chl and 1S-Chl over time, and to calculate 
their constant of elimination (kel), half-life (t
1/2
), and volume of distribution (Vd).  48 
female Balb/c mice were divided into three groups of 16 mice each.  Group 1 received 100 
µL (100 nmol) of 1mM 1R-Chl, group 2 received the same amount of 1S-Chl, and group 
3 received an equal volume of PBS (control) via I.V. bolus injection.  0.5 mL of blood 
was collected from each animal at specific time-points (0, 5, 15, 30 min and 1, 4, 8 and 
24 h) in heparinized tubes, then allowed to coagulate at ambient temperature for 24 h, and 
centrifuged at 3,100 rpm for 10 min to separate the serum from the clot.  
Concentrations of 1R-Chl and 1S-Chl in the serum were determined by mass 
spectrometry (see below).  Each time-point had two animals per group.  Data collected 
was plotted as concentration (y-axis) vs. time (x-axis), and subjected to first order kinetic 
analysis in order to calculate the PK parameters.  From this graph, t
1/2
 was calculated, and 
from the natural logarithm (ln) of the concentration vs. time, kel (slope) and Vd (dose/
anti-ln y-intercept) were determined (y-intercept represents the theoretical concentration 
at t = 0).  Vd for humans was predicted by multiplying the Vd by 70 kg (average human 
weight).  
1R-Chl distribution in the mouse body was analyzed as follows: mice were injected 
with 500 nmol of 1R-Chl or PBS and euthanized after either 2 h or 24 h; organs were fixed 
in formalin.  A small piece from each major organ was weighed, homogenized in PBS 
buffer, and sonicated by two pulses of 15 s each.  1R-Chl concentration was determined by 
mass spectrometry (see below).
Mass spectrometry determination of 1R-Chl and 1S-Chl  
A control polyamide-Chl conjugate, with the sequence ImImPyIm- (R)Chlγ-
PyPyPyPy-β-Dp, was used as an internal standard for concentration determination by 
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mass spectrometry.  The molecular mass of this molecule differs from 1R-Chl and 1S-
Chl by 79.1 amu.  From each sample, a 200 µL serum aliquot was taken to which 2 µL of 
100 pmol/µL control polyamide solution was added along with 800 µL of chilled 100 % 
methanol.  Samples were vigorously vortexed for 1 min and then incubated for 15 min at 4 
ºC.  They were subsequently centrifuged at 12,000 rpm for 10 min, and the supernatant was 
harvested and concentrated to 50 µL by methanol extraction.  Standards with concentrations 
from 100 to 12,500 fmol/µL of 1R-Chl or 1S-Chl were prepared in serum and extracted by 
the above procedure.  Concentrations were determined by electrospray mass spectrometry 
with an Agilent 1100 single quadrapole instrument coupled to an Agilent 1100 liquid 
chromatography system, and a 50 mm x 2.0 mm C18 column for injection and separation.
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III. Substituent Effects in the γ Turn Unit of Hairpin 
Py-Im Polyamides
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Chapter IIIA
Next Generation Hairpin Polyamides with (R)-3,4-
Diaminobutyric Acid Turn Unit
The text of this chapter was taken in part from a manuscript co-authored with Christian 
Dose, David M. Chenoweth, and Peter B. Dervan (California Institute of Technology)
(Dose, C.; Farkas, M.E.; Chenoweth, D.M.; Dervan, P.B. J. Am. Chem. Soc. 2008, 130, 
6859-6866)
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Abstract
The characterization of a new class of pyrrole-imidazole hairpin polyamides with 
β-amino-γ-turn units for recognition of the DNA minor groove is reported.  A library of 
eight hairpins containing (R)-and (S)-3,4-diaminobutyric acid (β-amino-γ-turn) has been 
synthesized, and the impact of the molecules on DNA-duplex stabilization was studied 
for comparison with the parent γ-aminobutyric acid (γ-turn) and standard (R)-2,4-
diaminobutyric acid (α-amino-γ-turn)-linked eight-ring polyamides.  For some, but not all 
sequence compositions, melting temperature analyses have revealed that both enantiomeric 
forms of the β-amino-γ-turn increase the DNA-binding affinity of polyamides relative 
to the (R)-α-amino-γ-turn.  The (R)-β-amine residue may be an attractive alternative 
for constructing hairpin polyamide conjugates.  Biological assays have shown that (R)-β-
amino-γ-turn hairpins are able to inhibit androgen receptor-mediated gene expression in 
cell culture similar to hairpins bearing the standard (R)-α-amino-γ-turn, from which we 
infer that they are cell-permeable.
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Introduction
The ability to modulate the expression of eukaryotic gene networks by small 
molecules is a challenge in the field of chemical biology.  Hairpin pyrrole-imidazole 
polyamides are a class of programmable small molecules that bind to the minor groove of 
DNA with affinities similar to transcription factors and have been shown to inhibit gene 
expression in living cells by interfering with transcription factor/DNA interfaces.1-3  The 
DNA sequence specificity of polyamides arises from interactions of pairs of the aromatic 
amino acids N-methylpyrrole (Py), N-methylimidazole (Im), and N-methylhydroxypyrrole 
(Hp) with the edges of the Watson-Crick base pairs.4,5  The generality of the polyamide 
pairing rules has been demonstrated by numerous studies,6-9 and applications of polyamide 
conjugates include DNA alkylations,10-13 DNA templated ligations,14 sequence-specific DNA 
intercalators,15-17 fluorescent DNA paints,18,19 DNA nanoarchitectures,20-22 and transcription 
factor mimics.23-28  Efforts have been made to improve the DNA-binding properties of 
hairpin polyamides with modified turn units.29-32 Substitution of γ-aminobutyric acid (γ-
turn) by (R)-2,4-diaminobutyric acid (α-amino-γ-turn) increases the DNA-binding affinity 
by ~15-fold.30,33  In contrast, hairpins containing the opposite enantiomer, (S)-R-amino-γ-
turn, result in diminished binding affinities. This decrease is most likely caused by an 
unfavorable steric clash of the amine residue with the DNA minor groove.30  Sugiyama 
and co-workers have introduced polyamides containing the α-hydroxy-γ-turn.31  These 
hairpins provide discrimination for A·T/T·A base pairs at the turn position, although a 
~70-fold reduced DNA-binding affinity relative to analogous (R)-α-amino-γ-turn-linked 
polyamides has been observed.
Here we introduce a new class of hairpin polyamides which are linked by 3,4-
diaminobutyric acid which results in a β-amine residue at the turn unit (β-amino-γ-
turn) (Figure IIIA.1).  DNA binding affinities of four different eight-ring polyamide core 
sequences (with incrementally increasing numbers of Im/Py pairs) have been investigated 
and were compared to analogous hairpins bearing the parent γ-turn and the standard (R)-
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α-amino-γ-turn.  We show that for certain series of hairpin polyamides both enantiomers 
of the β-amino-γ-turn are able to increase the relative DNA binding affinity. However, this 
is sequence context dependent.  Biological assays reveal that hairpin polyamides bearing 
the (R)-β-amino-γ-turn are able to inhibit specific gene expression in cell culture, which 
is taken as evidence of cell permeability.
Figure IIIA.1. Schematic representation of hairpin polyamides with increased DNA-binding affinity caused 
by varying γ-turn units. Hairpin polyamides targeted to DNA sequence 5’-TGGTCA-3’ are shown as ball-
and-stick models. Ball-and-stick representation legend: black and white circles represent N-methylimidazole 
and N-methylpyrrole units, respectively, half-circles represent γ-aminobutyric acid, white diamonds repre-
sent β-alanine units, and half-circles containing a cross represent 3-(dimethylamino)-1-propylamine (Dp) as 
tail.
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Results and Discussion
Thermal stabilization of DNA duplexes by hairpin polyamides
	 Hairpin polyamides 1-16	 were synthesized with different Im/Py and Py/Py 
compositions targeted to four DNA sequences with increasing G/C content 5′-TGTTCA-
3′, 5′-TGGTCA-3′, 5′-TGGGCA-3′, and 5′-TGGGGA-3′ (Figure IIIA.2).  The 
energetics of DNA-binding properties of polyamides are typically characterized by 
quantitative DNase I footprint titrations.34  These measurements provide precise information 
regarding the affinity and specificity of DNA/polyamide complexes. Unfortunately, 
quantitative footprinting experiments revealed similar equilibrium association constants 
(Ka values ~ 2 × 10
10 M-1) for hairpins 1-8, reaching an upper limit of the standard 
procedure (Figure IIIA.3 - 6, Table IIIA.1).  For quantitative footprinting experiments, 
the DNA concentrations of equilibrium mixtures should be at least 10-fold less than the 
total association constant of the DNA/ligand complex in order to ensure the approximation 
[ligand]free = [ligand]total for numerical analysis.  However, the concentration of the labeled 
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Figure IIIA.2. Chemical structures for hairpins 1-16 targeted to DNA sequences: (A) 5’-TGTTCA-3’, (B) 
5’-TGGTCA-3’, (C) 5’-TGGGCA-3’, and (D) 5’-TGGGGA-3’.
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Figure IIIA.3. Quantitative DNase I footprint titration experiments on (A) the 285 base pair, 5’ end-labeled 
PCR product of plasmid pCDMF-2 for polyamides (B) 2, (C) 3, and (D) 4: lanes 1-11, 100 nM, 30 nM, 3 nM, 
1 nM,  300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 pM polyamide, respectively; lane 12, DNase I standard; 
lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction.  Each footprinting gel is accompanied by its 
respective binding isotherms (below).
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Figure IIIA.4. Quantitative DNase I footprint titration experiments on (A) the 285 base pair, 5’ end-labeled 
PCR product of plasmid pCDMF-2 for polyamides (B) 6, (C) 7, and (D) 8: lanes 1-11, 100 nM, 30 nM, 3 nM, 
1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 pM polyamide, respectively; lane 12, DNase I standard; 
lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction.  Each footprinting gel is accompanied by its 
respective binding isotherms.  Site E is a matched binding site located within the pUC19 plasmid (below).
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A
Figure IIIA.5. Quantitative DNase I footprint titration experiments on the (A) 293 base pair, 5’ end-labeled 
PCR product of plasmid pCDMF-1 for polyamides (B) 10, (C) 11, and (D) 12: lanes 1-11, 100 nM, 30 nM, 
3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 pM polyamide, respectively; lane 12, DNase I 
standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction.  Each footprinting gel is accompanied 
by its respective binding isotherms (below).
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Figure IIIA.6. Quantitative DNase I footprint titration experiments on (A) the 293 base pair, 5’ end-labeled 
PCR product of plasmid pCDMF-1 for polyamides (B) 14, (C) 15, and (D) 16: lanes 1-11, 100 nM, 30 nM, 
3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 pM polyamide, respectively; lane 12, DNase I 
standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction.  Each footprinting gel is accompanied 
by its respective binding isotherms (below).
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Polyamides
+
+
+
(6)
(7)
(8)
+ (5)
+
+
+
(10)
(11)
(12)
5’-CGA TGGGCA AGC-3’ 5’-CGA TGGGCT AGC-3’ 
5’-CGA TGGGGA AGC-3’ 5’-CGA TGGGGT AGC-3’ 
??? ???
5’-CGA TGGTCA AGC-3’ 5’-CGA TGGTCT AGC-3’ 
+
+
+
(14)
(15)
(16)
+ (9)
+ (13) 2.8 (±0.2) x 107 [b]
6.6 (±1.8) x 109
2.1 (±0.6) x 108
9.4 (±3.0) x 107
n. d.
n. d.
n. d.
n. d.
1.5 (±0.2) x 1010
5.9 (±0.9) x 109
3.0 (±0.4) x 109
n. d.
n. d.
n. d.
n. d. n. d.
1.3 (±0.7) x 1010 [b]
3.1 (±0.5) x 1010
2.4 (±0.3) x 1010
2.3 (±0.3) x 1010
n. d.
n. d.
n. d.
n. d.
K
a
 / M-1 K
a
 / M-1
NH
3
+
NH
3
+
NH
3
+
NH
3
+
NH
3
+
NH
3
+
NH
3
+
NH
3
+
NH
3
+
+
+
+
(2)
(3)
(4)
+ (1)
5’-CGA TGTTCA AGC-3’ 5’-CGA TGTTCT AGC-3’ 
3.0 (±0.8) x 1010 [b]
2.6 (±0.6) x 1010
2.1 (±0.1) x 1010
2.7 (±0.3) x 1010
n. d.
n. d.
n. d.
n. d.
NH
3
+
NH
3
+
NH
3
+
Table IIIA.1. Equilibrium association constants for hairpin polyamides determined by quantitative DNase I 
footprint titrations.  Equilibrium association constants reported are mean values from at least three quantita-
tive DNase I footprint titration experiments.  Standard deviations are shown in parentheses. [b]Equilibrium 
association constants have been reported previously.33  (n. d. = not determined)  
DNA fragment specified by the standard DNA/polyamide footprinting protocol is ~5 pM.34 
Consequently, DNA association constants become compressed and hence unreliable for 
comparison studies at Ka values ≥ 2x10
10 M-1.35,36
 Prior results have shown that the increase in melting temperature (ΔTm) of DNA 
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duplexes bound by hairpin polyamides correlates with DNA-binding affinity and can be 
utilized to detect single base pair mismatched DNA/polyamide complexes.37,38  Accordingly, 
we have used melting temperature analysis for dissecting differences in DNA affinities of 
hairpin polyamides.  Spectroscopic analyses were performed on 12mer DNA duplexes 
containing the appropriate match sequence in the absence and presence of polyamides in 
order to derive the desired ΔTm values (Figure IIIA.7).  Table IIIA.2 shows that all hairpins 
provided an increase in melting temperature relative to the individual DNA duplexes, 
confirming the formation of DNA/polyamide complexes.  As expected, spectroscopic 
analysis with (R)-α-amino-γ-turn hairpins revealed stronger stabilizations than the 
parent γ-turn analogues.  For example, achiral polyamide 1 targeted to DNA sequence 5’-
TGTTCA-3’ resulted in a ΔTm value of 15.9 °C, while chiral hairpin (R)-α-2	led to a 3.6 °C 
higher melting temperature (ΔTm = 19.5 °C).  Remarkably, melting temperature analyses 
in the presence of β-amino-γ-turn hairpins (S)-β-3	(ΔTm = 20.9 °C) and (R)-β-4	(ΔTm = 
22.2 °C) revealed higher ΔTm values compared to those for the α-series hairpin (R)-α-2	
(ΔTm = 19.5 °C).  
Figure IIIA.7. Normalized UV denaturation profiles of 12mer DNA duplex 5’-CGATGGTCAAGC-3’/
5’-GCTTGACCATCG-3’ in the absence and presence of hairpin polyamides 5-8.
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Table IIIA.2. Melting temperatures of DNA/polyamide complexes for A·T and T·A base pairs at the turn 
position of hairpin polyamides.  All values reported are derived from at least three melting temperature ex-
periments with standard deviations indicated in parentheses (n.d. = not determined).  ΔTm values are given 
as Tm
(DNA/polyamide)- Tm
(DNA).
Polyamides ΔTm / °CTm / °C ΔTm / °CTm / °C
??? ???
5’-CGA ?????A AGC-3’ 5’-CGA ?????? AGC-3’ 
5’-CGA ?????A AGC-3’ 5’-CGA ?????? AGC-3’ 
57.5 (±0.1) 57.9 (±0.1)
+
+
+
(14)
(15)
(16)
66.6 (±0.1)
6.7
6.8
64.2 (±0.1)
64.3 (±0.3)
9.1 67.0 (±0.1)
6.3
6.564.4 (±0.3)
9.1
64.2 (±0.1)
+ (13) 60.9 (±0.1) 3.4 61.4 (±0.3) 3.5
NH
3
+
NH
3
+
NH
3
+
+
+
+
(10)
(11)
(12)
73.4 (±0.2)
13.6
13.3
73.8 (±0.1)
73.5 (±0.1)
13.2
5’-CGA ?????A AGC-3’ 
60.2 (±0.2)
5’-CGA ?????? AGC-3’ 
59.8 (±0.3)
72.0 (±0.1)
11.5
10.7
71.3 (±0.3)
70.5 (±0.3)
12.2
+ (9) 68.8 (±0.2) 8.6 67.4 (±0.3) 7.6
NH
3
+
NH
3
+
NH
3
+
+
+
+
(6)
(7)
(8)
74.1 (±0.3) 
18.9
20.3
+ (5) 70.6 (±0.2) 
76.1 (±0.2) 
77.5 (±0.3) 
16.9
13.4
72.9 (±0.2) 
17.4
18.4
69.0 (±0.3) 
73.2 (±0.1) 
74.2 (±0.1) 
17.1
13.2
5’-CGA ?????A AGC-3’ 
57.2 (±0.1)
5’-CGA ?????? AGC-3’ 
55.8 (±0.1)
NH
3
+
NH
3
+
NH
3
+
+
+
+
(2)
(3)
(4)
73.5 (±0.2) 
20.9
22.2
+ (1) 69.9 (±0.3) 
74.9 (±0.2) 
76.2 (±0.2) 
19.5
15.9
n. d.
n. d.
n. d.
n. d.
54.0 (±0.2) n. d.
NH
3
+
NH
3
+
NH
3
+
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The same trend was observed for hairpins 5-8	 targeted to DNA sequence 5’-
TGGTCA-3’ (Table IIIA.2, Figure IIIA.2).  First, it is noteworthy that both the (R)- and (S)-
β-amino-γ-turn generated higher melting temperatures than the standard (R)-α-amino-γ-
turn.  Second, the enhancement observed for the (R)-β-series is almost twice that of the (R)-
α-series (relative to achiral hairpins) targeted to DNA sequences 5’-TGTTCA-3’ and 5’-
TGGTCA-3’.  For example, polyamide (R)-β-8	provided a ΔΔTm value of 6.9 °C, while the 
α-series (R)-α-6	led to a ΔΔTm value of 3.5 °C relative to achiral hairpin 5.  Interestingly, by 
further increasing the numberss of Im/Py pairs in the polyamides, significantly diminished 
DNA duplex stabilizations have been observed.  For example, achiral polyamide 9	and 
chiral hairpin (R)-α-10	targeted to DNA sequence 5’-TGGGCA-3’ yielded ΔTm values of 
8.6 and 13.2 °C, while the β-series (S)-β-11	and (R)-β-12	led to ΔTm values of 13.3 and 
13.6 °C, respectively (Table IIIA.2).  Even lower melting temperatures were observed for 
hairpins 13-16	designed to bind DNA sequence 5’-TGGGGA-3’.  Both β-amino-γ-turns, 
as in (S)-β-15	(ΔTm = 6.7) and (R)-β-16	(ΔTm = 6.8), resulted in significantly lower ΔTm 
values than the α-series analogue (R)-α-14	(ΔTm = 9.1).  These results imply that the impact 
of polyamide turn units on DNA-duplex stabilization is sequence context dependent.
The general increase in DNA-binding affinity for polyamides containing the (R)-α-
substitued γ-turn, relative to achiral hairpins, is most likely caused by a superposition of 
favorable non-covalent interactions of the positively charged substituent and conformational 
preferences of the turn unit.30  The (R)-α-amino-γ-turn can exist in two different 
conformations.  One conformation orients the α-ammonium in a pseudo-equatorial position 
(Figure IIIA.8A), which directs the substituent toward the wall of the minor groove with 
the potential of steric interactions.  The alternate conformation places the α-amine residue 
in a pseudo-axial position out of the minor groove, orienting the β-methylene to the floor 
of the double helix (Figure IIIA.8B).  Modeling of the (S)-β-amino-γ-turn conformations 
suggests that the β-ammonium in a pseudo-axial position is directed out of the minor groove, 
(Figure IIIA.8C) relieving the potential steric interactions with the wall in comparison to 
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Figure IIIA.8. Illustrative models of different turn conformations for hairpin polyamides containing: (A) and 
(B) the (R)-a-amino-γ-turn; (C) and (D) (S)-β-amino-γ-turn; and (E) and (F) the (R)-β-amino-γ-turn bound 
to the minor groove of DNA (dark gray = carbons, white = hydrogen, blue = nitrogen, red = oxygen).
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the α-series.  In contrast, the (S)-β-amine in a pseudo-equatorial orientation follows the 
curvature of the minor groove (Figure IIIA.8D).  The possibility of favorable non-covalent 
interactions should exist in both conformations without the detriment of steric interactions. 
As shown in Figure IIIA.8E, the pseudo-equatorial β-amine residue of the (R)-β-amino-
γ-turn is well accommodated in the DNA minor groove, while the pseudo-axial position 
should result in a steric clash of the substituent with the groove floor (Figure IIIA.8F).
Previous results have shown that polyamides constructed with several continuous 
Im/Py pairs are over-curved with respect to the DNA minor groove, significantly influencing 
the DNA binding affinity and sequence specificity.39,40  We assume that this curvature 
affects the alignment of the turn units in the DNA minor groove.  This is supported by the 
observation that the presence of fewer continuous imidazoles improves the DNA affinity 
of β-amino-γ-turns while diminishing the affinity of α-amino-γ-turns, and vice-versa. 
However, illustrative modeling is not sufficient to explain the sequence context dependence 
of chiral hairpin polyamides, highlighting the pressing need for high resolution structural 
studies.
Sequence specificity at the turn position 
Hairpin polyamides containing the γ-turn have been shown to possess an equal 
preference for A· T/T ·A over G· C/C ·G base pairs at the turn position, presumably for steric 
reasons.41  Sugiyama’s α-hydroxy-γ-turns have been demonstrated to discriminate A·T 
versus T·A at the turn position.31  In order to study the sequence specificity of polyamides 
5-16, we performed melting temperature analyses in the presence of DNA duplexes bearing 
a T·A base pair at the turn position.  Experiments involving hairpins 1-4	have been omitted 
due to the palindromic core sequence specified by the polyamides.  As shown in Table 
IIIA.2, most γ-turn and (R)-α-amino-γ-turn hairpins provided similar ΔTm values for 
T·A and A·T base pairs.  In contrast, significantly lower thermal stabilizations for T·A 
over A·T base pairs were observed for β-amino-γ-turn-linked polyamides targeting DNA 
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sequences 5’-TGGTCA-3’ (5-8) and 5’-TGGGCA-3’ (9-12).  Even more diminished duplex 
stabilizations were observed in presence of C·G and G·C base pairs (Table IIIA.3).  
These observations suggest that polyamides containing β-amino-γ-turns prefer 
A·T > T·A >> C·G > G·C base pairs at the turn position.  However, sequence specificity 
studies by using thermal denaturation measurements require binding enthalpies (ΔH
b
) of 
DNA/polyamide complexes in order to determine equilibrium association constants.37  One 
could also imagine using six-ring hairpin polyamides with lower DNA binding affinities 
in order to discriminate sequence specificities at the turn position by quantitative DNase I 
footprint titration methods.
Table IIIA.3. Melting temperatures of DNA/polyamide complexes for polyamides 5-8 with C•G and G•C 
base pairs at the turn position DNA binding sites.  All values reported are derived from at least three melting 
temperature experiments with standard deviations indicated in parentheses. ΔTm-values are given as Tm
(DNA/
polyamide) - Tm
(DNA). 
+
+
+
(6)
(7)
(8)
+ (5)
67.3 (±0.2) 
10.0
10.4
65.9 (±0.3) 
69.7 (±0.3) 
70.1 (±0.1) 
7.6
6.2
Polyamides
???
5’-CGA ?????C AGC-3’ 
59.7 (±0.3)
ΔTm / °CTm / °C
NH
3
+
NH
3
+
NH
3
+
64.7 (±0.2) 
5.7
6.4
64.3 (±0.1) 
66.1 (±0.2) 
66.8 (±0.2) 
4.3
3.9
???
5’-CGA ?????? AGC-3’ 
60.4 (±0.2)
ΔTm / °CTm / °C
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Acetylated chiral hairpin polyamides
Several approaches have been reported wherein the (R)-α-amino-γ-turn was 
utilized as a position for synthetic modifications of hairpin polyamides.10-14,42-45  It has been 
shown that acetylation of the (R)-α-amine in six-ring hairpin polyamides results in ~15-
fold reduced DNA-binding affinity.30  To study the tolerance of synthetic modifications in 
eight-ring polyamides containing the β-amino-γ-turns, we examined acetylated hairpins 
17-19	by melting temperature analysis (Figure IIIA.9).  Indeed, hairpin 17 containing the 
acetylated (R)-α-amino-γ-turn yielded a markedly lower ΔTm value (12.8 °C) than non-
acetylated analogue 6	(ΔTm = 16.9 °C, Table IIIA.2 and 4).  Even more pronounced was 
the decrease in DNA duplex stabilization for acetylated (S)-β-amino-γ-turn hairpin 18	
leading to a ΔTm value of 11.7 °C.  Remarkably, the opposite enantiomer (R)-β-19	resulted 
in significantly less destabilization (ΔTm = 17.8 °C).  All hairpins lose the positive charge 
at the turn unit by acetylation.  This implies that the cationic state of the amine residue is 
not the only contribution impacting the energetics of the DNA/polyamide complexes, as 
evidenced by the differences in melting temperatures between hairpins 17-19.  Increased 
steric demands of the acetylated substituents may also be responsible for differing binding 
affinities, due to the restricting DNA minor groove and alternate conformations of the γ-
turn units (Figure IIIA.8).
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Figure IIIA.9. Chemical structures and ball-and-stick models of acetylated hairpin polyamides 17-19 tar-
geted to DNA sequence 5’-TGGTCA-3’.
Table IIIA.4. Melting temperatures for DNA complexes containing acetylated hairpin polyamides targeted to 
DNA Sequence 5’-TGGTCA-3’.  All values reported are derived from at least three melting temperature ex-
periments with standard deviations indicated in parentheses. ΔTm values are given as Tm
(DNA/polyamide)- Tm
(DNA).
Polyamides
DNA sequence = 5’-CGA TGGTCA AGC-3’ 
ΔTm / °C
12.8
11.7
17.8
NHAc
NHAc
NHAc
(17)
(18)
(19)
+
+
+
68.9 (±0.2)
75.0 (±0.1)
70.0 (±0.1)
Tm / °C
57.2 (±0.2)
130
Biological assay for cell permeability 
Hairpin polyamide conjugates bearing the standard (R)-α-amino-γ-turn have been 
shown to modulate the expression of certain gene pathways in living cells by interfering 
with transcription factor/DNA interfaces.1-3  Recently, a hairpin designed to bind the 
DNA sequence 5’-AGAACA-3’, found in the androgen response element (ARE), has 
been demonstrated to inhibit androgen receptor-mediated expression of prostate specific 
antigen (PSA) in LNCaP cells (Figure IIIA.10).2  We utilized this cell culture transcription 
assay to investigate the cell permeability of (R)-β-amino-γ-turn hairpins because small 
structural changes within polyamides can influence nuclear uptake properties.46,47  Hairpin 
TBP
5’-AGAACAGCAAGTGCT-3’
3’-TCTTGTCGTTCACGA-5’
PSA ARE
AR AR
Med
Pol II
p160
Med
p300
Med
p1
60
p160
ARAR
Pol 
II
PSAp300
NH3
+
IPA
Figure IIIA.10. Schematic representation of the androgen receptor (AR)-mediated transcription complex 
with the prostate specific antigen (PSA) androgen response element (ARE) DNA sequence.
polyamide 21	was examined in comparison with the previously used (R)-α-amino-γ turn 
hairpin 20	(Figure IIIA.11A).  Chiral polyamides 22	and 23, designed to target different 
DNA sequences, have been used as controls.  Melting temperature analyses for polyamide 
conjugates 20-23	confirmed the results obtained for hairpins 1-4, revealing highest DNA-
duplex stabilizations for (R)-β-amino-γ-turn hairpins (Table IIIA.5).  The induction of 
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PSA mRNA by dihydrotestosterone (DHT) in LNCaP cells treated with matched and 
mismatched polyamides 20-23	was measured by quantitative real-time RT-PCR.  Hairpin 21	
provided significant inhibition of AR-mediated expression of PSA mRNA, KLK2, FKBP5, 
and TMPRSS2 mRNA, which supports cell permeable properties for (R)-β-amino-γ-turn 
hairpins (Figure IIIA.11B).
Figure IIIA.11 (A) Chemical structures and ball-and-stick models of matched and mismatched polyamides 
20-23, targeted to DNA sequence 5’-AGAACA-3’. (B) Inhibition of DHT-induced PSA, KLK2, FKBP5, and 
TMPRSS2 expression by 20-23 measured by quantitative real-time RT-PCR.
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Table IIIA.5. Melting temperatures of polyamides targeted to DNA-sequence 5’-AGAACA-3’ in complex 
with DNA.  All values reported are derived from at least three melting temperature experiments with standard 
deviations indicated in parentheses.  ΔTm values are given as Tm
(DNA/polyamide) - Tm
(DNA).
Polyamides
DNA sequence = 5’-TTGC AGAACA GCAA-3’ 
ΔTm / °C
14.3
16.2
(20)
(21) 76.3 (±0.2)
74.4 (±0.2)
Tm / °C
60.1 (±0.2)
IPA NH3+
NH3
+
IPA
NH3
+
IPA
(23) 6.866.9 (±0.1)
4.5(22) 64.6 (±0.1)IPA NH3+
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Conclusion
Herein we have introduced (R)- and (S)-β-amino-γ-turn hairpin polyamides.  Eight 
new polyamides targeting different DNA-binding motifs have been synthesized, and their 
impact on DNA duplex stabilization in relation to hairpins containing the parent γ-turn 
and the standard (R)-α-amino-γ-turn was investigated.  It was found that changing the 
turn unit from the (R)-α-amino-γ-turn to either enantiomeric forms of the β-amino-γ-
turn increases the relative DNA-binding affinity of polyamides targeted to 5’-TGTTCA-3’ 
and 5’-TGGTCA-3’ but not to 5’-TGGGCA-3’ and 5’-TGGGGA-3’ sequences, rendering 
the impact of β-amino-substituted γ-turns sequence context dependent.  Acetylation of 
the (S)-β-amino-γ-turn has been demonstrated to significantly impact the DNA-binding 
affinity but has minimal effect for the (R)-β-amino-γ-turn, which makes the (R)-β-
amino residue attractive for synthetic modifications and conjugate design.  Upper limits 
presented by DNase I footprinting titrations of high affinity binders rendered melting 
temperature analysis a more practical choice for dissecting improvements in new turn 
units of hairpin polyamides.  Due to the strong thermal stabilizations reported for eight-
ring hairpin polyamides 1-8	targeted to 5’-TGTTCA-3’ and 5’-TGGTCA-3’ sequences, it 
is not unreasonable to estimate that the DNA-binding equilibrium association constants 
are markedly higher than Ka = 2 × 10
10 M-1.  Biological experiments have demonstrated 
that (R)-β-amino-γ-turn hairpins possess biological activity to inhibit AR-mediated gene 
expression within a human cancer cell line and may have uptake properties similar to 
polyamides bearing the standard (R)-α-amino-γ-turn.  Ongoing work is focused on the 
use of the next generation hairpins in biological investigations as well as turn unit sequence 
specificity and high-resolution crystallographic studies for DNA/chiral hairpin polyamide 
complexes.  These efforts will be reported in due course.
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Materials and Methods
General 
Chemicals and solvents were purchased from Sigma-Aldrich and were used without 
further purification.  Boc-γ-Abu-OH was purchased from Novabiochem. (R)-2,4-Fmoc 
Dbu(Boc)-OH and Boc-β-Ala-PAM resin were purchased from Peptides International. 
(R)-3,4-Cbz-Dbu(Boc)-OH and (S)-3,4-Cbz-Dbu(Boc)-OH were purchased from Senn 
Chemicals AG.  All DNA oligomers were purchased HPLC purified from Integrated DNA 
Technologies.  Water (18 MΩ) was purified using a Millipore MilliQ purification system. 
The pH of buffers was adjusted using a Beckman 340 pH/temp meter.  Analytical HPLC 
was performed on a Beckman Gold system equipped with a diode array detector using 
a Phenomenex Gemini column (5 μm particle size, C18 110A, 250 × 4.6 mm, 5 μm). 
Preparative HPLC was performed on a Beckman Gold system equipped with a single-
wavelength detector monitoring at 310 nm using a Phenomenex Gemini column (5 μm 
particle size, C18 110A, 250 × 21.2 mm, 5 μm).  For both analytical and preparative 
HPLC, solvent A was 0.1% (v/v) aqueous trifluoroacetic acid (TFA) and solvent B was 
acetonitrile.  Solvent gradients were adjusted as needed. Polyamide concentrations were 
measured in 0.1% (v/v) aqueous TFA on a Hewlett-Packard diode array spectrophotometer 
“Model 8452 A” and were determined by using an extinction coefficient of 69200 M-1 ·cm-1 
at λ
max
 near 310 nm.  Matrix-assisted, LASER desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS) was performed on an Applied Biosystems Voyager DR 
Pro spectrometer using α-cyano-4-hydroxycinnamic acid as matrix.
Synthesis of polyamides 
Polyamide monomers and oligomers were synthesized as described previously.48 
All β-amino-γ-turn hairpins were synthesized by performing the following procedure: 
the polyamide was cleaved from the resin with 3-(dimethylamino)-1-propylamine, purified 
by preparative HPLC, and characterized by MALDI-TOF MS, UV-Vis spectroscopy, 
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and analytical HPLC.  A 500 nmol fraction of the Cbz-protected hairpin polyamide was 
dissolved in a 9:1 mixture (500 μL) of TFA and trifluoromethanesulfonic acid (TFMSA). 
After 5 min reaction time, the solution was flash-frozen by liquid N2 and overlaid with 
N,N’-dimethylformamide (1 mL).  The thawed solution was diluted with 20% aqueous 
acetonitrile (8 mL), purified by preparative HPLC, and characterized by MALDI-TOF 
MS, UV-Vis spectroscopy, and analytical HPLC.  Acetylated polyamides 17-19	 were 
synthesized by performing the following procedure: A 500 nmol fraction of the polyamide 
was dissolved in N,N′-dimethylformamide (900 μL) and a 9:1 mixture of pyridine:acetic 
anhydride (100 μL) was added.  After 5 min reaction time, the solution was diluted with 
10% aqueous TFA (8 mL), purified by preparative HPLC, and characterized by MALDI-
TOF MS, UV-vis spectroscopy, and analytical HPLC. Polyamide conjugates 20-23	were 
synthesized as described previously.2
Polyamide 1: MALDI-TOF MS C58H72N21O10+ calculated [M+H]+: 1222.6; found: 1222.7  
Polyamide 2: MALDI-TOF MS C58H73N22O10+ calculated [M+H]+: 1237.6; found: 1237.8  
Polyamide 3: MALDI-TOF MS C58H73N22O10+ calculated [M+H]+: 1237.6; found: 1237.8  
Polyamide 4: MALDI-TOF MS C58H73N22O10+ calculated [M+H]+: 1237.6; found: 1237.8  
Polyamide 5: MALDI-TOF MS C57H71N22O10+ calculated [M+H]+: 1223.6; found: 1223.5  
Polyamide 6: MALDI-TOF MS C57H72N23O10+ calculated [M+H]+: 1238.6; found: 1238.6  
Polyamide 7: MALDI-TOF MS C57H72N23O10
+ calculated [M+H]+: 1238.6; found: 1238.5
Polyamide 8: MALDI-TOF MS C57H72N23O10+ calculated [M+H]+: 1238.6; found: 1238.5  
Polyamide 9: MALDI-TOF MS C56H70N23O10+ calculated [M+H]+: 1224.6; found: 1224.8
Polyamide 10: MALDI-TOF MS C56H71N24O10+ calculated [M+H]+: 1239.6; found: 
1239.6  
Polyamide 11: MALDI-TOF MS C56H71N24O10+ calculated [M+H]+: 1239.6; found: 
1239.5  
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Polyamide 12: MALDI-TOF MS C56H71N24O10+ calculated [M+H]+: 1222.6; found: 
1222.7  
Polyamide 13: MALDI-TOF MS C56H70N23O10+ calculated [M+H]+: 1224.6; found: 
1224.6  
Polyamide 14: MALDI-TOF MS C56H71N24O10+ calculated [M+H]+: 1239.6; found: 
1239.7 
Polyamide 15: MALDI-TOF MS C56H71N24O10+ calculated [M+H]+: 1239.6; found: 
1239.4
Polyamide 16: MALDI-TOF MS C56H71N24O10+ calculated [M+H]+: 1239.6; found: 
1239.5  
Polyamide 17: MALDI-TOF MS C59H74N23O11
+ calculated [M+H]+: 1280.6; found: 
1280.6  
Polyamide 18: MALDI-TOF MS C59H74N23O11+ calculated [M+H]+: 1280.6; found: 
1280.7  
Polyamide 19: MALDI-TOF MS C59H74N23O11+ calculated [M+H]+: 1280.6; found: 
1280.6  
Polyamide 20: MALDI-TOF MS C65H77N22O12+ calculated [M+H]+: 1357.7; found: 
1357.6  
Polyamide 21: MALDI-TOF MS C65H77N22O12+ calculated [M+H]+: 1357.6; found: 
1357.7  
Polyamide 22: MALDI-TOF MS C64H76N23O12+ calculated [M+H]+: 1358.6; found: 
1358.6  
Polyamide 23: MALDI-TOF MS C64H76N23O12+ calculated [M+H]+: 1358.6; found: 
1358.6  
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Construction of Plasmids pCDMF-1 and pCDMF-2
 Oligonucleotides were purchased from Integrated DNA Technologies. The plasmids 
pCDMF-1 and pCDMF-2 were constructed by annealing the oligonucleotides: 5’-
AGCTGCGGCTCGAGACGGCTAACCCATCGAGACGGCTAGCCCATCGAGA-
CGGCTATCCCATCGAGACGGCTACCCCATCGAGAGGATC-3’ and 5’-GATCG-
ATCCTCTCGATGGGGTAGCCGTCTCGATGGGATAGCCGTCTCGATGGGCTAG-
CCGTCTCGATGGGTTAGCCGTCTCGAGCCGC-3’; 5’-AGCTGCGAGACGGCTC-
GAGACGGCTTGAACATCGAGACGGCTCGAGACGGCTTGACCATCGAGACG-
GCTCGAGACGGCTC-3’ and 5’-GATCGAGCCGTCTCGAGCCGTCTCGATGGTCA-
AGCCGTCTCGAGCCGTCTCGATGTTCAAGCCGTCTCGAGCCGTCTCGC-3’, 
respectively, followed by ligation into the BamHI/HindIII restriction fragment of pUC19 
using T4 DNA ligase. 
 The plasmid was then transformed into Escherichia coli JM109 competent cells. 
Ampicillin-resistant white colonies were selected from 25 mL Luria–Bertani (LB) 
agar plates containing 50 mg/mL ampicillin treated with XGAL and isopropyl-β-D-
thiogalactopyranoside (IPTG) solutions and grown overnight at 37 °C.  Cells were 
harvested the following day and purification of the plasmid was performed with a Wizard 
Plus Midiprep DNA purification kit (Promega). DNA sequencing of the plasmid insert was 
performed by the sequence analysis facility at the California Institute of Technology.  
 
DNase I footprinting titrations
 Polyamide equilibrations and DNase I footprint titrations were conducted on the 5’ 
end-labeled PCR product of pCDMF-1 and pCDMF-2 according to standard protocols.34 
DNA was incubated with polyamides or water (control) for 12 h at room temperature prior 
to reaction with DNase I. 
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UV absorption spectrophotometry 
Melting temperature analysis was performed on a Varian Cary 100 spectrophotometer 
equipped with a thermo-controlled cell holder possessing a cell path length of 1 cm.  The 
buffer for the spectroscopic measurements was chosen to match as closely as possible the 
conditions of DNase I footprinting experiments.  We used 10 mM sodium cacodylate since 
the temperature dependence of Tris-HCl makes it poorly suited for melting temperature 
analyses.37  A degassed aqueous solution of 10 mM sodium cacodylate, 10 mM KCl, 10 
mM MgCl2, and 5 mM CaCl2 at pH 7.0 was used as analysis buffer.  DNA duplexes and 
hairpin polyamides were mixed in 1:1 stoichiometry to a final concentration of 2 μM for 
each experiment.  Prior to analysis, samples were heated to 90 °C and cooled to a starting 
temperature of 25 °C with a heating rate of 5 °C/min for each ramp.  Denaturation profiles 
were recorded at λ = 260 nm from 25 to 90 °C with a heating rate of 0.5 °C/min.  The 
reported melting temperatures were defined as the maximum of the first derivative of the 
denaturation profile.
Molecular modeling 
DNA/polyamide models are based on coordinates derived from NMR structure 
studies using standard bond length and angles.8  The molecular graphics images are non-
minimized and have been created by introducing ammonium residues to the appropriate 
position of the turn unit using the UCSF Chimera package from the Resource for 
Biocomputing, Visualization, and Informatics at the University of California, San Francisco 
(supported by NIH P41 RR-01081).49
Measurement of androgen-induced PSA mRNA 
Experiments were performed as described previously.2
139
Acknowledgments 
This work was supported by the National Institutes of Health (GM27681). C.D. is 
grateful to the Alexander von Humboldt foundation for a postdoctoral research fellowship. 
M.E.F. is grateful for a pre-doctoral NIH NRSA training grant.  D.M.C. is grateful to the 
Kanel Foundation for a pre-doctoral fellowship.
References
1. Olenyuk, B. Z.; Zhang, G. J.; Klco, J. M.; Nickols, N. G.; Kaelin, W. G.; Dervan, P. B. 
    Proc. Natl. Acad. Sci. �. S. A.      2004.  101, 16768-16773.
2. Nickols, N. G.; Dervan, P. B. Proc. Natl. Acad. Sci. �. S. A. 2007.  104, 10418-10423.
3. Nickols, N. G.; Jacobs, C. S.; Farkas, M. E.; Dervan, P. B. Nucleic Acids Res. 2007.  
    35, 363-370.
4. Dervan, P. B. Bioorg. Med. Chem. 2001.  9, 2215-2235.
5. Dervan, P. B.; Edelson, B. S. Curr. Opin. Struct. Biol. 2003.  13, 284-299.
6. Kielkopf, C. L.; White, S.; Szewczyk, J. W.; Turner, J. M.; Baird, E. E.; Dervan, P. B.; 
    Rees, D. C. Science. 1998.  282, 111-115.
7. Kielkopf, C. L.; Baird, E. E.; Dervan, P. D.; Rees, D. C. Nat. Struct. Biol.  1998.  5, 
    104-109.
8. Zhang, Q.; Dwyer, T. J.; Tsui, V.; Case, D. A.; Cho, J. H.; Dervan, P. B.; Wemmer, 
    D. E. J. Am. Chem. Soc.  2004.  126, 7958-7966.
9. Puckett, J. W.; Muzikar, K. A.; Tietjen, J.; Warren, C. L.; Ansari, A. Z.; Dervan, P. B. J. 
    Am. Chem. Soc. 2007.  129, 12310-12319.
10. Wurtz, N. R.; Dervan, P. B. Chem. Biol. 2000.  7, 153-161.
11. Sasaki, S.; Bando, T.; Minoshima, M.; Shimizu, T.; Shinohara, K.; Takaoka, T.; 
      Sugiyama, H. J. Am. Chem. Soc. 2006.  128, 12162-12168.
12. Tsai, S. M.; Farkas, M. E.; Chou, C. J.; Gottesfeld, J. M.; Dervan, P. B. Nucleic Acids 
      Res. 2007.  35, 307-316.
140
13. Minoshima, M.; Bando, T.; Sasaki, S.; Shinohara, K.; Shimizu, T.; Fujimoto, J.; 
      Sugiyama, H. J. Am. Chem. Soc.  2007.  129, 5384-5390.
14. Poulin-Kerstien, A. T.; Dervan, P. B. J. Am. Chem. Soc. 2003.  125, 15811-15821.
15. Fechter, E. J.; Dervan, P. B. J. Am. Chem. Soc. 2003.  125, 8476-8485.
16. Fechter, E. J.; Olenyuk, B.; Dervan, P. B. Angew. Chem., Int. Ed. 2004.  43, 3591-
      3594.
17. Fechter, E. J.; Olenyuk, B.; Dervan, P. B. J. Am. Chem. Soc. 2005.  127, 16685-
      16691.
18. Rucker, V. C.; Foister, S.; Melander, C.; Dervan, P. B. J. Am. Chem. Soc. 2003.  125, 
      1195-1202.
19. Chenoweth, D. M.; Viger, A.; Dervan, P. B. J. Am. Chem. Soc. 2007.  129, 2216-2217.
20. Cohen, J. D.; Sadowski, J. P.; Dervan, P. B. Angew. Chem., Int. Ed. 2007.  46, 7956-
      7959.
21. Schmidt, T. L.; Nandi, C. K.; Rasched, G.; Parui, P. P.; Brutschy, B.; Famulok, M.; 
      Heckel, A. Angew. Chem., Int. Ed. 2007.  46, 4382-4384.
22. Cohen, J. D.; Sadowski, J. P.; Dervan, P. B. J. Am. Chem. Soc. 2008.  130, 402-403.
23. Arndt, H. D.; Hauschild, K. E.; Sullivan, D. P.; Lake, K.; Dervan, P. B.; Ansari, A. Z. 
      J. Am. Chem. Soc.  2003.  125, 13322-13323.
24. Kwonj, Y.; Arndt, H. D.; Qian, M.; Choi, Y.; Kawazoe, Y.; Dervan, P. B.; Uesugi, M. 
     J. Am. Chem. Soc. 2004.  126, 15940-15941.
25. Hauschild, K. E.; Metzler, R. E.; Arndt, H. D.; Moretti, R.; Raffaelle, M.; Dervan, 
      P. B.; Ansari, A. Z. Proc. Natl. Acad. Sci. �.S.A. 2005.  102, 5008-5013.
26. Stafford, R. L.; Arndt, H. D.; Brezinski, M. L.; Ansari, A. Z.; Dervan, P. B. J. Am. 
      Chem. Soc. 2007.  129, 2660-2668.
27. Stafford, R. L.; Dervan, P. B. J. Am. Chem. Soc. 2007.  129, 14026-14033.
28. Xiao, X. S.; Yu, P.; Lim, H. S.; Sikder, D.; Kodadek, T. Angew. Chem., Int. Ed. 2007.  
      46, 2865-2868.
29. Mrksich, M.; Parks, M. E.; Dervan, P. B. J. Am. Chem. Soc. 1994.  116, 7983-7988.
141
30. Herman, D. M.; Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc.  1998.  120, 1382-1391.
31. Zhang, W.; Minoshima, M.; Sugiyama, H. J. Am. Chem. Soc. 2006.  128, 14905-
14912.
32. Farkas, M. E.; Tsai, S. M.; Dervan, P. B. Bioorg. Med. Chem. 2007.  15, 6927-6936.
33. Hsu, C. F.; Phillips, J. W.; Trauger, J. W.; Farkas, M. E.; Belitsky, J. M.; Heckel, A.; 
      Olenyuk, B. Z.; Puckett, J. W.; Wang, C. C. C.; Dervan, P. B. Tetrahedron. 2007.  63, 
      6146-6151.
34. Trauger, J. W.; Dervan, P. B. Meth. Enzymol. 2001.  340, 450-466.
35. Brenowitz, M.; Senear, D. F.; Shea, M. A.; Ackers, G. K. Method Enzymol. 1986.  
      130, 132-181.
36. Senear, D. F.; Dalmaweiszhausz, D. D.; Brenowitz, M. Electrophoresis. 1993.  14, 
      704-712.
37. Pilch, D. S.; Poklar, N.; Gelfand, C. A.; Law, S. M.; Breslauer, K. J.; Baird, E. E.; 
      Dervan, P. B. Proc. Natl. Acad. Sci. �. S. A. 1996.  93, 8306-8311.
38. Pilch, D. S.; Poklar, N.; Baird, E. E.; Dervan, P. B.; Breslauer, K. J. Biochemistry. 
      1999.  38, 2143-2151.
39. Turner, J. M.; Swalley, S. E.; Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc. 1998.  
      120, 6219-6226.
40. Floreancig, P. E.; Swalley, S. E.; Trauger, J. W.; Dervan, P. B. J. Am. Chem. Soc. 
      2000.  122, 6342-6350.
41. Swalley, S. E.; Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc. 1999.  121, 1113-1120.
42. Weyermann, P.; Dervan, P. B. J. Am. Chem. Soc.  2002.  124, 6872-6878.
43. Herman, D. M.; Baird, E. E.; Dervan, P. B. Chem.-Eur. J. 1999.  5, 975-983.
44. Wang, C. C. C.; Dervan, P. B. J. Am. Chem. Soc. 2001.  123, 8657-8661.
45. Edayathumangalam, R. S.; Weyermann, P.; Gottesfeld, J. M.; Dervan, P. B.; Luger, K. 
      Proc. Natl. Acad. Sci. �. S. A. 2004.  101, 6864-6869.
46. Best, T. P.; Edelson, B. S.; Nickols, N. G.; Dervan, P. B. Proc. Natl. Acad. Sci. 
      �. S. A. 2003.  100, 12063-12068.
142
47. Edelson, B. S.; Best, T. P.; Olenyuk, B.; Nickols, N. G.; Doss, R. M.; Foister, S.; 
      Heckel, A.; Dervan, P. B. Nucleic Acids Res. 2004.  32, 2802-2818.
48. Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc. 1996.  118, 6141-6146.
49. Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; 
      Meng, E. C.; Ferrin, T. E. 2004.  25, 1605-1612.
143
Chapter IIIB
DNA sequence selectivity of hairpin polyamide turn units
The text of this chapter was taken in part from a manuscript co-authored with Benjamin 
C. Li, Christian Dose, and Peter B. Dervan (California Institute of Technology)
(Farkas, M.E.; Li, B.C.; Dose, C.; Dervan, P.B. Bioorg. Med. Chem. Lett.  2009, 19, 
6859-6866)
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Abstract
 A class of hairpin polyamides linked by 3,4-diaminobutyric acid, resulting in a 
β-amine residue at the turn unit, showed improved binding affinities relative to their α-
amino-γ-turn analogs for particular sequences.  We incorporated β-amino-γ-turns in six-
ring polyamides and determined whether there are any sequence preferences under the turn 
unit by quantitative footprinting titrations.  Although there was an energetic penalty for 
G•C and C•G base pairs, we found little preference for T•A over A•T at the β-amino-γ-
turn position.  Fluorine and hydroxyl substituted α-amino-γ-turns were synthesized for 
comparison.  Their binding affinities and specificities in the context of six-ring polyamides 
demonstrated overall diminished affinity and no additional specificity at the turn position. 
We anticipate that this study will be a baseline for further investigation of the turn subunit 
as a recognition element for the DNA minor groove.
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Introduction
Hairpin pyrrole-imidazole (Py/Im) polyamides are a class of programmable synthetic 
ligands able to bind a broad repertoire of  DNA sequences with affinities and specificities 
comparable to those of DNA-binding proteins.1,2  They have been shown to localize to 
the nuclei of living cells3,4 and regulate endogenous gene expression by interfering with 
transcription factor/DNA interfaces.5-10  Discrimination of the four Watson-Crick base 
pairs is dependent upon Py/Im ring pairings in the minor groove.  Pairing rules have been 
established whereby N-methyl imidazole/N-methylpyrrole (Im/Py) pairs target G•C, the 
reverse (Py/Im) target C•G, and Py/Py pairs target A•T and T•A.11-13 
 The turn unit in the hairpin is a recognition element, favoring T•A / A•T over G•C 
/ C•G.14  There is an energetic penalty for unfavorable steric interaction with the exocyclic 
amine present at the edge of the G•C base pair (Figure IIIB.1).  The question arises whether 
discrimination between T•A and A•T with the turn unit can be achieved. Previous efforts 
toward the improvement of hairpin binding affinity have involved modifications of the turn 
unit.  Early studies showed the optimal length of the turn element to be three methylene 
units, resulting in the use of γ-aminobutyric acid (γ-turn).15  Modification of the α-position 
of the parent γ-turn with (R)-2,4-diaminobutyric acid (α-amino-γ-turn) results in an 
approximately 15-fold increase in DNA-binding affinity.16  In contrast, hairpins containing 
the opposite enantiomer, (S)-α-amino-γ-turn, bind DNA with diminished affinities likely 
due to a steric clash of the amine with the wall of the minor groove.  Polyamides containing 
α-hydroxy-γ-turns17 and α-diaminobutyric acid18 turns have been reported to impart 
additional elements of specificity, but with the cost of diminished binding affinities. 
 In a formal sense, a DNA minor groove binding hairpin Py/Im polyamide is an 
early example of a class of oligomers encoded by the order of monomer units that fold to 
a desired shape with a specific function, referred to as “foldamers.”19-21  The ring order of 
Py/Im polyamides codes in a programmable manner for a specific, contiguous sequence 
of Watson-Crick base pairs.22  The turn unit is both a shape element as well as a DNA 
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Figure IIIB.1. Schematic diagram of six-ring hairpin polyamide (ImImPy-turn-PyPyPy) targeting the DNA 
sequence 5’-WWGGWW-3’. Dashed lines indicate hydrogen bonds between the polyamide and DNA base 
pairs.
recognition element, allowing the molecule to fold in a U-conformation.  The turn unit 
deserves more attention and this paper represents an effort to create a baseline for the 
field. 
 Recently, we introduced a new class of hairpin polyamides linked by 3,4-
diaminobutyric acid, resulting in a β-amino-γ-turn.23  These molecules showed improved 
binding affinities relative to their α-amino-γ-turn analogs for A/T-rich sequences. 
Additionally, polyamides containing the β-amino-γ-turn were found to have improved 
tolerance for synthetic modification at the amine position presumably due to their more 
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central location on the floor of the minor groove.  Due to limitations of quantitative DNase 
I footprinting titrations24-26 for compounds where Ka ≥ 10
10 M-1, relative binding affinities 
for high affinity molecules are compared by using their thermal stabilization of DNA 
duplexes.  It has been shown previously that increases in melting temperatures (ΔTm) of 
DNA duplexes bound by hairpin polyamides correlate with DNA-binding affinity.27,28
 We report herein a comparison of the sequence specificities of hairpin Py/Im 
polyamides containing the α-amino-γ-turn and the β-amino-γ-turn.  Additionally, we 
have synthesized both hydroxyl and fluoro-substituted α-amino-γ-turns and determined 
their affinities and specificities in polyamides with analogous core ring pairs.  By 
employing six-ring polyamides, which have lower binding affinities compared to eight-ring 
polyamides,29 we are able to determine reliable equilibrium association constants (Ka) via 
quantitative DNase I footprinting titrations, and compare them with DNA duplex thermal 
stabilizations.
Results and Discussion
Polyamide synthesis 
Six-ring hairpin polyamides (ImImPy-turn-PyPyPy) targeting the DNA sequence 
5’-WWGGWW-3’ were synthesized by solid phase methods on Pam resin (Figure 
IIIB.2).23,30  In addition to the parent molecule containing an unsubstituted γ-aminobutyric 
acid hairpin (1), oligomers containing an amine moiety in the α and β turn positions (2R, 
4R, 4S) and two polyamides with acetylated amines (3R, 5R) were also synthesized.  The 
acetylated, or capped, molecules were used to determine tolerance for modifications at the 
turn.  Acetylated turn units have been shown to improve nuclear uptake of polyamides.4   In 
order to expand the repertoire of molecules studied, two other series of polyamides, 6-11 
(Figure IIIB.3), targeting the DNA sequences 5’-WWGWWW-3’ and 5’-WWGGCW-3’ 
were also synthesized.  For these series, only molecules containing amines in the α and β 
turn positions were made.
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Thermal stabilization of DNA duplexes
Spectroscopic analyses of the polyamides targeting 5’-WWGGWW-3’ were 
performed on the 11mer DNA duplex shown in Table IIIB.1.23  All hairpins analyzed 
provided an increase in melting temperature, confirming the formation of DNA/polyamide 
complexes.  The ΔTm values obtained for polyamides containing a free amine were within 
error of each other.  However, acetylated polyamide 3R (α-amino turn) showed a greater 
decrease in affinity than 5R (β-amino-γ-turn). As had been demonstrated with eight-ring 
hairpin molecules,23 improvements in binding affinities for β- over α-amino-γ-turn six-
ring polyamides are more pronounced with decreasing imidazole content (Table IIIB.2). 
Polyamides 6-9, which contain only a single imidazole ring, were analyzed on two different 
duplexes: one where the binding site is flanked by C•G, and another by T•A, for the purpose 
of reducing binding affinity in subsequent footprinting analyses.
Table IIIB.1. Melting temperatures of DNA/polyamide complexes targeting 5’-WWGGWW-3’.  All values 
are derived from at least three melting temperature experiments, with standard deviations indicated in paren-
theses. ∆Tm values are given as Tm (DNA/polyamide) - Tm (DNA).
ΔTm / °CTm / °C
DNA = 5’-CTATGGTAGAC-3’
45.1 (±0.1)
Polyamides
+ NH
3
+ 59.8 (±0.3) 14.72
+
NH
3
+ 59.8 (±0.2) 14.74
+
NH
3
+ 14.960.0 (±0.2) 3
+ NHAc 54.9 (±0.1) 10.12-Ac
+
NHAc 12.257.0 (±0.2) 3-Ac
+ 54.3 (±0.2) 9.21
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Table IIIB.2. Melting temperatures of DNA/polyamide complexes. All values are derived from at least three 
melting temperature experiments, with standard deviations indicated in parentheses. ∆Tm values are given as 
Tm (DNA/polyamide) - Tm (DNA).
DNA binding affinity and sequence selectivity  
 The plasmid pCDMF6 was prepared to characterize polyamides targeting the 
sequence 5’-WWGGWW-3’ (Figure IIIB.4A), while pCDMF4 was prepared to characterize 
polyamides targeting 5’-WWGWWW-3’ (Figure IIIB.4B).  The designed inserts each 
contain four binding sites, varying the nucleotide base pair present under the turn unit.  In 
order to avoid the compression of binding affinities (Ka) for polyamides 6-8, pCDMF4 
was designed to have C•G base pairs under the polyamide dimethylpropylamine tail unit, 
diminishing binding.  Quantitative DNase I footprinting titrations were performed with the 
polyamides in order to measure their binding site affinities and specificities, as previously 
described.25   
As expected, the parent hairpin containing the γ-turn retained the lowest binding 
affinity, while experiments for 2R, 4R, and 4S (Figure IIIB.5, Table IIIB.3) corroborated 
the similar ΔTm values obtained for duplex stabilization.  None of these molecules bound 
the G•C base pair, and binding to C•G was greatly diminished.  Polyamide 4R revealed 
only a ~2-fold specificity for T•A over A•T (Table IIIB.4).  Analysis of polyamides 3R 
and 5R revealed a greater decrease in binding affinities for the α-amino-γ-turn molecule 
Polyamides ΔTm / °CTm / °C
+
+
+
58.9 (±0.2) 
13.0
58.2 (±0.4) 
 60.3 (±0.3) 
11.6
10.9
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47.3 (±0.3)
NH
3
+
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+
NH
3
+
+
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3
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3
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Figure IIIB.4. Illustration of the EcoRI/PvuII restriction fragment derived from plasmid (A) pCDMF6 and 
(B) pCDMF4, used to characterize polyamides. The designed polyamide binding sites are indicated by boxes; 
single base-pair mismatches are indicated by shaded regions.
than the β.  Between 2R and 3R there is a five-fold decrease over T•A, and an eight-fold 
decrease over A•T.  For β-amino-γ-turn polyamides 4R and 5R, there are 1.7 and 3.2-fold 
decreases for T•A and A•T, respectively.  5R shows ~3-fold preference for binding T•A 
versus A•T (Table IIIB.4). Studies of polyamides targeting 5’-WWGWWW-3’ revealed 
similar trends (Figure IIIB.6, Table IIIB.5 and 6).
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Figure IIIB.5.  Quantitative DNase I footprinting titration experiments for polyamides 1, 2R, and  4R (top, 
left to right) and 4S, 3R, and 5R (bottom, left to right) on the 5’ end labeled PCR product of plasmid pCD-
MF6: lanes 1-11, 100 nM, 30 nM, 10 nM, 3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 pM 
polyamide, respectively; lane 12, DNase I standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G 
reaction.  Respective isotherms are shown below.
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5’-ATGGTT-3’ 5’-ATGGTA-3’ 5’-ATGGTC-3’
1.6 (± 0.7) x 109 1.7 (± 0.9) x 109 3.9 (± 2.0) x 1072R
3.3 (± 0.1) x 109 1.8 (± 0.2) x 109 5.0 (±1.1) x 10 74R
1.1 (± 0.1) x 109 1.3 (± 0.2) x 109 6.0 (± 0.4) x 1074S
3.2 (± 0.4) x 108 2.1 (± 0.3) x 108  < 1073R
2.0 (± 0.4) x 109 5.2 (± 1.6) x 108 8.9 (±2.8) x 10 75R
2.1 (± 0.6) x 108 2.0 (± 0.5) x 108 < 1071
< 107
< 107
< 107
 < 107
< 107
< 107
5’-ATGGTG-3’
Table IIIB.3.  Binding affinities for polyamides targeting 5’-WWGGWW-3’.  Equilibrium association con-
stants (M-1) are reported as mean values from three DNase I footprinting titration experiments. Standard 
deviations are shown in parentheses.
H
N
O
NH
O
R1
R
R
2
3
R  ,R  ,1     2 R3
T.
A
< 0.01H, H, H 1.0 1.0
A
T
.
< 0.01NH-Ac, H, H 1.0 0.7
H, NH  , H3
+ 1.0 1.2 0.05
H, H, NH3
+ 1.0 0.5 0.02
NH  , H, H3
+ 1.0 0.9 0.02
.C
G
.G
C
1.0 0.3 0.04
< 0.01
< 0.01
< 0.01
< 0.01
< 0.01
< 0.01H, H, NH-Ac
Table IIIB.4.  Relative binding affinities for polyamides. Relative binding affinities are reported as ratios of 
binding affinities (Ka) as determined by DNase I footrpinting titration experiments for polyamides targeting 
5’-WWGGWW-3’. Affinities less than 107 cannot be determined.
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Figure IIIB.6.  Quantitative DNase I footprinting titration experiments on plasmid pCDMF4 for polyamides 
6, 7, and 8. Lanes 1-11, 100 nM, 30 nM, 10 nM, 3 nM, 1 nM, 300 pM, 100 pM, 30 pM, 10 pM, 3 pM, and 1 
pM, respectively; lane 12, DNase I standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction. 
Respective binding isotherms are shown below.
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2.0 (± 0.1) x 108
8.2 (± 0.2) x 108
3.2 (± 0.2) x 108
5’-CTGTTT-3’
2.8 (± 0.2) x 108
1.3 (±0.3) x 10 9
5.0 (± 0.4) x 108
5’-ATGATT-3’5’-CTGTTA-3’
2.8 (± 0.3) x 108
2.2 (± 1.5) x 109
5.3 (± 0.5) x 108
7
8
6
5’-CTGTTC-3’
< 107
< 107
< 107
5’-CTGTTG-3’
< 107
< 107
< 107
Table IIIB.5. Binding affinities for polyamides targeting 5’-WWGWWW-3’.  Equilibrium association con-
stants (M-1) are reported as mean values from three DNase I footprinting titration experiments. Standard 
deviations are shown in parentheses. Affinities less than 107 cannot be determined.
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C
H, NH  , H3
+ 1.0 1.6 < 0.01 < 0.01
H, H, NH3
+ 1.0 2.7 < 0.01 < 0.01
NH  , H, H3
+ 1.0 1.4 < 0.01 < 0.01
Table IIIB.6.  Relative binding affinities for polyamides. Relative binding affinities are reported as ratios of 
binding affinities (Ka) as determined by DNase I footrpinting titration experiments for polyamides targeting 
5’-WWGWWW-3’.
Fluoro and hydroxyl substituted turn units 
α−Fluoro and hydroxyl substituted hairpin turns were synthesized and incorporated 
in six-ring hairpin polyamides targeting the DNA sequence 5’-WWGGWW-3’ (Figure 
IIIB.7).  Both (R) and (S) enantiomers of each turn subunit were examined. Polyamides 
were synthesized on Pam resin using standard solid phase methods.  
 Thermal stabilization analysis of the polyamides on 11mer DNA duplexes 
revealed that fluoro and hydroxyl substituted hairpins resulted in lower stabilizations 
than the corresponding amine-substituted and acetylated polyamides (Table IIIB.7). The 
presence of T•A and A•T base pairs under the hairpin turn subunit were probed.  DNase I 
footprinting titrations on the plasmid pCDMF6 (Figure IIIB.8, Table IIIB.8) showed that 
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Figure IIIB.7. Chemical and ball-and-stick structures of polyamides containing fluoro and hydroxyl sub-
stituted hairpin turns. Ball and stick symbols are defined as follows: pyrrole is denoted by an open circle, 
imidazole is denoted by a filled circle, and β-alanine is denoted by a diamond shape.
both enantiomers of the hydroxyl and fluoro-hairpin turns resulted in decreased polyamide 
binding affinities relative to their amine substituted counterparts.  Additionally, none 
of these subunits resulted in increased elements of specificity at the turn position of the 
molecule (Table IIIB.9).  
Table IIIB.7. Melting temperatures of DNA/polyamide complexes. All values are derived from at least three 
melting temperature experiments, with standard deviations indicated in parentheses. ∆Tm values are given as 
Tm (DNA/polyamide) - Tm (DNA).
ΔTm / °CTm / °C
DNA = 5’-CTATGGTAGAC-3’
45.1 (±0.1)
Polyamide
+ OH 55.1 (±0.2) 10.05
5.850.9 (±0.2) 7 + OH
 7.953.0 (±0.2) 8 + F
53.4 (±0.2)  8.36 + F
ΔTm / °CTm / °C
DNA = 5’-CTATGGTAGAC-3’
46.7 (±0.4)
57.4 (±0.4) 10.7
5.652.3 (±0.2) 
 8.755.4 (±0.2) 
55.1 (±0.1)  8.4
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Figure IIIB.8  Quantitative DNase I footprinting titration experiments for polyamides 12R, 13R, 12S, and 
13S (left to right) on the 5’ end labeled PCR product of plasmid pCDMF6. For 12R: lanes 1-11, 100nM, 
30nM, 10nM, 3nM, 1nM, 300pm, 100pM, 30pM, 10pM, 3pM, and 1pM polyamide, respectively; lane 12, 
DNase I standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G reaction. Polyamides 13R, 12S, and 
13S: lanes 1-11, 10 μM, 3 μM, 1 μM, 300 nM, 100 nM, 30 nM, 10 nM, 3 nM, 1 nM, 300 pM, and 100 pM 
polyamide, respectively; lane 12, DNase I standard; lane 13, intact DNA; lane 14, A reaction; lane 15, G reac-
tion. Respective isotherms are shown below.
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Table IIIB.9.  Relative binding affinities for polyamides containing fluoro- and hydroxyl-substituted turn 
units. Relative binding affinities are reported as ratios of binding affinities (Ka) as determined by DNase I 
footrpinting titration experiments for polyamides.
12R
13R
12S
5’-ATGGTT-3’
2.1 (± 0.4) x 108
5.3 (± 1.1) x 107
2.6 (± 0.6) x 107
6.1 (± 2.3) x 107
5’-ATGGTA-3’
2.0 (± 0.5) x 108
4.5 (± 0.6) x 107
3.4 (± 1.2) x 107
3.9 (± 1.3) x 107
5’-ATGGTC-3’
 < 107
 < 107
3.6 (±1.1) x 10 7
3.5 (±1.2) x 10 7
5’-ATGGTG-3’
 < 107
 < 107
2.0 (±0.7) x 10 7
 < 10713S
Table IIIB.8. Binding affinities for polyamides containing fluoro- and hydroxyl-substituted turn units.  Equi-
librium association constants (M-1) are reported as mean values from three DNase I footprinting titration 
experiments. Standard deviations are shown in parentheses. Affinities less than 107 cannot be determined.
Conclusion
By utilizing six-ring hairpin polyamides, we were able to combine DNase I 
footprinting titration and duplex stabilization analyses in order to fully characterize the 
binding preferences of various hairpin turn subunits.  Although the hairpin turns investigated 
herein show modest DNA binding specificities, we anticipate that further study will yield 
moieties enabling discrimination amongst all four Watson-Crick base pairs and add an 
additional recognition element for DNA recognition.
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Materials and Methods
Polyamide synthesis
Polyamides were synthesized with Boc-β-Ala-PAM resin (Peptides International) 
according to published synthesis protocols.23,30  Boc-4-Abu-OH was purchased from 
Novabiochem, (R)-2,4-Fmoc-Dbu(Boc)-OH was purchased from Bachem.  (R)-3,4-CBZ-
Dbu(Boc)-OH and (S)-3,4-CBZ-Dbu(Boc)-OH were purchased from Senn Chemicals 
AG.  Generation of the hydroxyl and fluoro hairpin turns is described below. All DNA 
oligomers were purchased from Integrated DNA Technologies. Polyamides were purified 
via preparative HPLC on an Agilent Technologies 1200 Series system using a Phenomenex 
Gemini column. Matrix-assisted, LASER desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS) was performed on an Applied Biosystems Voyager DR 
Pro spectrometer. 
Polyamide 1: MALDI-TOF MS C46H60N17O8+ calculated [M+H]+: 979.1; found:  978.8 
Polyamide 2R: MALDI-TOF MS C46H62N18O8+ calculated [M+H]+ : 994.1; found: 993.9
Polyamide 3R: MALDI-TOF MS C48H63N18O9+ calculated [M+H]+: 1036.1; found: 1036.0
Polyamide 4R: MALDI-TOF MS C46H62N18O8+ calculated [M+H]+: 994.1; found: 994.0
Polyamide 5R: MALDI-TOF MS C48H63N18O9+ calculated [M+H]+ : 1036.1; found: 
1035.9
Polyamide 4S: MALDI-TOF MS C46H62N18O8+ calculated [M+H]+ : 994.1; found: 993.9
Polyamide 6: MALDI-TOF MS C47H62N17O8+ calculated [M+H]+ : 992.5; found: 992.2
Polyamide 7: MALDI-TOF MS C47H62N17O8+ calculated [M+H]+ : 992.5; found: 992.6
Polyamide 8: MALDI-TOF MS C47H62N17O8+ calculated [M+H]+ : 992.5; found: 992.3
Polyamide 9: MALDI-TOF MS C45H60N19O8+ calculated [M+H]+ : 995.5; found: 995.0
Polyamide 10: MALDI-TOF MS C45H60N19O8+ calculated [M+H]+ : 995.5; found: 995.2
Polyamide 11: MALDI-TOF MS C45H60N19O8+ calculated [M+H]+ : 995.5; found: 995.7
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Polyamide 12R: MALDI-TOF MS C46H60N17O9+ calculated [M+H]+ : 995.1; found: 995.0 
Polyamide 13R: MALDI-TOF MS C46H59FN17O8+ calculated [M+H]+: 996.5; found: 
996.7 
Polyamide 12S: MALDI-TOF MS C46H60N17O9+calculated [M+H]+ : 995.1; found: 995.1
Polyamide 13S: MALDI-TOF MS C46H59FN17O8+ calculated [M+H]+ : 996.5; found: 
996.6
Polyamide assays
Melting temperature analysis was performed as previously described22 on a Varian 
Cary 100 spectrophotometer equipped with a thermo-controlled cell holder, using 10 mM 
sodium cacodylate buffer.
 Plasmids were constructed as previously described18 by annealing the 
following oligonucleotide pairs: 5’-AGCTGCTGACTGACTATGGTTCT-
G A C T G A C TAT G G TA C T G A C T G A C TAT G G T C C T G A C T G A C TAT G G T-
GCTGACTGACTGCCGC-3’  and 5’-AGCTGCGGCAGTCAGTCAGCACCATAGT-
CAGTCAGGACCATAGTCAGTCAGTACCATAGTCAGTCAGAACCATAGTCAGTCAGC-3’ 
for pCDMF6;   5’-AGCTGATCCTCTCGCTGTTTATCCTGCTCGCTGTTAATCCT-
GCTCGCTGTTCATCCTGCTCGCTGTTGCAGTCACTGTAGCCGC-3’ and 5’-AGCT-
GCGGCTACAGTGACTGCAACAGCGAGCAGGATGAACAGCGAGCAGGATTAA-
CAGCGAGCAGGATAAACAGCGAGAGGATC-3’ for pCDMF4.  5’-labeling of primers 
with 32P and subsequent DNase I footprinting titrations were performed as previously de-
scribed.18,26
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Synthesis of fluoro and hydroxyl turn precursors
Synthetic schemes for the synthesis of fluorine and hydroxyl substituted hairpin 
turns are shown in Figure IIIB.9 and IIIB.10, respectively.31,32 Enantiopurities of precursors 
were probed via analytical chiral HPLC assays of their tryptamide derivatives (data not 
shown).
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Figure IIIB.9.  Synthetic procedures for the generation of fluorine-substituted hairpin turns.
Reagents and conditions: (a) phthalic anhydride, 140 °C, 0.5 h; (b) 1M HCl, MeOH, Et2O, r.t., 3 h, 76% over 
2 steps; (c) DAST, pyridine, DCM, 0 °C to r.t., 16 h, 44%; (d) 6M HCl, H2O, reflux, 16 h, 91%; (e) Boc2O, 
NaHCO3, THF, H2O, 0 °C to r.t., 16 h, 71%; (f) p-NO2-C6H4CO2H, PPh3, DIAD, THF, 0 °C to r.t., 4 h, 93%; 
(g) Et3N, MeOH, r.t., 4 h, 95%; (h) DAST, pyridine, DCM 0  C to r.t., 16 h, 41%; (i) 6M HCl, H2O, reflux, 16 
h, 99%; (j) Boc2O, NaHCO3, THF, H2O, 0 °C to r.t., 16 h, 70%.
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Figure IIIB.10.  Synthetic procedures for the generation of hydroxyl-substituted hairpin turns.
Reagents and conditions: (a) Boc2O, NaHCO3, 1,4-dioxane, H2O, 0 °C to r.t., 16 h, 82%; (b) MeI, K2CO3, 
DMF, r.t., 44 h, 57%; (c) p-NO2-C6H4 CO2H, PPh3, DIAD, THF, 0 °C to r.t., 8 h, 84%; (d) Et3N, MeOH,  r.t., 
1.5 h, 99%; (e) 1M NaOH, MeOH, H2O, 0 °C to r.t., 0.5 h, then 1M HCl, H2O, 0 °C, 93%.
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(S)-(-)-4-amino-2-hyroxybutyric acid (14), phthalic anhydride, solid sodium 
hydrogensulfonate (NaHSO4), 2M HCl in diethyl ether (Et2O), pyridine, diethylaminosulfur 
trifluoride (DAST), di-tert-butyldicarbonate (Boc2O), triphenyl phosphine (PPh3), 4-
nitrobenzoic acid, diisopropylazodicarboxylate (DIAD), triethylamine, methyl iodide 
(CH3I), 1M aqueous HCl, anhydrous N,N-dimethylformamide (DMF) and tryptamine 
were purchased from Sigma-Aldrich. 1M aqueous NaOH, concentrated HCl, solid sodium 
sulfate (Na2SO4), and solid sodium bicarbonate (NaHCO3) were purchased from EMD 
Chemicals. Benzotriazole-1-yl-oxy-tris-pyrrolidino-phophonium hexafluorophosphate 
(PyBOP) was purchased from Novabiochem.  Solid citric acid hexahydrate was purchased 
from Mallinckrodt Chemicals.  All NMR spectroscopy data was obtained on a Variant 
instrument operating at 500 MHz. HRMS were acquired using an Agilent 6200 Series TOF 
with an Agilent G1978A Multimode source in electrospray ionization (ESI), atmospheric 
pressure chemical ionization (APCI) or mixed (MM) ionization mode. Optical rotation 
measurements were measured on a Jasco P-1010 polarimeter at 589 nm in spectrophotometric 
grade solvents.
(S)-methyl 4-(1,3-dioxoisoindolin-2-yl)-2-hydroxy-butanoate (15)
 (S)-(-)-4-amino-2-hyroxybutyric acid (4.00 g, 33.6 mmol) 14 was combined with 
phthalic anhydride (4.97 g, 33.6 mmol).  The solids were ground, mixed, and heated to 
140 oC, at which point the phthalic anhydride melted and dissolved 14.  After 30 min, the 
reaction mixture was cooled to room temperature and re-dissolved in EtOAc (300mL).  The 
solution was extracted with 1M NaHSO4 (100 mL, pH 3), washed with water (3 x 100 mL), 
and brine (100 mL).  The organic layer was dried over Na2SO4, filtered, and concentrated 
in vacuo.  To the crude mixture (8.3 g) dissolved in anhydrous methanol (250 mL) was 
slowly added 2M HCl in Et2O (250 mL).  The reaction was stirred at room temperature; 
TLC indicated completion after 3 h.  The mixture was concentrated on rotovap and purified 
on a short silica gel column (9:1 DCM:EtOAc).  The desired fractions were combined, 
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concentrated and dried to give product 15 as a fine white powder (6.68 g, 76% yield).  1H 
NMR [499.8 MHz, DMSO-d6]: d 7.83 (m, 4H), 5.57 (d, J = 5.5 Hz, 1H), 4.11 (m, 1H), 
3.68 (t, J = 7.25 Hz, 2H), 3.59 (s, 3H), 2.01 (m, 1H), 1.84 (m, 1H); 13C NMR [125.7 MHz, 
DMSO-d6]: d 173.9, 167.8, 134.3, 131.7, 122.9, 68.0, 51.5, 34,3, 32.2; HRMS (MM: ESI–
APCI) calcd for C13H13NO5 [M+Na]
+ 286.0686, found 286.0684; [a]22D +10.40 (c = 0.5, 
CHCl3)
(R)-methyl 4-(1,3-dioxoisoindolin-2-yl)-2-fluorobutanoate (16) 
 To hydoxy ester 15 (5.00 g, 19.0 mmol) in DCM (50 mL) was added pyridine 
(1.923 mL, 23.7 mmol) at 0 oC.  The solution was purged with argon and DAST (3.11 
mL, 23.7 mmol) was added drop-wise under argon pressure.  The reaction was stirred 
at room temperature for 18 h and poured slowly into a cold saturated NaHCO3 solution. 
The organic layer was extracted, washed with water (50 mL), 0.1M HCl (50 mL), water 
(50 mL) and brine (50 mL), and dried (Na2SO4), filtered, and concentrated in vacuo.  The 
product was purified via silica gel column chromatography (100% DCM to 9:1 DCM:
EtOAc).  The desired fractions were combined, concentrated and dried to yield compound 
16 as a pale yellow solid (2.21 g, 44% yield).  1H NMR [499.8 MHz, DMSO-d6]: d 7.85 
(m, 4H), 5.24 (ddd, JH-H = 3.5 Hz, JH-H = 8.5 Hz, JH-F = 48 Hz, 2H), 3.72 (m, 2H), 3.65 (s, 
3H), 2.09-2.29 (brm, 2H); 13C NMR [125.7 MHz, DMSO-d6]: d 169.3 (2JC-F = 23.5 Hz), 
167.7, 134.3, 131.7, 123.0, 86.7 (1JC-F = 181.0 Hz), 52.2, 33.1 (
3JC-F = 3.3 Hz), 30.3 (
2JC-
F = 20.7 Hz); HRMS (MM: ESI–APCI) calcd for C13H12FNO4 [M+H]
+ 266.0823, found 
266.0830; [a]22D -2.64 (c = 0.5, CHCl3)
(R)-4-amino-2-fluorobutanoic acid (17) 
 Ester 16 (300 mg, 1.13 mmol) was suspended in 6M HCl (3.0 mL) and refluxed 
for 16 h under argon pressure.  The mixture was cooled to room temperature, the phthalic 
acid precipitate was removed by filtration.  The filtrate was concentrated in vacuo, and the 
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product was purified by recrystallization in iPrOH and Et2O to afford 17 as white crystals 
(124mg, 91% yield).  1H NMR [499.8 MHz, D2O]: d 5.08 (ddd, JH-H = 4.0 Hz, JH-H = 8.0 
Hz, JH-F = 49.0 Hz, 2H), 3.10 (m, 2H), 2.09-2.32 (brm, 2H); 
13C NMR [125.7 MHz, D2O]: 
d173.4 (2JC-F = 23.0 Hz), 87.6 (1JC-F = 180.0 Hz), 36.0 (3JC-F = 3.8 Hz), 29.6 (2JC-F = 20.7 Hz); 
HRMS (MM: ESI–APCI) calc’d for C4H8FNO4 [M+H]
+ 122.0612, found 122.061; [a]22D 
+10.64 (c = 0.5, H2O)
(R)-4-(tert-butoxycarbonylamino)-2-fluorobutanoic acid (18)
 To a solution of amino acid 17 (40 mg, 0.33 mmol) in THF (1 mL) and water (1 
mL), solid NaHCO3 (83 mg, 0.99 mmol) and Boc2O (87 mg, 0.40 mmol) was added at 0 
oC.  After 30 min, the solution was slowly warmed to room temperature and stirred for 
16 h, followed by extraction with Et2O (2 x 1.5mL) to remove generated tert-butanol and 
unreacted Boc2O.  The aqueous layer was carefully acidified to pH 2.5 with half-saturated 
citric acid at 0 oC, and extracted with DCM (3 x 1.5 mL).  The combined organic phase was 
dried (Na2SO4), filtered, concentrated and dried to give product 18 as a colorless oil (52 mg, 
71% yield).  1H NMR [499.8 MHz, DMSO-d6]: d 13.4 (brs, 1H), 6.91 (t, J = 5.5 Hz, 1H), 
4.95 (ddd, JH-H = 3.5 Hz, JH-H = 8.5 Hz, JH-F = 49.0 Hz, 2H), 3.04 (m, 2H), 1.75-2.01 (brm, 
2H), 1.37 (s, 9H); 13C NMR [125.7 MHz, DMSO-d6]: d 170.9 (2JC-F = 23.0 Hz), 155.6, 86.6 
(1JC-F = 180.5 Hz), 77.7, 35.7, 32.4 (
2JC-F = 20.2 Hz), 28.2; HRMS (MM: ESI–APCI) calcd 
for C9H16FNO4 [M-H]
- 220.0991, found 220.1018; [a]22D +5.32 (c = 0.5, MeOH)
(R)-methyl 4-(1,3-dioxoisoindolin-2-yl)-2-hydroxy-butanoate (19)
 To a solution of 15 (5.00g, 19.0 mmol) in THF (125 mL) was added PPh3 (5.485 g, 
20.9 mmol) followed by 4-nitrobenzoic acid (9.53 g, 57.0 mmol). DIAD (4.06 mL, 20.9 
mmol) was added dropwise to the solution at 0 oC, and the reaction was stirred at room 
temperature.  TLC showed reaction completion after 4 h, and the solution was concentrated 
in vacuo.  The product was isolated via silica gel column chromatography (100% DCM), 
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and the combined fractions were concentrated and dried in vacuo to afford the Mitsunobu 
intermediate (R)-4-(1,3-dioxoisoindolin-2-yl)-1-methoxy-1-oxobutan-2-yl 4-nitrobenzoate 
as a pale yellow powder (7.3 g, 93% yield).  1H NMR [499.8 MHz, DMSO-d6]: d 8.30 (dd, 
J = 2.5 Hz, J = 9 Hz, 2H), 8.17 (dd, J = 2.5 Hz, J = 9 Hz, 2H), 7.78 (m, 4H), 5.33 (dd, J 
= 5 Hz, J = 7.5 Hz, 1H), 3.84 (m, 2H), 3.65 (s, 3H), 2.33 (m, 2H); 13C NMR [125.7 MHz, 
DMSO-d6]: d 169.4, 167.9, 163.6, 150.4, 134.3, 134.0, 131.6, 130.7, 123.9, 123.0, 71.2, 
52.5, 33.9, 30.0; HRMS (MM: ESI–APCI) calcd for C20H16N2O8 [M+H]
+ 413.0979, found 
413.0975; [a]22D +28.6 (c = 0.5, CHCl3).
 To obtain the desired product 19, triethylamine (9.93 mL, 77.5 mmol) was added 
to the intermediate (6.4 g, 15.5 mmol) in anhydrous methanol (480 mL).  The reaction 
was monitored by TLC and was complete after 4 h.  The solution was then concentrated 
and purified via column chromatography (100% DCM to 9:1 DCM:EtOAc).  The desired 
fractions were combined, concentrated and dried to afford compound 19 as a fine white 
powder (3.86 g, 95% yield).  1H NMR [499.8 MHz, DMSO-d6]: d 7.84 (m, 4H), 5.57 (d, 
J = 5.5 Hz, 1H), 4.12 (m, 1H), 3.68 (t, J = 7.5 Hz, 2H), 3.59 (s, 3H), 2.02 (m, 1H), 1.84 
(m, 1H); 13C NMR [125.7 MHz, DMSO-d6]: d 173.9, 167.8, 134.3, 131.7, 122.9, 67.9, 
51.5, 34.3, 32.1; HRMS (MM: ESI–APCI) calcd for C13H13NO5 [M+Na]
+ 286.0686, found 
286.0688 [a]22D -10.28 (c = 0.5, CHCl3).
(S)-methyl 4-(1,3-dioxoisoindolin-2-yl)-2-fluorobutanoate (20) 
 Synthesis was performed using R-enantiomer 19 (3.85 g, 14.6 mmol) in conjunction 
with the method for the synthesis of fluoroester 16.  The product 20 was synthesized and 
isolated as a pale yellow solid (1.60 g, 41% yield).  1H NMR [499.8 MHz, DMSO-d6]: d 
7.85 (m, 4H), 5.24 (ddd, JH-H = 3.5 Hz, JH-H = 8.5 Hz, JH-F = 48.0 Hz, 2H), 3.72 (m, 2H), 
3.65 (s, 3H), 2.09-2.29 (brm, 2H); 13C NMR [125.7 MHz, DMSO-d6]: d 169.3 (2JC-F = 23.5 
Hz), 167.7, 134.3, 131.7, 123.0, 86.7 (1JC-F = 181.3 Hz), 52.2, 33.1 (
3JC-F = 3.8 Hz), 30.3 
(2JC-F = 20.2 Hz); HRMS (MM: ESI–APCI) calcd for C13H12FNO4 [M+H]
+ 266.0823, found 
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266.0828; [a]22D +2.4 (c = 0.5, CHCl3).
(S)-4-amino-2-fluorobutanoic acid (21)
 This compound was synthesized by following the method used for the synthesis 
of amino acid 17, but using the S-enantiomer 20 (1.60 g, 6.03 mmol) as starting material. 
The product was synthesized and isolated as fluffy white crystals (725 mg, 99% yield).  1H 
NMR [499.8 MHz, D2O]: d 5.08 (ddd, JH-H = 4.0 Hz, JH-H = 8.0 Hz, JH-F = 49.0 Hz, 2H), 3.09 
(m, 2H), 2.08-2.32 (brm, 2H); 13C NMR [125.7 MHz, D2O]: d 173.4 (2JC-F = 23.0 Hz), 87.7 
(1JC-F = 180.0 Hz), 36.0 (
3JC-F = 3.3 Hz), 29.6 (
2JC-F = 20.7 Hz); HRMS (MM: ESI–APCI) 
calcd for C4H8FNO4 [M+H]
+ 122.0612, found 122.0613; [a]22D -11.2 (c = 0.5, H2O).
 (S)-4-(tert-butoxycarbonylamino)-2-fluorobutanoic acid (22)
 This compound was synthesized by following the method used for the synthesis of 
amino acid 18, but using the S-enantiomer 21 (40 mg, 0.33 mmol) as starting material.  The 
product 22 was synthesized and isolated as a colorless oil (51 mg, 70% yield).  1H NMR 
[499.8 MHz, DMSO-d6]: d 13.3 (brs, 1H), 6.91 (t, J = 5.5 Hz, 1H), 4.95 (ddd, JH-H = 3.5 
Hz, JH-H = 8.5 Hz, JH-F = 49.0 Hz, 2H), 3.04 (m, 2H), 1.75-2.01 (brm, 2H), 1.37 (s, 9H); 
13C 
NMR [125.7 MHz, DMSO-d6]: d 170.8 (2JC-F = 23.5 Hz), 155.4, 86.4 (1JC-F = 180.5 Hz), 
77.6, 35.6, 32.3 (2JC-F = 19.9 Hz), 28.1; HRMS (MM: ESI–APCI) calcd for C9H16FNO4 [M-
H]- 220.0991, found 220.1017; [a]22D -5.04 (c = 0.5, MeOH).
(S)-4-(tert-butoxycarbonylamino)-2-hydroxybutanoic acid (23)
 To a solution of (S)-(-)-4-amino-2-hydroxybutyric acid 14 (2.00 g, 16.8 mmol) 
dissolved in water (50 mL) and 1,4-dioxane (50 mL), NaHCO3 (1.55 g, 18.5 mmol) and 
added Boc2O (4.04 g, 18.5 mmol) was added at 0 
oC.  After 15 min, the turbid solution was 
slowly warmed to room temperature and stirred for 16 h.  The solution was extracted with 
Et2O (2 x 50 mL) to rid of the generated tert-butanol and unreacted di-tert-butyldicarbonate. 
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The aqueous layer was carefully acidified to pH 2.5 with 1M HCl (~20 mL) at 0 oC, and 
extracted with DCM (3 x 50 mL).  The combined organic phase was dried (Na2SO4), filtered, 
concentrated and dried to give product 23 as a colorless oil (3.03 g, 82% yield).  1H NMR 
[499.8 MHz, DMSO-d6]: d 6.75 (t, J = 5.0 Hz, 1H), 3.93 (dd, J = 4.0 Hz, J = 8.5 Hz, 1H), 
3.00 (m, 2H), 1.77 (m, 1H), 1.57 (m, 1H), 1.36 (s, 9H); 13C NMR [125.7 MHz, DMSO-d6]: 
d 175.6, 155.5, 77.5, 67.7, 36.7, 34.1, 28.2; HRMS (MM: ESI–APCI) calcd for C9H17NO5 
[M+Na]+ 242.0999, found 242.0997; [a]22D -3.96 (c = 0.5, MeOH).
(S)-methyl 4-(tert-butoxycarbonylamino)-2-hydroxybutanoate (24) 
 To a solution of Boc-protected amino acid 23 (2.00 g, 9.1 mmol) dissolved in DMF 
(20 mL) was added K2CO3 (1.32 g, 9.54 mmol) at 0 
oC.  After 15 min, CH3I (4.13 g, 29.12 
mmol) was added slowly and the solution was stirred for 44 h at room temperature.  The 
solution was then partitioned between H2O (100mL) and ethyl acetate (4 x 50 mL).  The 
organic fractions were combined, dried (Na2SO4), filtered, concentrated and dried to give 
product 24 as a pale yellow oil (1.20 g, 57% yield).  1H NMR [499.8 MHz, DMSO-d6]: 
d 6.76 (t, J = 5.0 Hz, 1H), 5.39 (d, J = 6.0 Hz, 1H), 4.04 (m, 1H), 3.62 (s, 3H), 2.99 (m, 
2H), 1.75 (m, 1H), 1.59 (m, 1H), 1.36 (s, 9H); 13C NMR [125.7 MHz, DMSO-d6]: d 174.4, 
155.5, 77.5, 67.8, 51.4, 36.4, 34.1, 28.2; HRMS (MM: ESI–APCI) calcd for C10H19NO5 
[M+Na]+ 256.1155, found 256.1159; [a]22D +4.56 (c = 0.5, MeOH).
(R)-methyl 4-(tert-butoxycarbonylamino)-2-hydroxybutanoate (25) 
 To a solution of ester 24 (650 mg, 2.75 mmol) in THF (13 mL) was added PPh3 
(795 g, 3.02 mmol) followed by 4-nitrobenzoic acid (1.38 g, 8.26 mmol). DIAD (589 mL, 
3.03 mmol) was added dropwise to the solution at 0 oC, and the reaction was stirred at room 
temperature.  TLC showed a completed reaction after 8 h, and the solution was concentrated 
in vacuo.  The product was isolated via silica gel column chromatography (95:5 DCM:
EtOAc to 9:1 DCM:EtOAc), and the combined fractions were concentrated and dried in 
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vacuo to afford the Mitsunobu intermediate (R)-4-(tert-butoxycarbonylamino)-1-methoxy-
1-oxobutan-2-yl 4-nitrobenzoate as a colorless oil (890 mg, 84% yield).  1H NMR [499.8 
MHz, DMSO-d6]: d 8.38 (dd, J = 2.0 Hz, J = 9.0 Hz, 2H), 8.24 (dd, J = 2.0 Hz, J = 9.0 
Hz, 2H), 6.99 (t, 5.5 Hz, 1H), 5.20 (m, 1H), 3.70 (s, 3H), 3.16 (m, 2H), 2.05 (m, 2H), 1.34 
(s, 9H); 13C NMR [125.7 MHz, DMSO-d6]: d 169.9, 163.8, 155.6, 150.5, 134.3, 130.8, 
124.0, 77.7, 70.9, 52.4, 35.8, 30.8, 28.1; HRMS (MM: ESI–APCI) calcd for C17H2N2O8 
[M-Boc+2H]+ 283.0925, found 283.0934; [a]22D +16.64 (c = 0.5, MeOH).
 To obtain the desired product 25, triethylamine (750 mL, 5.38 mmol) was added to 
the intermediate (410 mg, 1.07 mmol) in anhydrous methanol (30 mL).  The reaction was 
monitored by TLC and was complete after 1.5 h.  The solution was then concentrated and 
run through a silica plug.  DCM was run till the eluent was no longer UV active, at which 
point EtOAc was used to flush out the product.  The EtOAc fractions were combined, 
concentrated and dried to afford compound 25 as a pale yellow oil (250 mg, 99% yield). 
1H NMR [499.8 MHz, DMSO-d6]: d 6.76 (t, J = 5.0 Hz, 1H), 5.39 (d, J = 6.0 Hz, 1H), 4.04 
(m, 1H), 3.62 (s, 3H), 2.99 (m, 2H), 1.76 (m, 1H), 1.60 (m, 1H), 1.36 (s, 9H); 13C NMR 
[125.7 MHz, DMSO-d6]:d d 174.4, 155.5, 77.5, 67.8, 51.4, 36.5, 34.1, 28.2; HRMS (MM: 
ESI–APCI) calcd for C10H19NO5 [M+Na]
+ 256.1155, found 256.1158; [a]22D -4.28 (c = 0.5, 
MeOH).
(R)-4-(tert-butoxycarbonylamino)-2-hydroxybutanoic acid (26) 
 To a solution of Boc-protected amino acid 25 in MeOH (2.5 mL) was added dropwise 
1M NaOH (2.5 mL) at 0 oC.  The reaction mixture was warmed to room temperature and 
TLC showed a completed reaction after 30 min.  The solution was cooled to 0 oC and re-
acidified to pH2 by dropwise addition of 1M HCl (2.5 mL), and extracted with EtOAc (3 x 
2.5 mL).  The organic fractions were then combined, dried (Na2SO4), filtered, concentrated 
and dried to give product 26 as a colorless oil (108 mg, 93% yield).  1H NMR [499.8 MHz, 
DMSO-d6]: d 6.75 (t, J = 5.0 Hz, 1H), 3.92 (dd, J = 4.0 Hz, J = 8.5 Hz, 1H), 3.00 (m, 2H), 
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1.77 (m, 1H), 1.56 (m, 1H), 1.36 (s, 9H); 13C NMR [125.7 MHz, DMSO-d6]: d 175.6, 
155.5, 77.4, 67.8, 36.7, 34.1, 28.2; HRMS (MM: ESI–APCI) calcd for C9H17NO5 [M+Na]
+ 
242.0999, found 242.0998; [a]22D +4.12 (c = 0.5, MeOH).
Acknowledgements 
We are grateful to the National Institutes of Health for research support. We thank 
David M. Chenoweth for helpful discussions. Mass spectrometry analyses were performed 
in the Mass Spectrometry Facility of the Division of Chemistry and Chemical Engineering 
at the California Institute of Technology.
170
References
1. Dervan, P. B. Bioorg. Med. Chem. 2001.  9, 2215-2235.
2. Dervan, P. B.; Edelson, B. S. Curr. Opin. Struct. Biol. 2003.  13, 284-299.
3. Best, T. P.; Edelson, B. S.; Nickols, N. G.; Dervan, P. B. Proc. Natl. Acad. Sci. U. S. A.  
    2003.  100, 12063-12068.
4. Edelson, B. S.; Best, T. P.; Olenyuk, B.; Nickols, N. G.; Doss, R. M.; Foister, S.; 
    Heckel, A.; Dervan, P. B. Nucleic Acids Res. 2004.  32, 2802-2818.
5. Olenyuk, B. Z.; Zhang, G. J.; Klco, J. M.; Nickols, N. G.; Kaelin, W. G.; Dervan, P. B. 
    Proc. Natl. Acad. Sci. U. S. A. 2004.  101, 16768-16773.
6. Kageyama, Y.; Sugiyama, H.; Ayame, H.; Iwai, A.; Fujii, Y.; Huang, L. E.; Kizaka-
    Kondoh, S.; Hiraoka, M.; Kihara, K. Acta Oncol. 2006.  45, 317-324.
7. Fukuda, N.; Ueno, T.; Tahira, Y.; Ayame, H.; Zhang, W.; Bando, T.; Sugiyama, H.; 
    Saito, S.; Matsumoto, K.; Mugishima, H.; Serie, K. J. Am. Soc. Nephrol. 2006.  17, 
    422-432.
8. Nickols, N. G.; Jacobs, C. S.; Farkas, M. E.; Dervan, P. B. Nucleic Acids Res. 2007.  
    35, 363-370.
9. Nickols, N. G.; Jacobs, C. S.; Farkas, M. E.; Dervan, P. B. ACS Chem. Biol. 2007.  2, 
    561-571.
10. Matsuda, H.; Fukuda, N.; Yao, E. H.; Ueno, T.; Sugiyama, H.; Matsumoto, K. J. 
      Hypertens. 2008.  26, S197-S197.
11. Kielkopf, C. L.; Baird, E. E.; Dervan, P. D.; Rees, D. C. Nat. Struct. Biol. 1998.  5, 
      104-109.
12. White, S.; Szewczyk, J. W.; Turner, J. M.; Baird, E. E.; Dervan, P. B. Nature. 1998.  
      391, 468-471.
13. Pelton, J. G.; Wemmer, D. E. Proc. Natl. Acad. Sci. U. S. A.      1989.  86, 5723-5727.
14. Swalley, S. E.; Baird, E. E.; Dervan, P. B.; J. Am. Chem. Soc. 1999.  121, 1113-1120.
 
15. Mrksich, M.; Parks, M. E.; Dervan, P. B. J. Am. Chem. Soc. 1994.  116, 7983-7988.
16. Herman, D. M.; Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc.  1998.  120, 1382-1391.
171
17. Zhang, W.; Minoshima, M.; Sugiyama, H. J. Am. Chem. Soc.  2006.  128, 14905-
      14912.
18. Farkas, M. E.; Tsai, S. M.; Dervan, P. B. Bioorg. Med. Chem. 2007.  15, 6927-6936.
19. Gellman, S. H.; Adams, B. R.; Dado, G. P. J. Am. Chem. Soc. 1990.  112, 460-461.
20. Appella, D. H.; Christianson, L. A.; Klein, D. A.; Powell, D. R.; Huang, X. L.; Barchi, 
      J. J.; Gellman, S. H. Nature. 1997.  387, 381-384.
21. Gellman, S. H. Accounts Chem. Res. 1998.  31, 173-180.
22. Hsu, C. F.; Phillips, J. W.; Trauger, J. W.; Farkas, M. E.; Belitsky, J. M.; Heckel, A.; 
      Olenyuk, B. Z.; Puckett, J. W., Wang, C. C. C.; Dervan, P. B. Tetrahedron 2007.  63, 
      6146-6151.
23. Dose, C.; Farkas, M. E.; Chenoweth, D. M.; Dervan, P. B. J. Am. Chem. Soc. 2008.  
      130, 6859-6866.
24. Brenowitz, M.; Senear, D. F.; Shea, M. A.; Ackers, G. K. Method Enzymol. 1986.  
      130, 132-181.
25. Senear, D. F.; Dalmaweiszhausz, D. D.; Brenowitz, M. Electrophoresis. 1993.  14, 
      704-712.
26. Trauger, J. W.; Dervan, P. B. Meth. Enzymol. 2001.  340, 450-466.
27. Pilch, D. S.; Poklar, N.; Gelfand, C. A.; Law, S. M.; Breslauer, K. J.; Baird, E. E.; 
      Dervan, P. B. Proc. Natl. Acad. Sci. U. S. A. 1996.  93, 8306-8311.
28. Pilch, D. S.; Poklar, N.; Baird, E. E.; Dervan, P. B.; Breslauer, K. J. Biochemistry. 
      1999.  38, 2143-2151.
29. Trauger, J. W.; Baird, E. E.; Dervan, P. B. Nature. 1996.  382, 559-561.
30. Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc.  1996.  118, 6141-6146.
31. Busby, G. W. Ph.D. Thesis, Harvard University. 1974. 48-54.
32. Hoshi, H.; Aburaki, S.; Iimura, S.; Yamasaki, T.; Naito, T.; Kawaguchi, H. J. Antibiot. 
      1990.  43, 858-872.
172
Appendix
Exploration of Methods for Genome-wide Analysis
of Polyamide Binding
Several experiments in this chapter used polyamides synthesized by Vadim Baidin and 
Daniel A. Harki (California Institute of Technology).
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Abstract
 Pyrrole-imidazole polyamides targeted to bind promoter sequences of DNA have 
been used to modulate gene expression by preventing the binding of transcriptional 
activators.  We would like to be able to determine the genome-wide binding of polyamides 
in the context of chromatin in vivo.  To this end, we have synthesized polyamide-biotin 
conjugates to pull down DNA-polyamide complexes using streptavidin beads.  Polyamides 
targeting the sequence 5’-WGWWCW-3’ located within the androgen response element 
(ARE) have been shown to down-regulate androgen responsive genes.  We have used RT-
PCR as a surrogate assay for cellular uptake of biotin-polyamides targeted to the ARE, 
and shown that our compounds are able to bind DNA and recruit streptavidin in vitro. 
We have also conducted experiments where chromatin from polyamide-treated cells has 
been harvested, sheared, and pulled-down with streptavidin beads.  The amplification of 
androgen responsive genes and loci containing multiple polyamide match sites has been 
measured using RT-PCR.  It is likely that the currently used method of shearing DNA results 
in polyamide displacement and subsequent re-equilibration.  Future efforts may involve 
redesign of the polyamide to include a moiety capable of cross-linking to DNA in order to 
prevent this.  The methods described herein should be applicable to these endeavors. 
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Introduction
 The androgen receptor (AR) is a member of the ligand-activated nuclear receptor 
family of transcription factors.1  Ligand binding to AR initiates its release from the 
cytoplasm followed by dimerization and binding to androgen response elements (ARE) 
of target genes, which results in gene activation through interaction with co-activators 
and the general transcription machinery.2  Functional AREs have the consensus sequence 
5’-GGTACAnnnTGTTCT-3’.3  Work in the Dervan laboratory has previously shown that 
a polyamide designed to target the sequence 5’-WGWWCW-3’, found in the consensus 
ARE, is cell-permeable, binds the ARE in the prostate specific antigen (PSA) promoter, and 
inhibits the expression of PSA and other androgen responsive genes in cultured prostate 
cancer cells (Figure A.1).  A control polyamide targeted to the sequence 5’-WGWCGW-3’ 
had little effect.  Chromatin immunoprecipitation (ChIP) has shown that match polyamide 
treatment results in reduced AR occupancy at the PSA promoter and enhancer.4 
 Polyamide binding has previously been studied in several in vitro contexts.  DNase 
I footprinting titrations on designed DNA fragments roughly 100 base pairs in size enable 
the determination of equilibrium association constants and allow for limited exploration 
of specificities.5,6  The more recently developed cognate site identifier (CSI) microarray 
platform, which presents 32,896 unique eight-mers, allows for an unbiased interrogation 
of polyamide binding preferences.7,8  We now wish to determine genome-wide profiles for 
polyamide binding in vivo by precipitation of complexes followed by DNA sequencing.  
 ChIP is a standard method by which the associations of proteins with DNA are 
determined.9  Typically, living cells are treated with formaldehyde in order to crosslink 
proteins to DNA, and then the chromatin is fragmented by sonication.  The resulting input 
sample is immunoprecipitated with an antibody that specifically recognizes a protein 
of interest; this enriches DNA sequences that associate with the protein in vivo.  The 
immunoprecipitation efficiency (IE) for an experiment is the amount of DNA in the IP 
sample divided by the amount of DNA in the input sample.  IP efficiencies for protein-
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Figure A.1. Polyamides targeting the androgen response element.  (A) Schematic diagram of the androgen 
receptor complex (top), and ball-and-stick models of polyamide A shown targeting the consensus ARE se-
quence (bottom).  (B) Match polyamide A results in a decrease in PSA mRNA, while control polyamide B 
shows little effect following treatment in cell culture.  No polyamide control samples are shown in black. (C) 
Chemical structures and ball-and-stick models of polyamides A (left) and B (right).4
bound regions are higher than for controls, and the relative level of protein binding is 
described as the fold enrichment over control. 
   The sensitivity of a ChIP experiment depends on the ability to separate protein-
bound fragments of DNA from the unbound fragment background.  For this reason, the 
quality of the antibody is a critical factor.  Additionally, a significant concern is the non-
specific association of the protein with DNA captured by crosslinking.  It has been shown 
that extensive fragmentation of chromatin significantly increases fold enrichments of 
protein binding sites in ChIP experiments.10
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  When individual regions are analyzed, amounts of DNA present are typically 
determined by quantitative PCR in real time (RT-PCR).  The resulting material can be 
analyzed on microarrays,11 or via high throughput DNA sequencing.12  ChIP followed by 
direct ultra high-throughput DNA sequencing of the immunoprecipitated sample (ChIP-
Seq) enables binding events to be resolved at 25 base pair resolution and requires no prior 
knowledge of sequence content. 
 The affinity of biotin for streptavidin is one of the most stable interactions in biology, 
with Kd = 10
-15.13  Streptavidin-coated magnetic particles provide for efficient binding and 
separation of biotinylated compounds, and have been widely used for the purification of 
proteins and nucleic acids.14,15  By utilizing polyamide-biotin conjugates, we plan to pull 
down polyamide-bound chromatin using streptavidin beads (Figure A.2).  We use the 
polyamide scaffold shown to affect androgen responsive genes in prostate cancer cells as 
a platform upon which to base these experiments.  Procedures common to ChIP serve as 
a starting-point for the pull-down of polyamides.  The work described here includes the 
synthesis and screening of polyamides by RT-PCR, electrophoretic mobility shift assays 
(EMSA) to determine polyamides’ abilities to recruit streptavidin, and experiments where 
chromatin from polyamide-dosed cells was harvested, sheared, pulled down, and analyzed 
for gene amplification by RT-PCR.     
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Figure A.2. Illustration of chromatin immunoprecipitation versus pull-down with polyamide-biotin con-
jugates.  Major steps for ChIP are shown with double blue circles representing one protein type, and red 
hexagons indicating another, green ‘Y’ shapes indicate red-hexagon-specific antibodies (left).  Major steps 
for polyamide pull-down are shown with red hexagons indicating polyamide, yellow circles indicating biotin, 
green pentagons represent streptavidin, and grey circles represent magnetic beads (right).   
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Results and Discussion
Polyamides conjugated to biotin at the turn unit
 Early efforts to establish biotin-polyamide conjugates as cell-permeable molecules 
resulted in compounds with minimal effects on gene expression.16  These compounds 
contained a biotin moiety at the tail position and targeted the hypoxia response element 
(HRE, 5’-TACGTG-3’).  The presence of an isophthalic acid (IPA) moiety in the tail region 
has been shown to yield high affinity conjugates with improved nuclear permeability.16 
Subsequently, a series of polyamides targeting the androgen response element (ARE, 5’-
WGWWCW-3’) were synthesized (Figure A.3).  Polyamides 1-3 contain IPA at the tail 
position, and biotin appended to the turn unit via various linkers.  
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Figure A.3. Structures of polyamides linked to biotin at the turn subunit.  Chemical and ball-and-stick struc-
tures of polyamides 1-3 are shown.  Ball-and-stick representations are as follows: an open circle is pyrrole, 
a closed circle is imidazole, ‘IPA’ within a hexagon is isopthalic acid, ‘B’ within a hexagon is biotin, a semi-
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 All three molecules were observed to down-regulate androgen responsive genes 
in LNCaP cells with 1 and 3 resulting in the greatest effects (Figure A.4).  However, both 
showed decreased binding to the PSA ARE sequence in comparison with polyamides 
containing acetylated amines at the turn unit (Table A.1).  Because hairpin polyamides 
linked by 3,4-diaminobutyric acid have been shown to possess improved binding affinities 
and tolerances for modification at the turn unit,17 analogues of 1 and 3 containing (R)-
3,4-diaminobutyric acid were prepared.  These molecules demonstrated no effect on gene 
expression (data not shown).  Similarly, an analogue of 1 was prepared using PAM resin, 
resulting in a β-alanine moiety in the tail portion of the polyamide.  This molecule showed 
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Figure A.4. Effects of polyamides 1-3 on the expression of androgen responsive genes.  LNCaP cells were 
treated with polyamides 1-3 at 0.5 µM and 2 µM concentrations.  The effects of these polyamides were 
compared to not induced (NI), induced (I), and A-Ac (the acetylated analogue of polyamide A) treatment 
conditions.  Expression levels for PSA (top, left), KLK2 (top, right), FKBP5 (bottom, left), and TMPRSS2 
(bottom, right) are shown.  DHT = dihydrotestosterone. 
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moderate effects on gene expression (data not shown).  The abilities of polyamides 1 and 
3 to access and bind streptavin while bound to DNA were evaluated by using EMSA.  A 
shift was not observed with either conjugate, leading us to believe that streptavidin was 
inaccessible for binding to the biotin moieties (data not shown).   
Polyamides conjugated to biotin at the tail unit
 Work in the Dervan lab showed that a polyamide-biotin conjugate was capable 
of binding to specific sequences in DNA nanostructures and recruiting streptavidin.  The 
molecule utilized possessed a polyethylene glycol (PEG) linked biotin moiety in the tail 
subunit of the polyamide, and was also shown to bind streptavidin via EMSA.18  This 
molecule served as inspiration for polyamides 4-9 (Figure A.5).  Polyamides 4-6 contain (R)-
2,4-diaminobutyric acid in the turn unit, whereas 7-9 contain (R)-3,4-diaminobutyric acid. 
In both series, molecules containing a free amine at the turn (4 and 7), acetylated amines at 
the turn (5 and 8), and IPA conjugated to the amine (6 and 9) were made.  Acetylation of the 
60.1 (±0.2)
Polyamides
74.9 (±0.1) 14.8C-Ac
59.8 (±0.2) 5.63
9.269.3 (±0.2) 1
70.1 (±0.2) 10.0A-Ac
DNA = 5’-TTGC AGAACA GCAA-3’
B
IPA
BIPA
NHAcIPA
NHAc
IPA
ΔTm / °CTm / °C
Table A.1.  Melting temperatures of DNA/polyamide complexes.  Polyamides 1 and 3 are compared 
against A-Ac and C-Ac (containing (R)-3,4-diaminobutyric acid in the turn subunit) in binding to a 14mer 
containing the PSA ARE sequence.  All values reported are derived from at least three melting temperature 
experiments with standard deviations indicated in parentheses. ΔTm values are given as Tm
(DNA/polyamide)- 
Tm
(DNA).
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Figure A.5. Structures of polyamides linked to biotin at the tail subunit.  Chemical and ball-and-stick struc-
tures of polyamides 4-6 (containing (R)-2,4-diaminobutyric acid in the turn unit (left), and 7-9 (containing 
(R)-3,4-diaminobutyric acid in the turn unit (right) are shown.  Ball-and-stick representations are as follows: 
an open circle is pyrrole, a closed circle is imidazole, ‘IPA’ within a hexagon is isopthalic acid, ‘B’ within a 
hexagon is biotin, a semi-circle represents the turn unit.
amine has previously been shown to improve cellular uptake of polyamides, and typically 
results in diminished binding affinities.  The presence of IPA in the tail unit also results in 
improved uptake, however, its conjugation to the turn unit and resulting effects on uptake 
and affinity had not been previously explored.
 Melting temperature analysis on the PSA ARE revealed that the polyamides 
containing (R)-3,4-diaminobutyric acid had a greater ability to bind DNA than the analogous 
molecules containing (R)-2,4-diaminobutyric acid (Table A.2).  Strikingly, the presence of 
the IPA moieties resulted in only a slight reduction in ΔTm’s compared to the acetylated 
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amines.  All six molecules were analyzed using RT-PCR (Figure A.6).  Polyamides 8 and 9 
resulted in the greatest effect on gene expression.  Subsequent EMSA analysis revealed that 
both were able to recruit streptavidin while bound to DNA (Figure A.7).  Because polyamide 
9 was shown to have slightly better activity in cell culture than 8, it was identified as the 
lead molecule.  Subsequent experiments demonstrated that polyamide 9 was also able to 
recruit streptavidin-bound magnetic beads while bound to radio-labeled DNA (data not 
shown).     
 
60.1 (±0.2)
Polyamides
DNA = 5’-TTGC AGAACA GCAA-3’
ΔTm / °CTm / °C
7.968.0 (±0.2) 6
B
IPA
76.4 (±0.3) 16.37
B
NH+3
74.9 (±0.1) 14.8C-Ac NHAcIPA
70.1 (±0.2) 10.0A-Ac
NHAcIPA
B
NH+3
13.273.3 (±0.3) 4
B
NHAc 8.568.6 (±0.1) 5
B
NHAc 72.4 (±0.1) 12.38
B
IPA 72.1 (±0.4) 12.09
Table A.2. Melting temperatures of DNA/polyamide complexes.  Polyamides 4-9 are compared alongside 
A-Ac and C-Ac in binding to a 14mer containing the PSA ARE sequence.  All values reported are derived 
from at least three melting temperature experiments with standard deviations indicated in parentheses. ΔTm 
values are given as Tm(DNA/polyamide)- Tm(DNA).
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Figure A.6. Effects of polyamides 4-9 on PSA expression.  LNCaP cells were treated with polyamides at 1 
µM and 5 µM concentrations.  The effects of these polyamides are compared with not induced (NI), induced 
(I), and C-Ac treatment conditions.  DHT = dihydrotestosterone.  Ball-and-stick models of polyamides are 
shown below.
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Figure A.7. Electrophilic mobility shift assay (EMSA) with polyamides 8 and 9.  Shown is a schematic 
diagram of the polyamide binding the PSA ARE promoter sequence.  Streptavidin is indicated by a black 
hexagon containing a removed wedge, and arrows indicate shift of radiolabeled DNA when streptavidin is 
and is not bound (left).  Polyamides are titrated from 300 pM to 1 µM, and DNA + PA (1 µM) and DNA only 
controls are shown for each gel shift assay (right).
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Polyamide pull-down of DNA
 Prior to pull-down experiments, polyamide 9 was synthesized on micro-molar scale 
in addition to polyamide 10, which targeted 5’-WGWCGW-3’ and was used as a mismatched 
control polyamide (Figure A.8).  As a preliminary pull-down experiment, polyamide 9 was 
equilibrated with cross-linked, sheared chromatin (150 or 15 µg) harvested from LNCaP 
cells, followed by addition of streptavidin coated magnetic beads.  The solution was mixed 
for 24 hours at 4 °C, and beads were removed from solution and washed.  The streptavidin-
biotin linkage and cross-links were reversed by heating, and the resulting DNA was 
purified prior to analysis via RT-PCR.  Interrogation of PSA ARE III and FKBP5 revealed 
polyamide concentration-dependant amplification of these loci (Figure A.9).  Samples not 
treated with polyamide had undetectable amplification.  
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Figure A.8. Structure of polyamide 10.  The chemical and ball-and-stick structures for control polyamide 10 
targeting 5’-WGWCGW-3’ are shown.  Ball-and-stick representations are as follows: an open circle is pyr-
role, a closed circle is imidazole, ‘IPA’ within a hexagon is isopthalic acid, ‘B’ within a hexagon is biotin, a 
semi-circle represents the turn unit.
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Figure A.9. Relative amplification levels of PSA ARE III and FKBP5 as determined by RT-PCR following 
polyamide incubation with sheared chromatin.  Polyamide 9 was incubated with 150 µg and 15 µg chro-
matin-bound protein at 5 µM, 1 µM, and 0.5 µM concentrations.  No amplification was detectable for non-
treated samples.  Samples have been normalized to the 0.5 µM/150 µg sample for each of the two loci. 
 Polyamides 9 and 10 were dosed in LNCaP cells at 5 µM concentration, the cells 
cross-linked and harvested, and the chromatin sheared by sonication as previously.  Samples 
were split into 1 mg chromatin aliquots and streptavidin beads were added.  The solutions 
were typically mixed for 24 hours at 4 °C, and beads were removed from solution and 
washed.  The streptavidin-biotin linkage and cross-links were reversed by heating, and the 
resulting DNA was purified prior to analysis via RT-PCR.  Interrogation of PSA ARE I, 
PSA ARE III, and FKBP5 loci showed that polyamide 9 resulted in greater amplification 
than untreated and 10-treated samples (Figure A.10).  Because of the promiscuity of 9 in 
binding to mismatched and reverse sites, no appropriate negative locus was found.  We 
also examined regions of DNA containing four repeats of the sequence 5’-WGWWCW-
3’ in chromosomes 11 and 12 (Figure A.11).  Relative levels of enhancement for samples 
treated with polyamide 9 versus untreated and 10 treated samples were not as significant.  A 
site in chromosome 15 containing four repeats of the sequence 5’-WGWCGW-3’ was also 
probed.  Although we expected enhancement for samples treated with 10 to increase in this 
instance, levels were uniformly low across all treatment conditions (data not shown).
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Figure A.10. Relative amplification levels of PSA ARE I, PSA ARE III, and FKBP5 following polyamide 
treatment in LNCaP cells.  Polyamides 9 and 10 were dosed in cells at 5 µM concentrations.  Cells were 
harvested, chromatin sheared via sonication, and each treatment condition was aliquoted into 1 mg chroma-
tin-bound protein per sample.  Each sample was incubated with 2 mg streptavidin beads.  Amplification is 
determined by RT-PCR; polyamide-treated samples were normalized to untreated control (NT).  
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Figure A.11. Relative amplification levels of loci containing 5’-WGWWCW-3’ repeats.  Sequences contain-
ing four repeats of the match polyamide site for 9 were interrogated.  One region was located in chromosome 
11 (left) and the other in chromosome 12 (right).  Polyamide-treated samples were normalized to untreated 
control (NT).  
 In order to improve selectivity of pull-down by preventing non-specific interactions, 
bovine serum albumin (BSA) was used as a blocking agent.  Prior to addition of streptavidin 
to samples, beads were washed with a solution of BSA in PBS.  Also, a small amount of BSA 
solution (100 µL) was added to each sample while mixing with streptavidin.  The resulting 
amplification levels did not differ significantly from those of previous experiments (data 
not shown). 
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Conclusion
To determine the genome-wide binding of polyamides in the context of chromatin 
in vivo, we have synthesized polyamide-biotin conjugates to pull down DNA-polyamide 
complexes using magnetic streptavidin beads.  We have shown that these molecules are 
cell-permeable and are able to bind and recruit streptavidin in vitro.  The chromatin from 
polyamide-treated cells has been harvested, sheared, and pulled-down with streptavidin 
beads, and the amplification of androgen responsive genes and loci containing multiple 
polyamide match sites has been measured using RT-PCR.  It is likely that the current 
method of shearing DNA by sonication results in polyamide displacement and subsequent 
re-equilibration.  Chemical or enzymatic types of shearing such as the use of micrococcal 
nuclease19 or methidiumpropyl-EDTA (MPE)20 could serve as alternative methods, however 
obstacles to the use of both exist.  Future efforts in this arena may involve redesign of the 
polyamide to include a moiety capable of cross-linking to DNA so that sonication may 
continue to be used without polyamide displacement.  
Materials and Methods
Polyamide Synthesis
 Anhydrous N,N-dimethylformamide (DMF), diisopropylethylamine (DIEA), 
trifluoroacetic acid (TFA), and trifluoromethylsulfonic acid (TFMSA) were purchased 
from Sigma-Aldrich.  Biotin and N-(+)-biotinyl-6-aminohexanoic acid were purchased 
from Sigma-Aldrich. 6-((6-((biotinoyl)amino)hexanoyl)amino)-hexanoic acid, 
sulfosuccinimidylester sodium salt (biotin xx) was purchased from Invitrogen.  EZ-Link 
TFP-PEG3-Biotin was purchased from Thermo Scientific.  Bulk grade solvents were from 
Fisher Scientific.  Preparative HPLC purification was performed on an Agilent 1200 Series 
instrument equipped with a Phenomenex Gemini preparative column (250 x 21.2 mm, 5 
µm) with the mobile phase consisting of a gradient of acetonitrile (MeCN) in 0.1% TFA 
188
(aqueous). Matrix-assisted, laser desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) was performed on an Applied Biosystems Voyager DE-Pro spectrometer 
using α-cyano-4-hydroxycinnamic acid as matrix. 
 Polyamides were generated on solid phase and in solution using previously 
established methods.21,22  PEG-Biotin compounds were generated as follows: a solution 
of polyamide (8 µmol) and Tfp-PEG3-Biotin (19.4 mg, 27.9 µmol) in DIEA (5.6 µL, 32.1 
µmoles) and DMF (200 µL) was allowed to stand at 23 °C for 1 h.  The reaction was diluted 
with aqueous TFA (0.1%, 8 mL) and the crude reaction products were isolated by solid-
phase extraction on a Waters C-18 Sep-Pak cartridge (10 g sorbent).  The preactivated 
column (MeCN; followed by aqueous TFA) was loaded with the crude reaction material. 
The column was washed with aqueous TFA (0.1%, 50 mL) and the reaction products were 
eluted with MeCN (50 mL), followed by MeOH (25 mL), and concentrated in vacuo. 
The material was solubilized again with a minimal amount of MeCN, diluted with excess 
aqueous TFA (0.1%), frozen, and lyophilized to dryness. The benzyl carbamate (Cbz) 
protecting group was cleaved as previously described.17  A solution of isopthalic acid (81.8 
mg, 0.49 mmol) and PyBOP (133.1 mg, 0.26 mmol) in DIEA (428 µL, 2.46 mmol) and 
DMF (800 µL) was shaken at 40 °C for 10 min.  Separately, the polyamide-biotin conjugate 
(1.87 µL) was dissolved in DMF (500 µL). An aliquot (200 µL) of the PyBOP-activated 
isopthalic acid was added to the polyamide solution, which was allowed to stand at 23 °C 
for 30 min.  The reaction was then diluted with a solution of MeCN in aqueous TFA (20% 
MeCN in 0.1% TFA, 7 mL) and purified via prep-HPLC. 
Polyamide 1: MALDI-TOF C74H89N25O14S calculated [M+H]+: 1584.73, found: 1584.60.
Polyamide 2: MALDI-TOF C80H100N26O15S calculated [M+H]+: 1697.88, found: 1697.83.
Polyamide 3: MALDI-TOF C87H112N26O16S calculated [M+H]+: 1810.66, found: 1810.92.
Polyamide 4: MALDI-TOF C81H113N26O16S calculated [M+H]+: 1737.85, found: 1737.55.
Polyamide 5: MALDI-TOF C83H115N26O17S calculated [M+H]+: 1779.86, found: 1780.82.
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Polyamide 6: MALDI-TOF C89H116N26O19 S calculated [M+H]+: 1885.10, found: 1886.78.
Polyamide 7: MALDI-TOF C81H113N26O16 S calculated [M+H]+: 1737.85, found: 1737.50.
Polyamide 8: MALDI-TOF C83H115N26O17S calculated [M+H]+: 1779.86, found: 1779.81.
Polyamide 9:  MALDI-TOF C89H116N26O19S calculated [M+H]+: 1886.10, found: 1886.64.
Polyamide 10: MALDI-TOF C88H115N27O19S calculated [M+H]+: 1887.09, found: 1887.01.
Measurement of androgen-induced mRNA
 LNCaP cells were obtained from the ATCC and maintained in RPMI 1640 
media supplemented with 10%  fetal bovine serum (FBS), L-glutamine, and penicillin/ 
streptomycin.  RT-PCR experiments were performed and primers used as previously 
described.4
Melting temperature analysis
 Melting temperature analysis of polyamides was performed on the indicated DNA 
duplexes as previously described on a Varian Cary 100 spectrophotometer equipped with a 
thermo-controlled cell holder, using 10 mM sodium cacodylate buffer.17
EMSA assay for streptavidin recruitment
60 pmol of DNA strands (1: 5’-GCATTGCAGAACAGCAAGTGCTAGCT-
CTCCC-3’ and 2: 5’-GGGAGAGCTAGCACTTGCTGTTCTGCAATGC-3’) were 
annealed by heating to 95 °C for 10 min and allowing them to cool slowly to room 
temperature over several hours.  The strands were then radio-labeled at the 5’ ends using 
polynucleotide kinase (Roche).  Labeled DNA (3,000 cpm/lane) was then incubated with 
polyamide at the indicated concentrations for 2 h in TAEMg buffer followed by addition of 
streptavidin (10 µM, Rockland) for 30 min.  The total volume for each reaction was 20 µL. 
Running buffer (1 µL) was added to 9 µL of each reaction, and run on a 6% polyacrylamide 
gel and imaged using a Typhoon 8600 phosphorimager. 
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Polyamide/DNA pull-down with streptavidin beads
 Approximately 90% confluent LNCaP cells grown in 175 cm2 Falcon flasks were 
trypsinized by decanting the RPMI media, rinsing with PBS, and adding 5 mL trypsin. 
Following 15 min incubation, cells were diluted with 10 mL fresh RPMI, the flasks rinsed, 
and solution collected in a 15 mL conical tube.  Cells were pelleted by centrifuging for 5 min 
at 25 °C, 125 RCF.  The media was decanted, and 6 mL fresh media was added.  The cells 
were pipetted up and down, and then diluted 1:10 in media for counting by hemocytometer. 
The concentration of the cells was adjusted to 2 million cells/mL.  24 mL of RPMI media 
was added to each 15-cm cell culture plate, followed by 1 mL of cells.  After cells were 
added to plates, cells were dispersed by sliding in a vertical/horizontal motion.  Cell culture 
plates were placed in the 37 °C incubator containing 5% CO2 and were allowed to grow 
for 72 h.  After 72 h, media from cell culture plates was decanted and replaced with 25 mL 
RPMI 1640 supplemented with 10% charcoal stripped FBS.  Where indicated, polyamides 
were added in DMSO, for a total percentage of 0.1%.  For each experiment five plates of 
each condition (polyamide- or un-treated) were generated.  Plates were returned to 37 °C, 
and cells were allowed to grow for 64 h.   
 In order to fix cells, media was decanted from the plates and each was washed with 
~15 mL PBS (warmed to 37 °C) prior to addition of 20 mL 1% formaldehyde in PBS. 
Plates were rocked for 10 min at room temperature, followed by addition of 1 mL 2.5 M 
glycine (0.125 M final concentration) and rocking for 5 min.  The media was then decanted 
from plates, which were then washed with ~15 mL cold PBS (4 °C).  Scraping solution 
(generated fresh) consists of 250 µL PMSF solution (100 mM in isopropyl alcohol) in 50 
mL cold PBS.  2 mL scraping solution was added per plate, and cells were removed from 
plates with a razor blade and transferred via pipetting to a Falcon tube in an ice-water bath 
(4 °C).  Cells were then pelleted by centrifugation for 5 min at 2000 RPM.  Liquid was 
decanted, and cells were flash frozen in liquid nitrogen and stored at -80 °C.
 Prior to sonication, prepared Farnham lysis buffer (FLB) and radio 
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immunoprecipitation assay (RIPA) buffer freshly.  FLB: 5 mL 100 mM PIPES (pH 8.0), 
10 mL 850 mM KCl, 5 mL 10% NP-40, 100 mL in Millipore water.  Then added protease 
inhibitor cocktail (PIC, Roche, 2 x 50 mL tables), and sonicated to dissolve.  RIPA: 10 
mL 10x PBS, 10 mL 10% NP-40, 500 mg sodium deoxycholate, 1 mL 10% SDS 100 mL 
in Millipore water.  Sonicated to dissolve.  Resuspended cell pellets in 6 mL FLB each, 
and centrifuged cells for 5 min at 2000 RPM, 4 °C.  To 10 mL of RIPA, added mini-PIC 
(Roche, one 10 mL tablet). Decanted supernatant and added 1 mL RIPA (containing PIC) 
to each pellet.  Pipetted up and down to mix, and transferred to 1.7 mL eppendorf tube.  
 At 4 °C (in cold room) sonicated on -80 °C EtOH bath (50 mL falcon tube with 
EtOH stored on dry ice), 5 times 30 s at 25% amplitude.  Cycled through sample tubes, 
switching EtOH bath with each sample, 6 times (each sample sonicated 30 times 30 s 
total).  Between each sample sonicated with PBS for 30 s (once) to rinse.  Then centrifuged 
sheared solutions at 14,000 RPM for 12 min at 4 °C, and transferred supernatant to a new 
Eppendorf tube; discarded pellet.  Immediately performed Bradford assay to determine 
protein concentration using Cary UV-Vis and incubation with streptavidin beads.
 For each sample to be measured, made 1:10 dilution in RIPA, and added 10 µL to 
90 µL 0.15 M NaCl in disposable clear plastic cuvettes.  For blank sample added 10 µL 
RIPA, 90 µL 0.15 M NaCl.  For the standard curve used 2.0 mg/mL BSA, 1.5 mg/mL BSA, 
1.0 mg/mL BSA, 0.75 mg/mL BSA, 0.5 mg/mL BSA (Biorad).  Added 10 µL respective 
standard, 10 µL RIPA, and 80 µL 0.l5 M NaCl.  Once each cuvette has been prepared, 
added 1 mL 1x Bradford reagent (Biorad) to each tube in the order they are to be analyzed 
(including blank).  Let samples sit 5-10 min at room temperature and analyzed via UV-Vis 
by reading at 595 nm.  Measured the standards prior to samples.  Generated standard curve, 
and interpolated concentrations of samples.  Aliquotted samples such that 1 mg protein is 
present per tube.
 For experiments where chromatin was treated with polyamides following shearing, 
polyamides were added at appropriate concentrations in DMSO, and allowed to equilibrate 
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for 12-24 h at room temperature.  Then proceeded to streptavidin incubation step.  Where 
polyamides were added in cell culture, proceeded to streptavidin incubation immediately. 
Some material (~ 50 µL) was saved for input DNA sample for RT-PCR.  
 For experiments where binding and washing (B&W) buffer was used, prepared 
buffer (2x) as follows: 10 mM Tris-HCl (pH 7.5), 1 mM EDTA, 2 M NaCl.  Streptavidin 
beads (dynabeads, Invitrogen) were resuspended by vortexing in the original container.  The 
appropriate amounts of beads (10 mg/mL) were pipetted into eppendorf tubes, and placed 
on the magnet for 1-2 min.  Supernatant was removed by pipetting, and B&W buffer (twice 
the volume of beads originally removed) was added.  The samples were vortexed, spun at 
13,000 RPM for 30 s, and returned to magnet for 1-2 min.  Washed 3 times.  Following 
final removal of wash buffer, added chromatin sample to beads.  If dilution is required 
(optimal concentration for beads is 5  µg/µL), RIPA was used to obtain appropriate volume. 
Samples were incubated with beads for 24 h at 4 °C on end-over-end rotator.  
 For experiments where BSA was used as a blocking agent for streptavidin beads, 
prepared as follows (omitted washes with B&W buffer).  Resuspended streptavidin beads 
by vortexing in original container.  Pipetted appropriate amounts of beads (10 mg/mL) into 
eppendorf tubes, and placed on magnet for 1-2 min.  Removed supernatant by pipetting, 
and added 1 mL freshly prepared BSA solution (Amresco, 5 mg/mL in PBS).  Mixed on 
end-over-end rotator for 10 min, and place on magnet for 2 min.  Removed supernatant, 
and repeated wash two more times.  Incubated samples with beads and 100 µL BSA for 
24 h (or less where indicated) at 4 °C on end-over-end rotator.  If dilution was required to 
reach appropriate concentration, used RIPA to obtain desired volume.
 Following incubation with streptavidin beads, eppendorf tubes were centrifuged 
briefly and placed on magnet for 3 min.  Then liquid was decanted from the tube and pellet 
washed 5 times with 1 mL LiCl wash buffer (10 mL Tris (pH not adjusted, stored at -20 °C), 
10 mL LiCl, 10 mL 1% NP-40, 1g sodium deoxycholate, diluted to 100 mL with Millipore 
water).  After each addition of wash buffer, placed samples on end-over-end rotator for 
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3 min, centrifuged, and placed on magnet for 2 min.  Once final wash was completed, 
decanted all liquid from tube and washed beads once with 1 mL Tris-EDTA buffer (TE; 1 
mL Tris-HCl pH 8.0, 0.2 mL 0.5 M EDTA pH 8.0, 998.8 mL Millipore water) by placing 
on end-over-end rotator for 3 min, centrifuging, and placing samples on magnet for 2 min. 
All liquid from tubes was decanted, and then resuspended beads in 200 µL IP Elution 
buffer (1 mL 0.1 M sodium bicarbonate, 1 mL 1% SDS, 8 mL Millipore water).  Eluted 
complexes by incubating tubes on the heated shaker at 65 °C for 1 h, vortexing every 15 
min to resuspend beads.  Centrifuged samples, then placed them on magnet for 2 min and 
removed supernatant as the IP.  Added 150 µL IP elution buffer to input DNA sample. 
Cross-links were reversed by transferring all samples to O-ring screw-cap microcentrifuge 
tubes at 65 °C for ~16 h. 
 To purify DNA samples for RT-PCR, extracted once with 200 µL phenol/CHCl3/
isoamyl alcohol, vortexed for 3 s, and centrifuged at 14,000 RPM for 3 min.  Transferred 
aqueous phase (top) to a new 1.7 mL eppendorf tube, and back extracted organic phase once 
with 100 µL elution buffer, pooling both aqueous phases (back extraction is unnecessary 
for input DNA).  Used Qiagen PCR Cleanup Kit (Qiagen) for following steps.  Added three 
volumes of Qiagen Buffer PM, and transferred solution to Qiagen spin columns in two 
portions (spin for 30 s at 14,000 RPM and decanted flow-through before adding second 
half).  Washed columns with 750 µL Qiagen Buffer PE, spin 30 s, and discarded flow-
through.  Changed collection tube, and spun for 1 min at 14,000 RPM to dry column. 
Eluted DNA from column by adding 100 µL Qiagen Buffer EB (warmed to 55 °C) to IP 
samples, centrifuging for 30 s at 14,000 RPM, and running eluate through column again 
for second elution.  Added 200 µL to input DNA column, and centrifuge for 30 s at 14,000 
RPM.  
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RT-PCR of pulled-down DNA
 Each sample for RT-PCR was run in technical quadruplicate.  A single PCR reaction 
consisted of 5 µL template DNA and 15 µL primer and Roche FastStart Universal SYBR 
Green Master (Rox).  The primer/SYBR green solution was prepared as follows: 10.8 
µL of 100 µM forward and 10.8 µL of 100 µM reverse primers were added to 580 µL 
DEPC-treated water (USB), and the primer solution was added to SYBR green in a 1:2 
ratio.  A standard curve was run for each set of primers using the input DNA sample from 
each particular experiment performed.  If multiple plates were used with a single primer 
pair, the standard curve was repeated on each plate.  The standard curve consisted of wells 
containing 50 ng, 5 ng, 500 pg, and 50 pg input DNA as determined by NanoDrop UV/Vis. 
Dilutions were prepared in DEPC-treated water.  RT-PCR was performed on an ABI 7300. 
Primers used were as follows:
PSA ARE I: 5’-TGCATCCAGGGTGATCTAGT-3’ (forward);  5’-ACCCAGAGCTGTG-
GAAGG-3’ (reverse)
PSA ARE III: 5-‘GGATTGAAAACAGACCTACTCTGG-3’ (forward); 5’-CAACAG-
ATTTGTTTACTGTCAAGGA-3’ (reverse)
FKBP5: 5’-AGCAATTTTGTTTTGAAGAGCA-3’ (forward); 5’-CTGTCAGCACATC-
GAGTTCA-3’ (reverse)
Negative:  5’-AAAGACAACAGTCCTGGAAACA-3’ (forward); 5’-AAAAATTGCTC-
ATTGGAGACC-3’ (reverse)
GWWC-4x-Chr 11 (25063064-25063594): 5’-CTTTTCATGTGCAGTGTTTGG-3’ 
(forward); 5’- CGTTTTATCAGGAAGCGTGA-3’ (reverse)
GWWC-4x-Chr 12 (32538523-32539055): 5’-TTGCTGTGCAGTAATACCTAAA-3’ 
(forward); 5’- TCCTCCATCACATCCAATCA-3’ (reverse)
GWCG-4x-Chr 15 (99507897-99508423): 5’-TGAACCCCAAAACAACAAC-3’ 
(forward); 5’-ACTCACTGGGGAGGAAGTAT-3’ (reverse)
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Primers for 5’-GWWC-3’ and 5’-GWCG-3’ repeats were designed using primer3 software 
(v.0.4.0)23 for sites found using Python script software developed by James Puckett to 
search the human genome using Fuzznuc.24
References
1. Tsai, M. J.; Omalley, B. W. Annu. Rev. Biochem. 1994.  63, 451-486.
2. Tyagi, R. K.; Lavrovsky, Y.; Ahn, S. C.; Song, C. S.; Chatterjee, B.; Roy, A. K. Mol. 
     Endocrinol. 2000.  14, 1162-1174.
3. Roche, P. J.; Hoare, S. A.; Parker, M. G. Mol. Endocrinol. 1992.  6, 2229-2235.
4. Nickols, N. G.; Dervan, P. B. Proc. Natl. Acad. Sci. U. S. A. 2007.  104, 10418-10423.
5. Trauger, J. W.; Dervan, P. B. Meth. Enzymol. 2001.  340, 450-466.
6. Hsu, C. F.; Phillips, J. W.; Trauger, J. W.; Farkas, M. E.; Belitsky, J. M.; Heckel, A.; 
    Olenyuk, B.; Puckett, J. W.; Wang, C. C.; Dervan, P. B. Tetrahedron. 2007.  63, 6146- 
    6151.
7. Warren, C. L.; Kratochvil, N. C. S.; Hauschild, K. E.; Foister, S.; Brezinski, M. L.; 
    Dervan, P. B.; Phillips, G. N.; Ansari, A. Z. Proc. Natl. Acad. Sci. U. S. A. 2006.  103, 
    867-872.
8. Puckett, J. W.; Muzikar, K. A.; Tietjen, J.; Warren, C. L.; Ansari, A. Z.; Dervan, P. B. J. 
    Am. Chem. Soc. 2007.  129, 12310-12319.
9. Aparicio, O. M.; Geisberg, J. V.; Sekinger, E. A.; Yang, A.; Moqtaderi, Z.; Struhl, K. 
    Curr. Protoc. Mol. Biol. 2005.  69, 21.23.21-21.23.17.
10. Fan, X. C.; Lamarre-Vincent, N.; Wang, Q.; Struhl, K. Nucleic Acids Res. 2008.  36, 
      e125.
11. Buck, M. J.; Lieb, J. D. Genomics. 2004.  83, 349-360.
12. Johnson, D. S.; Mortazavi, A.; Myers, R. M.; Wold, B. Science. 2007.  316, 1497-
      1502.
196
13. Wilchek, M.; Bayer, E. A. Anal. Biochem. 1988.  171, 1-32.
14. de Boer, E.; Rodriguez, P.; Bonte, E.; Krijgsveld, J.; Katsantoni, E.; Heck, A.;  
      Grosveld, F.; Strouboulis, J. Proc. Natl. Acad. Sci. U. S. A.      2003.  100, 7480-7485.
15. Dejardin, J.; Kingston, R. E. Cell. 2009.  136, 175-186.
16. Nickols, N. G.; Jacobs, C. S.; Farkas, M. E.; Dervan, P. B. Nucleic Acids Res. 2007.  
      35, 363-370.
17. Dose, C.; Farkas, M. E.; Chenoweth, D. M.; Dervan, P. B. J. Am. Chem. Soc. 2008.  
      130, 6859-6866.
18. Cohen, J. D.; Sadowski, J. P.; Dervan, P. B. Angew. Chem.-Int. Edit. 2007.  46, 7956-
      7959.
19. Horz, W.; Altenburger, W. Nucleic Acids Res. 1981.  9, 2643-2658.
20. Hertzberg, R. P.; Dervan, P. B. Biochemistry. 1984.  23, 3934-3945.
21. Belitsky, J. M.; Nguyen, D. H.; Wurtz, N. R.; Dervan, P. B. Bioorg. Med. Chem. 2002. 
      10, 2767-2774.
22. Chenoweth, D. M.; Harki, D. A.; Dervan, P. B. J. Am. Chem. Soc.  2009.  131, 7175-
       7181.
23. Rozen, S.; Skaletsky, H. J. 2000. Bioinformatics Methods and Protocols: Methods in 
      Molecular Biology, 365-386.
24. Rice, P.; Longden, I.; Bleasby, A. Trends Genet. 2000.  16, 276-277.
